The role of prophages in Pseudomonas aeruginosa by Davies, Emily
The role of prophages in Pseudomonas aeruginosa 
Thesis submitted in accordance with the requirements of the University 
of Liverpool for the degree of Doctor in Philosophy 
 by 









To Gran, the kindest and wisest woman I have ever known. 




Pseudomonas aeruginosa is a common opportunistic respiratory pathogen of individuals 
with cystic fibrosis (CF), capable of establishing chronic infections in which the bacterial 
population undergoes extensive phenotypic and genetic diversification. The Liverpool 
Epidemic Strain (LES) is a widespread hypervirulent and transmissible strain that is capable 
of superinfection and is linked to increased morbidity and mortality, relative to other P. 
aeruginosa strains. The LES has six prophages (LESφ1-6) within its genome, of which three 
are essential to the competitiveness of this strain. Temperate bacteriophages are incredibly 
common in bacterial pathogens and can contribute to bacterial fitness and virulence through 
the carriage of additional genes or modification of existing bacterial genes, lysis of 
competitors, or by conferring resistance to phage superinfection. Furthermore, the LES 
phages are detected at high levels in the CF lungs and have been implicated in controlling 
bacterial densities. The aims of this study were to (i) further characterise the LES phages and 
their induction, (ii) determine the extent to which the LES phages contribute to bacterial 
phenotypic and (iii) genetic diversification and (iv) determine how the LES phages affect 
host competitiveness, using a variety of in vitro and in vivo infection models. 
LES phages are continuously produced by spontaneous lysis and this study found that 
environmental factors that are common to the CF lung, such as oxidative stress, 
pharmaceutical chelating agents and antibiotics, can alter phage production by clinical LES 
isolates. Characterisation of the phages highlighted differences between the phages with 
regards to their lytic cycles and ability to propagate in different environments.  
P. aeruginosa undergoes extensive phenotypic diversification in an artificial sputum
model (ASM) of infection, similar to that observed in chronic CF infections. 
Hypermutability, loss of motility and auxotrophy were phenotypes observed in bacteria 
evolved for approximately 240 bacterial generations in ASM in the presence and absence of 
the LES phages. However, the LES phages accelerated this process; loss of twitching 
motility occured earlier in populations evolved in the presence of phages. Sequencing of 
evolved populations revealed a high level of genetic diversification, with genes involved in 
motility, quorum sensing and genetic regulation experiencing loss of function mutations in 
parallel populations. In phage treated populations, LESφ4 had disruptively integrated into 
motility and quorum sensing genes, suggesting that temperate phages can provide an 
alternative (and quicker) route to adaptation. 
LES prophage carriage is important for bacterial competitiveness; PAO1 LES Phage 
Lysogens (PLPLs) successfully invaded a phage-susceptible population in vitro from when 
initially rare. Strain invasiveness was dependent on the LES prophage; LESφ4 lysogens were 
more invasive than PLPLφ2 or PLPLφ3, whereas carriage of all three prophages accelerated 
bacterial invasion. PLPLφtriple could also invade a susceptible competitor population in a 
rat model of chronic lung infection, although not as successfully as in vitro. These data 
suggest that prophage carriage is important for LES competitiveness and that phage-
mediated lysis of phage-susceptible competitors may explain why LES is adept at 
superinfection.  
The study indicates that the LES phages are important drivers of bacterial 
diversification and evolution and confer a competitive advantage to their bacterial host. This 
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Chapter 1  General Introduction 
1.1 Microbial infections in cystic fibrosis 
1.1.1 Cystic Fibrosis (CF) 
Cystic fibrosis (CF) is a genetic disorder caused by mutations in the gene encoding 
for the cystic fibrosis transmembrane conductance regulator (CFTR), an ion channel 
protein that is required for chloride ion transport across epithelial cell membranes.  
To date, nearly 2000 mutations have been identified in the CFTR gene (Consortium, 
2011), and the majority of these have been linked to CF, with disease severity 
dependent on the type of mutation (Riordan et al., 1989). Defective or absent CFTR 
proteins cause an ionic imbalance, which results in the production of abnormally 
thick, sticky mucus. This has pathological effects on multiple organs throughout the 
body, including the pancreas and digestive system, endocrine and reproductive 
systems.  
However, it is the respiratory system that is most affected; individuals are prone to 
bacterial infections, and whilst there is an immune response, it does not result in 
successful clearance, leading to chronic inflammation and lung damage. 
Inflammation is associated with reduced pulmonary function (Sagel et al., 2002) and 
thought to be predictive of structural lung disease (Mott et al., 2012). 
 It is still not completely understood why individuals with CF are initially so 
susceptible to bacterial infections, but contributory factors include decreased 
mucociliary clearance (Zahm et al., 1997) and the abnormal composition of airway 
secretions. High liquid surface absorption of CF sputa causes depletion of the 
lubricating periciliary liquid layer (a component of airway surface liquid), and this 
prevents mucus transport and subsequent bacterial clearance (Matsui et al., 1998). 
Furthermore, the viscosity of CF mucus impairs neutrophil chemotaxis and 
functionality (Matsui et al., 2005), and the pH imbalance resulting from defective ion 




Airway inflammation is observed in very young children with CF, even in the 
absence of any detectable infection (Khan et al., 2011). Inflammatory markers have 
even been detected in the lung of a foetus with CF (Verhaeghe et al., 2007), which 
suggests that an inflammatory phenotype is a feature of CF, and not just a secondary 
consequence of microbial infections. CFTR is a negative regulator of pro-
inflammatory cytokines (Vij et al., 2009) and is required for the process of 
autophagy (Luciani et al., 2010), hence defects trigger an innate immune response 
and chronic inflammation.  
The clinical course of respiratory disease in CF is characterised by episodes of acute 
illness, termed pulmonary exacerbations. Exacerbations cause an increase in 
respiratory (and frequently systemic) symptoms, and require aggressive intravenous 
or inhalation antimicrobial therapy (Bhatt, 2013). An increased frequency of 
exacerbations is associated with a reduced 5-year survival rate (Liou et al., 2001), 
and a poorer (and declining) baseline lung function (de Boer et al., 2011). Numerous 
studies have linked changes in the microbial community to exacerbations, but 
demonstrating causality is difficult. The exact triggers remain unknown, but the 
treatment is always aggressive antimicrobial therapy. 
1.1.1.1 Oxidative stress 
Oxidative stress results as an imbalance between oxidants and antioxidants, and CF 
patients (particularly adults) have higher levels of oxidative stress markers than 
healthy control subjects, in part due to depleted antioxidant levels (Back et al., 2004), 
but also as a consequence of inflammation. Activated immune cells (particularly 
neutrophils) produce reactive oxygen species; indeed, pulmonary inflammation has 
been associated with increased levels of oxidative stress in children with CF (Hull et 
al., 1997), and oxidative stress increases after exacerbations (Reid et al., 2007). High 
levels of oxidative stress are thought to cause injury to cells and contribute to the 
decline in lung function (Brown & Kelly, 1994), but one must also be aware that the 
toxicity of ROS is not limited to only human cells, and that high levels of oxidative 
stress are likely to impact on the microbial communities within the lung.   
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1.1.2 Common CF pathogens 
The abnormal nature of the CF lung means that the CF lung is frequently colonised 
by multiple microbes, including opportunistic pathogens such as Staphylococcus 
aureus, Pseudomonas aeruginosa, Haemophilus influenzae and the Burkholderia 
cepacia complex. Chronic P. aeruginosa and S. aureus are the most common airway 
infections in adults with CF, occurring in 51% and 21% of adults, respectively 
(Registry, 2014). For decades, culture-based methods have been used to determine 
the microbiology of CF airway infection, but more recently, culture-independent 
methods such as PCR and microbiome analyses have added to the array of microbes 
that are associated with the CF airways, although the role of many of these in 
pathogenesis remains unclear.  
There is evidence that the microbiology of the CF lung has changed over the past few 
decades, presumably due to changes in infection control and treatment strategies. 
Whilst the incidence of H. influenzae and S. aureus has decreased, MRSA has 
increased, and there has been a rise in the incidence of rare or previously undetected 
species such as atypical mycobacteria, Stenotrophomonas maltophilia and 
Achromobacter xylosoxidans (Millar et al., 2009).  
The (relatively) recent advent of molecular techniques such as 16S rDNA gene 
sequencing has helped identify putative pathogens that were not previously 
associated with CF (Bittar et al., 2008), including in children undergoing 
exacerbations who were culture negative (Harris et al., 2007). A study characterising 
unusual bacterial airway isolates found that the majority belonged to species that 
were not known to colonise CF patients, or were in completely novel taxa (Coenye et 
al., 2002). Chronic colonisation of individuals with Pandoraea species (Coenye et 
al., 2000) and Inquilinus limosus (Wellinghausen et al., 2005) has been described, 
but the clinical implications of this are not known. These studies highlight the 
complexity of the microbiology of the CF lung. 
In addition to the presence of multiple bacterial species, fungi and viruses are often 
frequently detected. Aspergillus fumigatus is the most prevalent fungal species; over 
1/5 of adults are chronically colonised, and incidence increases with age (Mortensen 
et al., 2011). Use of a variety of fungal culture methods has shown that the fungal 
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community in CF airways is diverse yet stable, with a variety of yeast and 
filamentous fungal species (Masoud-Landgraf et al., 2014). Like healthy children, 
children with CF suffer from acute respiratory infections. Interestingly, the frequency 
and duration of infections, and types of viruses detected, do not differ to healthy 
children, but the severity of lower respiratory tract disease is increased (van Ewijk et 
al., 2008). It has been suggested that exacerbations are triggered by respiratory viral 
infections (Wark et al., 2012), specifically rhinoviruses (Goffard et al., 2014), and 
viruses have also been associated with an increase in P. aeruginosa density (Wark et 
al., 2012). 
Community profiling studies have been beneficial in furthering our understanding of 
the polymicrobial nature of the CF lung. Pyrosequencing of the whole bacterial 
community present in sputum samples has shown that the community is diverse and 
relatively stable over time, and antibiotic treatment has little effect, particularly on 
the dominant pathogens such as Pseudomonas and Burkholderia (Fodor et al., 2012). 
A similar study that classified patients into clinically stable or declining found, 
similarly, that stable patients had a diverse bacterial community. However, antibiotic 
treatment drove loss of diversity in the declining patients, and P. aeruginosa became 
the dominant pathogen, to the exclusion of all others in some patients (Zhao et al., 
2012). Such studies can identify species as clinically important; for example, the 
Streptococcus milleri group (SMG) consists of several groups and was not previously 
recognised as a serious pathogen in CF. However, a longitudinal study that 
investigated bacterial airway communities and patient clinical status found that the 
community dynamics shifted prior to the onset of exacerbations, with the SMG 
increasing to become the dominant pathogen, evidence for a role as a serious CF 
pathogen (Sibley et al., 2008). 
1.2 Pseudomonas aeruginosa 
P. aeruginosa is a Gram negative bacterium that is found in a variety of 
environments, both clinical and environmental (Wiehlmann et al., 2007). It is an 
opportunistic pathogen, causing disease where normal host defences have been 
compromised, for example in immunocompromised individuals, individuals with 
severe burns, or contact-lens wearers (Lyczak et al., 2000), and it is capable of 
causing both acute and chronic infections. This makes it a significant nosocomial 
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pathogen; it is the most common nosocomial causative agent of pneumonia, and the 
second most common in the case of urinary tract infections (Weinstein et al., 2005). 
Despite being an opportunistic pathogen, P. aeruginosa is capable of expressing a 
large collection of virulence factors, specific to the type of infection (Rumbaugh et 
al., 1999). A recent study compared gene expression in acute and chronic murine 
wound mouse models, and identified fitness and virulence determinants using a 
library of transposon-insertion mutants. However, despite differential gene 
expression between the two types of infection, the genes required for fitness and 
virulence were similar between the two, with the exception of flagellar motility, 
which is only required in acute infections (Turner et al., 2014). 
1.2.1 Virulence in CF 
As discussed in the previous section, P. aeruginosa virulence factor expression 
differs between acute and chronic infections. The general consensus is that P. 
aeruginosa requires expression of multiple virulence factors to colonise and establish 
an infection, but that these can then have a fitness cost due to their immunogenicity, 
resulting in a switch to a chronic infection. Cell surface factors such as flagella and 
pili are required for motility (Bradley, 1980; Köhler et al., 2000) and adhesion to 
respiratory epithelial cells (Doig et al., 1988; Lillehoj et al., 2002). P. aeruginosa 
also produces numerous secreted factors with toxic effects, including phenazines 
(Cezairliyan et al., 2013; Mahajan-Miklos et al., 1999), proteases (Kida et al., 2008; 
Woods et al., 1982), phospholipase C (Ostroff et al., 1989), CFTR inhibitory factor 
(MacEachran et al., 2007), exotoxins (Woods et al., 1982), hydrogen cyanide 
(Gallagher & Manoil, 2001) and rhamnolipids (Read et al., 1992).  Levels of secreted 
exoproteins in CF sputa are higher during exacerbations (Jaffar-Bandjee et al., 1995) 
which may partly explain the morbidity associated with exacerbation. However, 
because virulence factors cause pulmonary inflammation (Wieland et al., 2002), loss 
or downregulation of their expression represents an immune evasion strategy. For 
example, neutrophil elastase has been shown to trigger reduced flagellin synthesis 
(Palmer et al., 2005; Sonawane et al., 2006), and chronic CF isolates often display 
loss of cell surface factors (Mahenthiralingam et al., 1994; Workentine et al., 2013). 
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The exopolysaccharide alginate is a virulence factor that is associated specifically 
with later stages of chronic infection, as overproduction leads to the development of 
a “mucoidy” phenotype. The mucoid phenotype does not elicit an immune response 
and suppresses host apoptosis, which may help prevent clearance (Cobb et al., 2004). 
Indeed, mucoid P. aeruginosa are more resistant to immune-mediated killing 
(Baltimore & Mitchell, 1980; Cabral et al., 1987; Leid et al., 2005) and form 
biofilms that are very resistant to antimicrobial treatment (Hengzhuang et al., 2011). 
Biofilm growth, however, is not limited to mucoid strains, and biofilm formation can 
be viewed as a virulence factor in chronic infection, as biofilms are intrinsically 
refractory to antibiotic treatment (Bjarnsholt et al., 2009; Singh et al., 2000).  
Chronic colonisation with P. aeruginosa has been associated with a gradual 
worsening of lung disease (Kosorok et al., 2001) and is a major predictive factor for 
morbidity and mortality (Emerson et al., 2002). Mucoid strains in particular are 
associated with a more rapid decline in lung function (Demko et al., 1995). 
1.2.2 Antimicrobial therapy of P. aeruginosa infection in CF 
CF respiratory infections are polymicrobial, so patients are often receiving a cocktail 
of antibiotics. However, as P. aeruginosa is a common and serious pathogen, therapy 
in CF is often primarily targeted at preventing or treating P. aeruginosa infections. 
Whilst prophylaxis to prevent colonisation is not advised (Döring et al., 2012), 
antibiotic eradication therapy is recommended for initial/ intermittent colonisation, 
and has been shown to be successful in clearing early-onset P. aeruginosa infections 
(Ratjen et al., 2010; Treggiari et al., 2011).  A Cochrane review examining antibiotic 
eradication strategies included 7 trials over a period of 20 years, and concluded that 
nebulised or oral and nebulised antibiotics could successfully eradicate early P. 
aeruginosa infection. However, differences in the methodologies of the individual 
trials meant that they could not recommend an optimal treatment regimen, and the 
authors emphasised the need for trials comparing different eradication strategies 
(Langton Hewer & Smyth, 2014).  
Once chronic colonisation has established (which it invariably does after a few years 
of intermittent colonisation), maintenance therapy is recommended to suppress 
infection and prevent exacerbations, with either daily inhaled colistin, or four week 
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on-off inhaled aminoglycoside therapy (Döring et al., 2012). Exacerbations can be 
treated with intravenous antibiotics, either as monotherapy or in combination, with 
the exception of fluoroquinolones, which are administered orally (Smyth & Elborn, 
2008). 
1.2.3 Infection and transmission in CF 
Until relatively recently, it was thought that individuals with CF were colonised with 
environmentally-acquired, patient-specific strains of P. aeruginosa. Common strains 
between patients were identified (Grothues et al., 1988; Wolz et al., 1989), but 
transmission was thought to be a rare event, occurring only after prolonged contact.  
P. aeruginosa was thought to have a non-clonal (i.e. freely recombining) population 
(Curran et al., 2004; Kiewitz & Tümmler, 2000). However, clonal strains have been 
identified, and a survey of the global population of P. aeruginosa, using a range of 
clinical and environmental isolates, identified multiple dominant clones (Wiehlmann 
et al., 2007) in a variety of geographical and environmental origins. Clone C in 
particular is very prevalent in CF centres across the UK (Hall et al., 2014; Martin et 
al., 2013; Scott & Pitt, 2004) but there is little evidence that it is transmitted between 
patients, and its prevalence likely reflects its abundance in the environment.  
Transmission between patients was first considered as a serious mode of strain 
acquisition after the observation of widespread ceftazidime resistance in P. 
aeruginosa isolates in a paediatric CF clinic in Liverpool. Genotyping revealed that a 
large number of children carried the same strain (Cheng et al., 1996), which became 
known as the Liverpool Epidemic Strain (LES). Compared with other P. aeruginosa 
genotypes, the LES is associated with worsened health and quality of life (Ashish et 
al., 2012a) and increased antibiotic resistance (Ashish et al., 2012b). Whilst a strict 
patient segregation policy has successfully reduced the proportion of P. aeruginosa 
infections that are LES (Ashish et al., 2013b), it remains the most common clone in 
those infected with P. aeruginosa (Martin et al., 2013), and has recently been 
identified in North America (Aaron et al., 2010). The characteristics of the LES are 
discussed further in section 3.1.1. 
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Since the LES, other transmissible strains have been identified, although they are not 
all associated with increased virulence. Several Australian epidemic strains have 
been identified, and a survey of P. aeruginosa isolates from multiple patients in 
Australian CF centres found high clonality, with more than 60% of patients infected 
with a shared genotype (Kidd et al., 2013). The Australian epidemic strains AES-1 
and AES-2 accounted for most of these and were thought to be acquired by patient to 
patient transmission. These two strains have been shown to produce more proteases 
than other, non-clonal isolates (Tingpej et al., 2007), which may be a contributory 
factor in the increased morbidity associated with these strains (Tingpej et al., 2010) 
and increased mortality associated with infection with AES-1 (Griffiths et al., 2012).  
There are numerous examples of other transmissible strains identified worldwide 
(Fothergill et al., 2012), including two further epidemic strains in the UK, the 
Manchester (MES) and Midland (Mid 1) strains (Scott & Pitt, 2004). Unlike the 
LES, there is little evidence to suggest that infection with the MES or Mid 1 has 
clinical significance; Mid 1 is not linked with antibiotic resistance or worsened 
disease state (Chambers et al., 2005) and MES does not elicit an increased 
inflammatory response, relative to other non-epidemic strains (Jones et al., 2003), 
although a small study did find that infection with transmissible strains (of which 
MES was the most common) was associated with an increased frequency of 
antibiotic treatment and hospitalisation (Jones et al., 2002).  
1.2.4 The genetics of P. aeruginosa 
P. aeruginosa has a large, circular chromosome (ranging from 5 – 7 million base 
pairs (Mbp)), with a relatively high GC content of 65-67%, and can carry additional 
extra-chromosomal plasmids. PAO1 was the first whole genome to be sequenced, 
and this revealed a 6.3 Mbp, high-complexity genome encoding 5,570 predicted open 
reading frames (ORFs) and a very high proportion (8.4%) of regulatory genes 
(Stover et al., 2000). Since then, numerous other P. aeruginosa genomes have been 
published, allowing identification of the genes that are shared between strains, and 
those that are strain specific. 
The core genome of P. aeruginosa is highly conserved (Mathee et al., 2008; 
Wolfgang et al., 2003), although the degree of conservation depends on which strains 
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are included; a recent study used 12 reference genomes, and found that when PA7 
(an outlier strain) was included, the core genome size dramatically decreased (Ozer 
et al., 2014). A comparison of a panel of strains from both clinical and environmental 
origins found that virulence genes are highly conserved between strains, suggesting 
that environmental strains have the capacity to cause infections (Wolfgang et al., 
2003).  
The core genome is interspersed with blocks of DNA in a mosaic-like fashion which 
account for the majority of inter-strain diversity (Klockgether et al., 2011), termed 
the accessory genome. The accessory genome represents between 7 and 18 % of the 
P. aeruginosa genome, has a much greater proportion of uncharacterised genes than 
the core genome and is enriched for horizontally acquired elements such as 
integrative and conjugative elements (ICEs) and phages (Ozer et al., 2014).  
Examination of the accessory genome of clinical isolates could be a useful strategy to 
determine genes required for virulence. The accessory genome of clinical isolates is 
quite strain-specific (Pohl et al., 2014) and consists of many sequences not present in 
PAO1 (Shen et al., 2006) or other P. aeruginosa strains. It includes sequences from 
other genera, evidence of interspecies HGT (Pohl et al., 2014) and lots of genes that 
are associated with mobile genetic elements such as bacteriophages (Pohl et al., 
2014; Shen et al., 2006). The accessory genome of CF epidemic strains is enriched 
for functions thought to aid survival in the CF lung, including antibiotic metabolism 
and redox genes (Dettman et al., 2013). 
When the genome sequence of LESB58 was published (the first historical isolate of 
LES), the most striking feature was the number of horizontally acquired elements, 
including five genomic islands and six prophages. Furthermore, a signature-tagged 
mutagenesis study found that genes in three of the prophages and one of the novel 
genomic islands were essential for LES competitiveness in a rat model of chronic 
lung infection (Winstanley et al., 2009).  
The genome sequence of LESB58 identified 350 genes with no homology to any 
other P. aeruginosa strain (at the time), and showed that LESB58 carries almost all 
known P. aeruginosa virulence genes (Winstanley et al., 2009). The presence of 
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these known virulence genes, in addition to the horizontally acquired novel DNA 
may explain the evolutionary success of the LES. However, prediction of virulence 
from genome sequence is not straightforward; a comparison of strain virulence in a 
Caenorhabditis elegans model found little correlation between the presence of 
virulence genes and virulence, suggesting that virulence depends on the specific 
combination of virulence factors (Lee et al., 2006). Furthermore, strains or isolates 
can exhibits difference in virulence between different animal models (Fothergill et 
al., 2012). 
The genome is constantly changing, and the P. aeruginosa genome undergoes 
extensive diversification through single nucleotide variations (SNVs), small 
insertions and deletions (INDELS) and horizontal acquisition of novel DNA, 
something that will be discussed in Chapter 5. These features of the P. aeruginosa 
genome contribute to its ability to rapidly adapt to new or changing environments.  
1.2.4.1 DNA mismatch repair (MMR) system 
DNA replication is not an error free process, and various systems exist to repair 
errors and DNA damage. The mismatch repair (MMR) system of Escherichia coli 
repairs post-replicative DNA errors and oxidative DNA damage (Wyrzykowski & 
Volkert, 2003), and consists of several proteins, including MutS, which recognises 
mismatched bases and small INDELS, and MutL, which forms a complex with MutS 
and mediates the activation of the endonuclease MutH. An uvrD (mutU)-encoded 
helicase unwinds the error-containing DNA strand (Li, 2008). Mutations in the genes 
encoding these proteins can lead to a heritable “hypermutator” phenotype, where a 
failure to repair mismatches leads to an elevated mutation rate. 
P. aeruginosa encodes orthologues for mutS, mutL and uvrD, but no homologue has 
been detected for mutH (Oliver et al., 2000; Stover et al., 2000). Despite sequence 
similarity, the P. aeruginosa MMR genes do not complement MMR-defective E. 
coli, suggesting a degree of difference between the two systems (Oliver et al., 2002). 
However, mutations in the MMR genes of P. aeruginosa result in a hypermutator 
phenotype, and each gene in this system has been shown to be capable of restoring a 
wild-type mutation rate in at least one clinical hypermutable isolate (Oliver et al., 
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2002), so there is no doubt that defects in the P. aeruginosa MMR system have a 
similar effect on cell phenotype to that observed in E. coli.  
Hypermutable P. aeruginosa is frequently isolated from the CF lung (Cramer et al., 
2011; Feliziani et al., 2010), but the reasons underlying this high frequency are still 
unclear and will be discussed further in section 4.1.2.3. 
1.2.5 Cell surface structures 
P. aeruginosa, like many other bacteria, express proteinaceous appendages on their 
cell surface, such as pili and flagella. These interact with the environment 
surrounding the cell and have numerous roles, including motility, biofilm formation 
and adhesion to host cells, both of which may be important when colonising new 
hosts. 
1.2.5.1 Pili 
Type IV pili are long, thin filaments that are made up of pilin protein subunits which 
are manufactured with a leader peptide sequence that is cleaved before pilus 
assembly. There are two main types of type IV pili in bacteria, type IVa and type 
IVb, which differ in the length of both pilin and leader peptide sequence and have 
two distinct assembly systems. P. aeruginosa is unusual in that both types of pili 
have been described (Bernard et al., 2009; Carter et al., 2010b; de Bentzmann et al., 
2006; Giltner et al., 2011), but type IVb is not associated with motility and is much 
less well characterised.  
Numerous genes are involved in type IVa pilus biogenesis and retraction (Figure 
1.1), and mutations in these genes can lead to different phenotypes, ranging from 
complete absence of pili, to hyperpiliation.  
PilA is the major structural protein (termed the major pilin), and mutations in pilA 
can result in a total absence of pili. Within P. aeruginosa there are 5 subtypes of pili, 
based on the pilA allele, with PAO1 classed as group II, and another common 
reference strain, PA14 (originally an acute infection isolate) as group III (Kus et al., 
2004). Interestingly, group I is overrepresented in clinical CF isolates (Kus et al., 
2004), and LES is group I (Giltner et al., 2011). Because of this, it has been 
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suggested that group I is a CF specific virulence factor. A recent study identified a 
potential mechanism for this; type I pilins are O-glycosylated, which confers 
resistance to pulmonary-surfactant protein A-mediated opsonisation and 
phagocytosis in a mouse model of acute lung infection (Tan et al., 2015). 
Each pilus type also has a specific set of minor pilin alleles, and it is thought that 
compatibility between the major and minor pilins is necessary for full functionality 
(Giltner et al., 2011). The minor pilins form the pilus shaft, along with PilA (Figure 
1.2) and function to prime pilus assembly (Nguyen et al., 2015). 
 
Figure 1.1 Genes involved in type IV pilus formation and twitching motility in P. aeruginosa strain PAO1. 
Each gene is represented by a coloured arrow: yellow represents structural, purple represents regulatory, 
and grey represents genes associated with type IV but lacking a pilus-related phenotype. The number 
above each gene is the PA accession number. Figure adapted from (Burrows, 2012). 
Type IV pili are produced by an apparatus that consists of four subcomplexes (Figure 
1.2). PilB, PilC, PilT and PilU putatively form the motor (Burrows, 2012); PilB is an 
ATPase that provided the required energy for pilus assembly, whereas PilT and PilU 
are retraction ATPases, required for pilus depolymerisation (Chiang et al., 2005). 
The major and minor pilins subcomplex forms the pilus itself, which is extruded 
through the secretin PilQ, localised by the lipoprotein PilF (Koo et al., 2008). The 
PilFQ outer membrane subcomplex is linked to the inner membrane subcomplex by 
the PilMNOP/FimV alignment subcomplex (Burrows, 2012). PilY1 is a non-pilin 
protein for which numerous roles have been identified, including twitching motility 
(Bohn et al., 2009; Heiniger et al., 2010), survival in a mouse model of infection 
(Bohn et al., 2009), calcium dependent regulation of pilus retraction (Orans et al., 
2010) and adhesion to human epithelial cells (Heiniger et al., 2010). A recent study 
found that the minor pilins are required to traffic PilY1 to the cell surface, and 
because of its role in adhesion and anti-retraction, the authors suggested that PilY1 
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may be localised at the tip of the pilus, but this remains to be determined (Nguyen et 
al., 2015). 
Type IV pili are required for several forms of motility, including twitching (1.2.6.3), 
swarming (1.2.6.1) and the more recently discovered walking (Gibiansky et al., 
2010) and slingshot motilities (Jin et al., 2011). Type IV pili-mediated motility 
enables exploration of novel, solid-surface environments, but type IV pili also 
function synergistically with flagella to detach from surfaces and disperse (Conrad et 
al., 2011). Type IV pili also have a major role in adhesion, and can bind to host 
epithelial cells (Bucior et al., 2012), DNA (van Schaik et al., 2005) and solid 
surfaces (Giltner et al., 2006), and adhesion is a necessary step in surface-attached 
biofilm formation (1.2.7). Furthermore, type IV pili are the receptor for many 
bacteriophages (Ceyssens et al., 2009b; James et al., 2012). More recently, it was 
discovered that type IV also play a role in sensing the environment; pili bind to solid 
surface and are retracted, triggering signal transduction through the Chp 
chemosensory pathway and subsequent upregulation of many genes, including those 
involved in virulence and twitching motility (Persat et al., 2015).  
 
Figure 1.2 Diagrammatic representation of the type IV pilus complex of P. aeruginosa and its location 
within the cell. The pilus is formed from the major pilin protein PilA, and the minor pilins (mp) FimU, 




Flagella are whip-like appendages that are required for chemotaxis and motility in 
less solid environments, especially swimming and swarming motility. P. aeruginosa 
has a single polar flagellum, consisting of subunits of flagellin protein (encoded by 
the fliC gene) and powered by a motor. The motor is powered by a flow of protons 
across the cell membrane and consists of two subunits, the stator (a static structure) 
and a rotor, which fits within the stator and causes the flagellum to rotate (Blair, 
2003). P. aeruginosa is unusual in that it encodes two different stators that have 
different roles with regards to motility; both are required for swarming motility, but 
either is sufficient for swimming (Toutain et al., 2005).  
There are two main types of flagella in P. aeruginosa (a and b) that differ in their 
FliC protein with regards to antigenicity, weight of flagellin subunits (Allison et al., 
1985) and amino acid sequence (Spangenberg et al., 1996). A small-scale study 
found no difference in the distribution of flagella type in strains from different 
clinical infections, or in the immunogenicity of the flagellin protein (Shanks et al., 
2010), so there are no obvious clinical implication of flagella-type.  
Flagella are thought to be important virulence factors as they are required for host 
colonisation (Montie et al., 1982), due to their role in motility and adhesion. Flagella 
help P. aeruginosa adhere to hydrophobic surfaces (Bruzaud et al., 2015) and the 
flagellin protein adheres to Muc1 mucin, a protein secreted by respiratory epithelial 
cells (Lillehoj et al., 2002). 
Furthermore, type IV pili and flagella are thought to act synergistically to adhere to 
host epithelial cells; type IV pili bind preferentially to N-glycans on the apical 
surface, and flagella to heparin sulphate on the basolateral surface of polarised 
epithelium, and it is this that mediates invasion of host cells (Bucior et al., 2012). 
Flagellin is detectable in the sputa of CF patients (Balloy et al., 2014), which is 
concerning as flagellin is known to be highly immunogenic, activating toll-like 
receptor 5 which triggers an inflammatory innate immune response (Hayashi et al., 
2001a; Zhang et al., 2005). Flagellin also causes hyper-secretion of mucins by 
human epithelial cells, which likely has clinical implications (Mohamed et al., 2012). 
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There is also evidence that flagellin can modulate the host immune response, as it 
induces proliferation of myeloid-derived suppressor cells which dampen T cell 
immune responses (Rieber et al., 2013). However, loss of flagella is also an effective 
strategy for avoiding the immune response (Patankar et al., 2013) and has been 
widely documented in CF isolates (Mahenthiralingam et al., 1994; Workentine et al., 
2013), including LES (Winstanley et al., 2009). 
1.2.6 Motility 
1.2.6.1 Swarming 
Swarming motility is a complex, flagella-driven multicellular form of motility. 
Bacteria “swarm” across the top of a surface, something that can easily be visualised 
in the laboratory using semi-solid media, although the conditions must be tightly 
controlled to avoid other forms of motility. For example, a high concentration of agar 
promotes twitching motility, and a low viscosity promotes swimming.  
Swarming bacteria form tendrils, long branches that radiate out from the centre, with 
the area between the tendrils remaining uncolonised due to inhibitory signals 
produced by neighbouring tendrils (Caiazza et al., 2005). The swarming pattern is 
strain specific (Tremblay & Déziel, 2008) and the differences between PAO1 and 
PA14 are illustrated in Figure 1.3. 
Both flagella and type IV pili are required for swarming in P. aeruginosa, with 
flagella responsible for swarm expansion, and type IV pili playing a role in 
controlling the swarm, slowing expansion through pilus-pilus interactions between 
cells and directing movement away from harmful compounds such as antibiotics in 
the environment (Anyan et al., 2014). Bacterial production of surfactants such as 
rhamnolipids is also necessary, as these function to reduce the surface tension 
(Köhler et al., 2000) and modulate the swarming pattern (Caiazza et al., 2005). There 
is evidence that rhamnolipid production is controlled by quorum sensing (QS) 
(1.2.8), so functional QS is required for swarming motility (Köhler et al., 2000). 
However, another study found that the QS control of swarming motility was 
dependent of the carbon source and that rhamnolipid production was not essential 




Figure 1.3 Swarming motility in the laboratory reference strains PA14 (left) and PAO1 (right). Swarming 
media was inoculated with a single colony and incubated for 16 hours at 37 °C. 
The role of swarming in colonisation and virulence is unclear. A study comparing 
over 200 isolates from different infections (but not CF) identified a positive 
association between the ability to swarm and both protease production and the 
likelihood of being positive for the type III secretion system, both of which are well-
known virulence factors, but this is only a correlational effect (Murray et al., 2010). 
However, when actually swarming, bacteria upregulate certain virulence genes and 
are more resistant to antibiotics (Overhage et al., 2008a), so swarming itself could be 
considered a virulence factor.   
1.2.6.2 Swimming  
Swimming is a form of motility that occurs in aqueous environments by rotation of 
the flagellum, which propels the bacterium forward. Flagella are essential for 
swimming motility, as evidenced by the complete lack of motility exhibited by fliC 
mutants, which do not produce flagella (Rashid & Kornberg, 2000). 
There is evidence that it is swimming motility, rather than the flagellum itself, that is 
required for full virulence, as paralysis of the flagellum results in attenuation of 
virulence in a burned mouse model of infection (Arora et al., 2005). Flagellin is 
immunogenic and the presence of flagella is required for nonopsonic phagocytosis 
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(Mahenthiralingam & Speert, 1995), so it was previously thought that loss of flagella 
was an immune evasion strategy, and that loss of swimming motility was a (perhaps 
unfortunate) consequence. However, another study with flagellated but paralysed 
cells demonstrated that it is loss of motility, not loss of the flagellum, that mediates 
resistance to phagocytosis (Amiel et al., 2010). 
1.2.6.3 Twitching 
Twitching is a form of motility that occurs on solid surfaces by extension and 
retraction of the type IV pili. Bacterial movement appears jerky under the 
microscope, hence the name, “twitching” motility. It can be assayed by examining 
bacterial colony expansion at the plastic-agar interface of a petri dish; bacteria that 
twitch spread out from the initial inoculation point and can be visualised by staining 
(Figure 1.4).  
 
Figure 1.4 Twitching motility of P. aeruginosa strains PAO1 (left; twitching proficient) and LESB58 (right; 
twitching deficient). A single colony was stab-inoculated to the LB-agar-petri dish interface and incubated 
for 24 hours at 37 °C, prior to staining with crystal violet. 
P. aeruginosa assembles and extends the type IV pilus, which attaches to a surface 
and is pulled taut. The pilus is retracted by rapid depolymerisation, and it is 
retraction that propels the cell forward (Skerker & Berg, 2001). It is thought that the 
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pilin subunits are recycled within the cell (Skerker & Berg, 2001), continuously 
being assembled and disassembled to enable twitching motility.  
Because type IV pili have numerous roles, especially in adhesion and biofilm 
formation, it is difficult to elucidate the role of twitching motility itself in virulence. 
Studies with mutants that still produce pili but are unable to twitch can be useful in 
this respect. For example, pilU and pilT mutants, which are deficient in pilus 
retraction display reduced cytotoxicity in epithelial cells (Comolli et al., 1999) and 
reduced colonisation and virulence in the murine cornea (Zolfaghar et al., 2003), 
suggesting that twitching is necessary for full virulence, not just the presence of pili.    
1.2.7 Biofilm formation 
Biofilms consist of bacteria in a self-produced matrix of polysaccharides, proteins 
and DNA (Høiby et al., 2010b), often attached to a surface. Biofilms can consist of a 
single bacterial species, but biofilms containing multiple bacterial species, fungi and 
archaea have all been described. The sessile nature of cells within the biofilm, and 
the physical protection afforded by the matrix means that biofilms are intrinsically 
resistant to attack from antibiotics, host immunity and phage predation.  Analysis of 
quorum sensing signals in CF sputa indicates that P. aeruginosa likely grows as a 
biofilm in the CF lung (Singh et al., 2000), and P. aeruginosa biofilm growth has 
been extensively studied in the laboratory, using the traditional surface-attached 
biofilm mode of growth (Hentzer et al., 2001; Klausen et al., 2003b; O'Toole & 
Kolter, 1998).  
Extracellular DNA is an important component of P. aeruginosa biofilms (Barken et 
al., 2008), as are polysaccharides that are produced by the bacteria. P. aeruginosa 
produces three extracellular polysaccharides: alginate, Psl and Pel (Franklin et al., 
2011). Surface attached PAO1 biofilms grow as mushroom-like structures, and 
alginate plays a key role in trapping cells in the cap of these structures, in addition to 
maintaining the viability of these cells (Ghafoor et al., 2011), whereas Pel mediates 
interactions between cells within the structures. Psl is important for initial surface 
attachment of cells (Ghafoor et al., 2011), and its production sets up a positive 
feedback loop, whereby Psl stimulates production of the secondary messenger 
molecule cyclic di-GMP, which is turn leads to increased Psl production and biofilm 
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formation (Irie et al., 2012). Lack of production of these polysaccharides, alone or in 
combination, results in changes to the biofilm architecture (Ghafoor et al., 2011). 
Type IV pili are also though to play an important role in surface-attached biofilm 
formation. Their role in initial surface adhesion is not clear; some studies have 
shown that pilus deficient mutants can still adhere to surfaces and form biofilms 
(Klausen et al., 2003b), but under certain conditions they cannot (Chiang & Burrows, 
2003). Other cell appendages can play a role in initial adhesion, including novel 
adhesins encoded by the cupA genes (Vallet et al., 2001). Mutations in the cupA 
genes of pilus-deficient PAO1 reduced surface adhesion and biofilm formation, and 
there may be numerous other undiscovered adhesins with a role in biofilm formation.  
Type IV pilus-mediated twitching motility may be more important for biofilm 
formation than the adhesive properties of type IV pili, and is necessary for 
microcolony formation, an early step in biofilm formation where cells twitch across 
the surface and aggregate together (O'Toole & Kolter, 1998). Furthermore, 
experiments with mixture of fluorescently-tagged wild-type and non-piliated mutants 
found that whilst the twitching-deficient strain could form the stalks of the 
aforementioned mushroom-like structure, twitching motility was required to move up 
the stalk to form the cap (Klausen et al., 2003a). 
Strains that produce defective pili (hence are non-motile) are still capable of biofilm 
formation. Hyperpiliated mutants (defective for twitching, swimming and swarming) 
have been identified that form highly adherent biofilms (Déziel et al., 2001), and 
hyperpiliated pilT mutants form very dense biofilms, suggesting that twitching 
motility is required for normal structure (Chiang & Burrows, 2003). 
Mature biofilms undergo dispersal, where planktonic cells are released from the 
biofilm. It has been hypothesised that dispersal of P. aeruginosa biofilms in the CF 
lungs may cause exacerbations, but there is little evidence to support or refute this 
hypothesis. A filamentous bacteriophage has also been shown to be critical for 
biofilm dispersal in PAO1 (Rice et al., 2008; Webb et al., 2004; Webb et al., 2003) 
and a panel of chronic CF isolates (Kirov et al., 2007). The bacteriophage is known 
as Pf4 in PAO1 (a member of the Inoviridae (1.4.3.2)) and normally exists as a 
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prophage, but can develop into a superinfective form that is capable of causing cell 
lysis of cells within biofilms (Webb et al., 2003) and drives the emergence of 
bacterial morphological variants (Webb et al., 2004). When Pf4 is deleted, the 
microcolonies formed are much smaller, and do not undergo the same cell death and 
hollowing in the centre that is observed in WT PAO1 biofilms, but complementation 
with exogenously added superinfective Pf4 restores cell lysis. Moreover, Pf4 is 
required for full virulence in a mouse model of acute pneumonia, although the exact 
mechanism for this was not elucidated (Rice et al., 2008). Both the presence of 
reactive oxygen and nitrogen species and a hypermutator phenotype result in 
increased/ earlier production of the superinfective form (Hui et al., 2014), and a 
recent deep-sequencing study of P. aeruginosa biofilms found that the Pf4 phage 
undergoes rapid evolution over a short-timescale, accumulating multiple mutations in 
the cI repressor gene that normally functions to maintain the phage in prophage form 
(McElroy et al., 2014). 
Despite the fact that biofilms are traditionally thought to be surface attached, 
aggregates of P. aeruginosa have been detected in CF sputa and removed lungs, 
suggesting that P. aeruginosa may grow as unattached biofilms in the CF lungs 
(Bjarnsholt et al., 2009). As most of the experimental work characterising biofilms 
has been done with surface attached biofilms, the role of certain factors, particularly 
those involved in surface attachment is thrown into question. Novel in vitro 
approaches are being used to model P. aeruginosa growth in the CF lung, most 
notably artificial sputum (1.3.1), in which P. aeruginosa forms “biofilm-like 
structures”. The structure of these biofilms is strain specific and dependent on the 
concentrations of free DNA and mucin (Haley et al., 2012), both of which contribute 
to the viscosity of CF sputum. 
Regardless of the types of biofilms formed in the CF lung, there are still clinical 
implications. When the reference strain PA14 is grown as microcolonies, over 40 
genes are differentially expressed compared to when at stationary phase in LB media 
(Fung et al., 2010). Gene expression is altered in biofilm bacteria (relative to 
planktonic), particularly in response to antibiotics (Whiteley et al., 2001). Through 
altered gene expression  and the physical protection afforded by the matrix, biofilms 
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are refractory to antibiotics (Mah & O'Toole, 2001) and the immune system 
(Kharazmi, 1991; Leid et al., 2005), leading to persistence in the lungs. 
1.2.8 Quorum sensing 
Quorum sensing (QS) is a chemically-mediated cell to cell communication system, 
whereby bacteria produce and detect QS molecules, termed autoinducers. 
Autoinducers accumulate in the environment, until they reach a threshold density, 
upon which the gene expression of the cell changes in response to the high density of 
cells, towards cooperative behaviours. QS has been linked to biofilm formation 
(Davies et al., 1998) and virulence factor production (Whiteley et al., 1999). This is 
presumably because expression of virulence factors, for example, is wasted if the cell 
density is low as they cannot reach a high enough concentration to have an effect on 
the host. 
Four different QS systems have been identified in P. aeruginosa, but they affect each 
other in a complex network of regulation. They are the Las, Rhl, PQS and recently 
discovered IQS systems (Lee et al., 2013). Both the Las and Rhl systems consist of 
an autoinducer protein (encoded by lasI and rhlI, respectively) that produce N-acyl-
homoserine lactone molecules that bind to the transcriptional regulators LasR and 
RhlR (encoded by lasR and rhlR genes) (Gray et al., 1994; Pearson et al., 1995). 
LasR and RhlR both regulate hundreds of genes (Schuster et al., 2003) and LasR also 
positively regulates lasI, setting up a positive feedback loop, in addition to rhlRI 
(Latifi et al., 1996), although this regulation of the Rhl system by the Las system is 
unidirectional.  
The PQS system is a chemically distinct system, utilising the signalling molecule 2-
heptyl-3-hydroxy-4-quinolone (also known as the Pseudomonas Quinolone Signal) 
(Pesci et al., 1999). The PQS system is positively regulated by the Las system 
(McGrath et al., 2004; Pesci et al., 1999) and itself (McGrath et al., 2004; Wade et 
al., 2005) and negatively regulated by the Rhl system (McGrath et al., 2004). PQS 
also has a dual function in iron acquisition, as it can chelate iron and positively 
regulates siderophore production (Diggle et al., 2007b). 
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The IQS is the most recently discovered QS system, produced by the ambABCDE 
gene cluster, and is co-regulated by Las QS system and the phosphate limitation 
stress response. Furthermore, IQS  is required for full virulence in an acute murine 
infection model (Lee et al., 2013). 
Mutants defective in QS are frequently isolated from chronic CF respiratory 
infections, particularly lasR mutants (Smith et al., 2006a), a phenomenon that is 
discussed further in Chapter 5. 
1.3 Models of CF 
P. aeruginosa, like many bacteria, behaves differently when grown in different 
environments, and many different models, both in vitro and in vivo, have been 
developed in an attempt to model the growth and evolution of P. aeruginosa in the 
CF lungs. 
1.3.1 Synthetic sputum models 
CF sputum can be used as a growth medium by dissolving sterile, lysophilised 
sputum in buffer, creating a medium that supports high densities of P. aeruginosa 
(Palmer et al., 2005) because of the high concentration of amino acids that bacteria 
use as a growth source (Barth & Pitt, 1996; Palmer et al., 2005). However, CF 
sputum is in limited supply and the chemical composition is unlikely to be consistent 
between different batches. Because of this, several synthetic sputum models have 
been developed for the study of P. aeruginosa and other CF pathogens.  
Artificial sputum media (ASM) was one of the first synthetic sputum models to be 
developed (Sriramulu et al., 2005). ASM contains a high concentration of free DNA, 
mucin, amino acids, salts and lipids, resulting in a medium that has a similar 
viscosity and chemical composition to CF sputum (Sriramulu et al., 2005). When 
grown in ASM, P. aeruginosa forms tight microcolonies that are not surface attached 
(Haley et al., 2012; Kirchner et al., 2012; Sriramulu et al., 2005), thought to be how 
P. aeruginosa grows in the CF lung (1.2.7). Bacteria grown in ASM undergo 
phenotypic diversification (Sriramulu et al., 2005; Wright et al., 2013), exhibiting 
changes in colony morphology (Sriramulu et al., 2005), pyocyanin production and 
antibiotic susceptibility (Wright et al., 2013). Furthermore, gene expression is altered 
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in ASM, with an upregulation of genes involved in biofilm formation, QS and 
phenazine biosynthesis (Fothergill et al., 2014). 
ASM can be filtered to remove contaminating bacteria without damaging the heat-
sensitive components, but a modified version (ASMDM) contains less DNA and 
more mucin, considered by the authors to better represent the CF lung (Fung et al., 
2010). The additional mucin makes filtration difficult, so antibiotics are added to 
ASMDM to inhibit growth of contaminants, but this is potentially concerning as 
subinhibitory antibiotic concentrations can have a wide range of effects on bacterial 
cells, including altered gene regulation (Davies et al., 2006). 
Other synthetic sputum models include synthetic CF sputum medium (SCFM), which 
contains amino acids but lacks DNA and mucin (Palmer et al., 2007), and a more 
recent version, SCFM2, which is supplemented with DNA, mucin, N-acetyl 
glucosamine and lipids to better represent CF sputum (Turner et al., 2015). The 
addition of these components probably makes SCFM2 more alike to ASM than its 
precursor. 
Support for the use of synthetic sputum as a model for the CF lung comes from a 
recent transposon-sequencing study that determined the genes required for P. 
aeruginosa fitness in both CF and synthetic sputa (they used SCFM2). The essential 
genes were very similar for both (Turner et al., 2015), suggesting that synthetic 
sputum is a good in vitro model to study P. aeruginosa.  
1.3.2 In vivo models 
As P. aeruginosa is an opportunistic pathogen, infection of healthy animals usually 
leads to rapid clearance (Southern Jr et al., 1970), unless the dose is sufficiently high 
or the animal is immunocompromised, in which case an acute infection is established 
and the animal quickly dies (Morissette et al., 1995). However, this is not 
representative of chronic P. aeruginosa infections in CF, which are characterised by 
a slow decline in health, often over many years (Kosorok et al., 2001). Although 
natural animal models of CF do not exist, attempts have been made to engineer 
CFTR deficient animals in order to replicate the CF disease phenotype. 
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Numerous murine CF models have been used that differ in CFTR functionality and 
range from a defective to completely absent CFTR, but the pathophysiology of lung 
disease is not reflective of that in humans and they are not intrinsically susceptible to 
respiratory bacterial infections (Fisher et al., 2011). The more recently developed 
ferret and pig models are more promising. CFTR defective pigs develop CF-like lung 
disease as adults (Ostedgaard et al., 2011; Stoltz et al., 2010), following colonisation 
with multiple bacterial species (Stoltz et al., 2010). Furthermore, CF pigs were 
unable to successfully eradicate bacteria when artificially infected, mimicking the 
defective clearance observed in CF humans (Stoltz et al., 2010). CFTR knock-out 
ferrets are susceptible to bacterial respiratory infections soon after birth and also 
demonstrate many other symptoms seen in CF humans (Sun et al., 2010). 
CFTR models are expensive and not readily available, so many animal models used 
in the study of P. aeruginosa infections in CF use phenotypically healthy animals, 
but the mode of infection is designed to make the resulting infection as close to 
chronic respiratory infection as possible. It was discovered that by embedding P. 
aeruginosa in agar beads and introducing the beads into the rat lung by intubation, a 
chronic lung infection could develop, resulting in a similar pathophysiology to 
chronic P. aeruginosa infections in individuals with CF (Cash et al., 1979). The rat 
agar bead model is still in use and has been used to study the growth and fitness of 
several P. aeruginosa strains (Kukavica-Ibrulj et al., 2008b).  
A major issue with these models is the artificial nature of infection. A pulmonary 
mouse model was developed that used an alginate-overproducing (mucoid) CF 
isolate, and the self-produced alginate protected the bacteria from the immune 
system, negating the need for artificial embedding (Hoffmann et al., 2005). 
However, such a model is obviously limited in the bacterial strains that can be used. 
Furthermore, implantation into the lungs by intubation bypasses the host’s normal 
defences, and analysis of P. aeruginosa in the paranasal sinuses and lungs of CF 
children suggests that P. aeruginosa colonises and “pre-adapts” to the upper 
respiratory tract before seeding down into the lungs and establishing chronic 
infection (Hansen et al., 2012). A recently developed murine model utilised a more 
natural infection route, as free bacteria were administered intranasally. Bacteria 
colonised the nasopharynx and although no bacteria were detected in the lungs 2 
25 
 
weeks post-infection, after 4 weeks bacteria were present in the lungs, suggesting the 
nasopharynx acts as an infection reservoir, leading to adaptation and re-seeding of 
the lungs (Fothergill et al., 2014).  
1.3.3 Other P. aeruginosa infection models  
An ex vivo porcine lung infection model has recently been developed as an 
alternative model that bridges the gap between in vivo and in vitro models of chronic 
P. aeruginosa infection. It involves bacterial inoculation of sections of fresh pig lung 
tissue suspended in ASM, and the lung tissue provides the spatial structure that is 
lacking in ASM (Harrison et al., 2014). The extent of tissue damage can then be 
evaluated to estimate the virulence of different strains. A major advantage of this 
model is that it is not subject to the same ethical constraints as in vivo models, as it 
uses pig carcasses from the food industry. 
Other models exist to assess P. aeruginosa virulence, including Caenorhabditis 
elegans (nematode) (Tan et al., 1999), Drosophila melanogaster (fruit fly) 
(Apidianakis & Rahme, 2009), Galleria mellonella (wax moth) larvae (Miyata et al., 
2003), plants (Rahme et al., 1997) and Dictyostelium discoideum (amoeba) (Cosson 
et al., 2002), but these models result in acute infection, which is not representative of 
P. aeruginosa infections in CF and involves different fitness requirements (Turner et 
al., 2014). 
1.4 Bacteriophages 
Bacteriophages, or phages as they are commonly known, are viruses that infect 
bacteria. The name bacteriophage is derived from the Greek word “phagein”, which 
translates as “to eat” i.e. bacteria-eater. Like all viruses, phages encode the genetic 
material necessary for their replication, but require a host cell for the metabolic 
requirements of replication.  
Phage genomes can be single or double stranded RNA or DNA, enclosed within a 
protein (or more rarely, lipid) capsid head, although filamentous phages of the genus 
Inovirus are an exception to this rule and are described in more detail in (1.4.3.2). 
The genetic material is protected within the capsid to enable survival in the 
environment, and phages may also have a tail, to facilitate bacterial infection.  
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1.4.1 Life cycles 
Phages have two main life cycles, the lytic and lysogenic. Some phages only follow 
one lifecycle e.g. obligately lytic phages are only capable of a lytic lifecycle, but 
others can follow either, and are known as temperate phages. 
1.4.1.1 Lytic 
The lytic life cycle involves phage replication and the production of phage virions, 
which are then released from the bacterial host by cell lysis, causing the inevitable 
death of the host. An overview of the lytic and lysogenic cycles is described in 
Figure 1.5, using the model temperate phage λ, which infects E. coli, because it is 
well-characterised and is similar to the phages used in this study.  
 
Figure 1.5 Diagrammatic representation of the lytic and lysogenic cycles of bacteriophages, based on the 
model E. coli phage λ. 
Phage gene expression is regulated to ensure that the lytic life cycle proceeds 
correctly. For example, λ has immediate early, delayed early and late genes; the 
immediate early genes are required for the default lytic life cycle to proceed (and 
prevent the lysogenic life cycle), delayed early genes enable phage DNA replication 
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and late genes enable virion assembly (Oppenheim et al., 2005). Transcription of the 
phage genome is controlled by phage-encoded regulatory and transcription 
antiterminator proteins. In λ, the regulatory protein Cro and antiterminator protein N 
are expressed early on. Cro is the essential lytic regulator, preventing synthesis of cI 
(a repressor of the lytic cycle that is expressed in lysogeny). The N protein allows 
expression of the early genes to proceed (Greenblatt et al., 1998) by preventing 
pausing of the replication complex at the transcription terminators. This allows the 
late gene regulator Q to be produced, and when it reaches a threshold density 
(Kobiler et al., 2005), it acts also as an antiterminator, allowing transcription of the 
late genes (Grayhack & Roberts, 1982). This mechanism of transcriptional control 
means that the genes required for DNA replication and phage particle formation are 
expressed at temporally discrete points in the phage life cycle, so the viral particles 
can be correctly assembled and are mostly infective upon lysis. 
1.4.1.2 Lysogenic 
Temperate phages are capable of following an alternative life cycle upon infection of 
a cell, known as the lysogenic cycle (Figure 1.5). The phage integrates into the 
bacterial cell chromosome, where it becomes known as a prophage, and the 
bacterium becomes known as a lysogen. The prophage can remain dormant in the 
cell for many generations, replicating with the host chromosome and being vertically 
transmitted to the daughter cell.  
1.4.1.2.1 Lysis/ lysogeny decision 
The decision of whether to enter the lytic or lysogenic pathway upon infection of the 
cell is largely dependent on the metabolic condition of the cell, and lysogeny is more 
likely in starving cells (Lieb, 1953). This is thought to be a survival tactic by the 
phage when resources are limited, allowing the phage to survive times of hardship; 
resource limitation can result in cells that are incapable of supporting lytic phage 
reproduction, and too low a density of neighbouring susceptible cells to support 
continued phage propagation (Stewart & Levin, 1984). Mathematical modelling of 
different phage strategies suggests that lysogeny will be favoured in fluctuating or 
isolated environments, and that the probability of a temperate phage establishing 
lysogeny is close to the probability of collapse of the local environment, thus 
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maximising the potential for growth but minimising the possibility of extinction, a 
form of bet-hedging (Maslov & Sneppen, 2015). The regulation of the lysis/ 
lysogeny decision and environmental factors that influence it will be discussed 
further in Chapter 3. 
1.4.1.2.2 Phage integration 
The establishment of lysogeny necessitates the phage to integrate itself into the 
bacterial chromosome, and there are two main strategies for this, integrase and 
transposase. Integrase is a phage-encoded, site-specific enzyme that mediates 
recombination between a specific sequence in the bacterial chromosome called the 
bacterial attachement site (attB) and a sequence in the phage genome known as the 
phage attachment site (attP). λ and  two of the phages in this study (LESφ2 and 
LESφ3) use integrase, and so have a specific integration site in the bacterial genome.  
Transposase is an enzyme that is utilised by transposable phages, including the well 
characterised E. coli phage Mu and one of the phages in this study (LESφ4). Mu-like 
prophages have been observed in a diverse range of bacteria (Morgan et al., 2002) 
and are commonly identified infecting P. aeruginosa (1.4.3.1.1.1). Mu integrates into 
the host chromosome by a conservative transposition event (Harshey, 1984), 
facilitated by transposase. Because of the homology-independent nature of 
transposition (Shapiro, 1979), Mu can integrate randomly in the bacterial 
chromosome (Bukhari & Zipser, 1972), occasionally disrupting coding genes as a 
result, hence its name Mu, short for “mutator”. The P. aeruginosa phage D3112 is 
also capable of insertional mutation (Rehmat & Shapiro, 1983).  
1.4.1.2.3 Induction 
Even if lysogeny is established, the lytic cycle can resume at any point, in a process 
known an induction. In the case of λ, the phage excises itself from the bacterial 
chromosome and re-enters the lytic cycle, producing virions and lysing the cell 
(Figure 1.5). Integrase is again required for excision, in combination with another 
phage-encoded enzyme, excisionase (Cho et al., 2002).  
Mu does not excise from the genome like λ, but instead remains in the same location 
within the genome and copies itself by replicative transposition (Shapiro, 1979). Mu 
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is not cleaved from the chromosome until late in the lytic cycle (Ljungquist & 
Bukhari, 1977), a characteristic also shared by the  P. aeruginosa transposable phage 
D3112 (Rehmat & Shapiro, 1983). 
Induction is known to be triggered by DNA damaging agents, including particular 
antibiotics, UV light and reactive oxygen species. It occurs as part of the bacterial 
SOS response, which is a global cellular response to non-lethal DNA damage that 
culminates in increased DNA repair, inhibition of cell division and prophage 
induction. The SOS response in E. coli involves activation of the RecA protease, 
which cleaves LexA, a repressor of genes involved in the SOS reponse (Little & 
Mount, 1982). The presence of activated RecA also results in autocleavage of the cI 
repressor, a phage-encoded protein that is essential for maintenance of lysogeny, 
triggering a cascade of genes involved in the λ lytic cycle (Ptashne, 2004). Prophage 
induction is thought to be a phage survival strategy, enabling a phage to escape a cell 
that is at risk of death (Refardt & Rainey, 2010).  
Mitomycin C is a DNA cross-linking agent (Iyer & Szybalski, 1964) and a potent 
phage inducer, so is used commonly in prophage induction studies (Castellazzi et al., 
1972; Jiang & Paul, 1996; Ramirez et al., 1999). Fluoroquinolone antibiotics such as 
norfloxacin and ciprofloxacin inhibit DNA synthesis (Hooper, 2001), and 
consequently induce the SOS response in E. coli (Phillips et al., 1987). In P. 
aeruginosa, exposure to ciprofloxacin (which is used in the management of P. 
aeruginosa infections) has been linked with upregulation of phage-related genes 
(Cirz et al., 2006) and increased production of phage virions (Fothergill et al., 2011). 
P. aeruginosa phages are detected at high levels in CF sputa, most likely as a result 
of phage induction of lysogenic bacteria (James et al., 2014); environmental factors 
affecting phage production are explored in Chapter 3. 
Induction can also occur in the absence of any known environmental triggers, and is 
known as spontaneous induction. This often occurs at low but detectable levels in 




1.4.1.2.4 Prophage degradation 
Some prophages accumulate mutations or deletions in genes required for lysis, and 
become known as cryptic, or defective prophages. However, some defective 
prophages are capable of forming infectious phage particles when in the presence of 
a helper phage. This has been described in the opportunistic pathogen Enterococcus 
faecalis; it has 7 prophages, one of which is dependent on another for encapsidation 
in order to produce infectious phage particles (Matos et al., 2013).  
Cryptic or defective prophages are common in bacterial genomes, although they can 
be difficult to detect, especially after extensive degradation and so their prevalence 
may actually be underestimated. A re-examination of a pathogenic E. coli strain 
questioned whether phages that are identified as defective from sequence data are 
defective at all. E. coli 0157 Sakai has 18 prophages, and genome sequence analysis 
found defects in all but one, for example in genes required for excision or 
morphogenesis. Despite this, half of the phages could excise and replicate, and many 
of those could form functional phage particles, even those that were defective in 
morphogenesis, strong evidence of phages complementing each other (Asadulghani 
et al., 2009). 
1.4.1.2.5 Benefits of prophage carriage 
Prophages carry multiple genes, some of which can confer a fitness benefit to the 
bacterium (discussed in more detail in Chapter 3), and this may help explain the high 
numbers of prophages observed in many bacterial genomes (Hayashi et al., 2001b; 
Matos et al., 2013; Wang et al., 2010b; Winstanley et al., 2009). Pathogenic strains 
have a higher proportion of phage-related genes than non-pathogenic strains (Busby 
et al., 2013) and many serious pathogens carry multiple prophages (Hayashi et al., 
2001b; Winstanley et al., 2009), suggesting that prophages may make a significant 
contribution to bacterial pathogenicity. 
1.4.2 Phage classification 
There is no universal gene in bacteriophages that is akin to the 16S rRNA gene of 
bacteria that can be used to determine phylogenies, so classification is based 
primarily on morphology and genetic material (King et al., 2011), but phages can 
31 
 
also be grouped according to characteristics such as host range, genome size, life 
cycle, sequence similarity and genome organisation (Ackermann, 2009). Following 
advances in technology, de novo peptide sequencing of major phage proteins has 
been used to determine relatedness between P. aeruginosa phages (Ceyssens et al., 
2009b), representing yet another potential mechanism for phage classification. 
In the most recent report by the International Committee on Taxonomy of Viruses 
(ICTV), there were over six orders, 87 families, 19 subfamilies and 348 genera of 
viruses (including, but not limited to, bacteriophages). Phages are grouped firstly by 
their genetic material (i.e. ss/ds DNA/ RNA), and within that, grouped into orders 
based on morphology, which are further subdivided into families, sub-families 
genera and species (King et al., 2011). Phage taxonomy is constantly evolving, and 
the ICTV recently published a report clarifying multiple changes to the system of 
virus classification and taxonomy that had been decided following the last official 
report in 2011 (Adams et al., 2013). 
1.4.2.1  Mosaicism 
Temperate phage genomes are highly mosaic, consisting of modules that are 
interchangeable between phages by recombination (Hendrix et al., 1999). Mosaicism 
obviously makes phage classification very difficult, as two phages could share 90% 
similarity for the tail genes for example, but very low sequence similarity across the 
rest of the genome. The dsDNA phages in particular are difficult to classify; multiple 
dsDNA phages from diverse bacterial genera have been shown to share sequence 
similarity, suggestive of a shared ancestry and extensive horizontal gene transfer 
(Hendrix et al., 1999). 
Many phages encode their own recombinases (Lopes et al., 2010), enzymes that 
catalyse recombination between homologous stretches of DNA. The Rad52-like 
recombinase of λ allows more “relaxed” recombination than the bacterial 
recombinase RecA (i.e. recombination between more diverse sequences), suggesting 
a key role for phage recombinases in the generation of mosaicism. Bioinformatic 
analysis identified evidence of homologous recombination in numerous phage 
genomes, but interestingly not between lytic and temperate phages (De Paepe et al., 
2014). Within the LESB58 prophage pool, several of the prophages share regions 
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with high sequence similarity, but otherwise are not homologous across the rest of 
the genome, suggestive of recombination-driven mosaicism (Winstanley et al., 
2009). 
1.4.3 Pseudomonas aeruginosa phages 
There are 128 Pseudomonas phage genomes in the EMBL-EBI database (at the time 
of writing) and many more as prophages in bacterial genomes (McWilliam et al., 
2013). P. aeruginosa phages isolated from geographically diverse locations can be 
closely related and classified into a limited number of subgroups (Ceyssens et al., 
2009b), although a more recent study of  phages isolated in Mexico suggested that 
the diversity of P. aeruginosa phages may be larger than previously thought, as 12 
different “species” were identified, six of which were novel (Sepúlveda-Robles et al., 
2012). 
1.4.3.1 Caudovirales 
The majority of known phages infecting bacteria and archaea are members of the 
order Caudovirales, consisting of the three families of dsDNA tailed phages, 
Siphoviridae, Myoviridae and Podoviridae (King et al., 2011). Classification of 
Caudovirales into families is based on tail morphology; Siphoviridae have long, non-
contractile tails, Myoviridae have long, contractile tails, and Podoviridae have short 
tails. All the phages used in this study belong to the family Siphoviridae, which is 
discussed in more detail in the following section. 
1.4.3.1.1 Siphoviridae 
The majority of Pseudomonas phages are Siphoviridae (Ackermann, 2007; Knezevic 
et al., 2009) with the long, non-contractile tails. The genome organisation of 
Siphoviridae tends to be quite conserved; for example, E. coli lambdoid phages have 
head and tail genes at the 5' end, genes involved in replication and recombination in 
the middle, and genes involved in host lysis at the 3' end (Casjens, 2005). 
1.4.3.1.1.1 Transposable phages 
Within the Siphoviridae family of phages that infect Pseudomonas, there exists a 
group of 100+ transposable phages, (Ceyssens & Lavigne, 2010), including the well-
33 
 
characterised D3112 (Wang et al., 2004). They use the type IV pilus as a receptor to 
infect the bacterium and encode transposases for integration and replicative 
transposition, like E. coli phage Mu. Like Mu, D3112 replicates across the genome, 
maintaining its original location until just before lysis, and can insert randomly into 
the genome (Rehmat & Shapiro, 1983). 
However, their genome organisation is λ-like (Wang et al., 2004; Winstanley et al., 
2009) and they are classed as Siphoviridae (like λ) based on virion morphology. The 
genome is organised 5' to 3' with the lysis and lysogeny genes, transposition and 
replication genes, and structural genes (Cazares et al., 2014). A comparative 
genomics study was recently undertaken for 12 P. aeruginosa transposable phages, 
and revealed a core genome conserved between phages, but also highly variable 
regions (accessory genome) that represent 6-10% of the phage genomes, 
hypothesised to include genes important for enhancing bacterial host fitness (Cazares 
et al., 2014). 
1.4.3.2 Inoviridae 
The Inoviridae are a family of ssDNA filamentous bacteriophages not assigned to the 
order Caudovirales. Pf1 was the first identified filamentous phage infecting P. 
aeruginosa; it infects the cell via the type IV pilus, and like other filamentous phages 
is unusual in that is does not cause cell lysis, but instead extrudes virions through the 
cell poles (Bradley, 1973; Hill et al., 1991). Pf1-like phages have since been 
discovered to be widespread, detectable in over 50% of P. aeruginosa strains as 
prophages (Knezevic et al., 2015). They are separated into 4 main clades: Pf4, which 
is the most abundant and found in PAO1, Pf5 (in PA14), Pf7 (in PA7) and Pf-LES 
(LES isolates, also referred to as LESφ6) (Knezevic et al., 2015). 
The Inoviridae are of interest because of their role in bacterial virulence and biofilm 
formation (1.2.7), but this is dependent on the prophage accumulating mutations and 
developing into a superinfective, replicative form that is capable of cell lysis 
(McElroy et al., 2014; Rice et al., 2008). Pf4 and Pf5 are intact prophages in the 
PAO1 and PA14 genomes, respectively (Knezevic et al., 2015), and consequently 
can develop into the replicative forms (Mooij et al., 2007; Webb et al., 2004). 
However, other Pf1-like phages, including Pf-LES cannot be confirmed as intact by 
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sequence analysis (Knezevic et al., 2015), and the replicative form has not been 
demonstrated, so their contribution (if any) to virulence is undetermined. 
1.4.4 Mechanisms of phage resistance 
The majority of phage infections result in cell lysis, so it is unsurprising that bacteria 
have numerous mechanisms to prevent or terminate phage infection. The first line of 
defence is to prevent phage adsorbtion; phages require a specific receptor, so 
rendering these absent or defective, through mutations, phase variation etc. prevents 
infection. For example, type IV pili are common phage receptors:  in a panel of 15 
diverse P. aeruginosa phages, 10 required type IV pili for infection (Ceyssens et al., 
2009a). Mutations that result in defective or absent pili, such as in the pilA gene, 
normally leads to loss of motility and phage resistance, but it is not always that 
simple. For example, mutations in pilU or pilT result in retraction deficient, 
hyperpiliated mutants that cannot twitch. However, a pilU mutation does not lead to 
phage resistance (Whitchurch & Mattick, 1994). Other common phage receptors 
include the flagellum and lipopolysaccharide (Garbe et al., 2010; Hosseinidoust et 
al., 2013b; Jarrell & Kropinski, 1976).  
Once phages have absorbed to cells, superinfection exclusion (Sie) systems can 
prevent phage DNA injection. The Sie proteins are often encoded by resident 
prophages in the bacterial genome and protect from infection against related phages 
(Chapter 3). For DNA phages making it past this point, chromosomal or plasmid-
borne restriction modification systems may cleave phage DNA or methylate it, 
making it resistant to restriction, thus inhibiting the phage lytic cycle (Gingeras & 
Brooks, 1983). Furthermore, the CRISPR-Cas system acts to recognise and destroy 
phage sequences to which it has had prior exposure. 
The CRISPR-Cas system is a recently discovered form of acquired immunity to 
bacteriophages found in many bacterial and archaeal species (Barrangou et al., 
2007), including 36% of clinical P. aeruginosa strains (Cady et al., 2011). In P. 
aeruginosa, two types of CRISPR-Cas have been discovered, the type I-E (similar to 
E. coli) and the more prevalent type I-F (Yersinia-like) (Cady et al., 2011). 
Experiments with strain PA14, which has a functional type I-F system, and a panel of 
phages demonstrated that the bacteria acquired CRISPR-mediated resistance in 
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response to phage challenge (Cady et al., 2012). The type I-E system is also active in 
P. aeruginosa (Pawluk et al., 2014). The CRISPR-Cas system and phage counter-
resistance mechanisms are described in Chapter 3. 
The last resort is an abortive infection system (Abi), whereby programmed death of 
the bacterium occurs prior to cell lysis and phage release, thus protecting bacterial 
kin from phage infection (Chopin et al., 2005; Fineran et al., 2009). However, no 
specific Abi system has (to my knowledge) been described in P. aeruginosa. 
1.5 Summary 
P. aeruginosa is a significant respiratory pathogen in individuals with CF, and 
chronic infections are difficult to eradicate. P. aeruginosa adapts easily to its 
environment, in part due to the large accessory genome of this species which 
includes numerous phage-derived sequences. The Liverpool Epidemic Strain is a 
successful transmissible strain of P. aeruginosa, and genome sequencing of isolate 
LESB58 revealed six prophages contained within the genome, several of which were 
necessary for LES competitiveness in vivo. LES bacteriophages are present at high 
densities in CF sputa, but the role of these bacteriophages in driving P. aeruginosa 
diversification, and their effects on bacterial fitness have yet to be elucidated. Novel 
in vitro and in vivo infection models enable us to model chronic P. aeruginosa 
infection in the CF lung and test hypotheses.   
1.6 Objectives of study 
 Characterise the LES phages φ2-4 further by reannotating their genomes and 
determining environmental factors that influence their production. 
 Determine the extent to which LES phages drive P. aeruginosa 
diversification using an experimental evolution approach, coevolving the 
well-characterised laboratory strain PAO1 with and without LES phages φ2-4 
in an artificial sputum model of infection. 
 Compare phage-driven diversification in vitro to that observed in a rat model 
of chronic lung infection. 
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 Consider how LES prophage carriage affects the ability of bacteria to invade 




Chapter 2  Materials and methods 
2.1  Bacterial strains and growth conditions 
The strains of Pseudomonas aeruginosa used in this study and their origin are listed 
in Table 2.1. All strains were stored in Lysogeny Broth (LB) (Appendix A), with the 
addition of 25% (v/v) glycerol, and frozen at -80˚C. When required, a small aliquot 
of frozen cells was plated onto Columbia agar (Oxoid) and incubated overnight at 
37˚C. When liquid cultures were required, a single colony was transferred into a 
glass universal containing a 5 ml aliquot of LB and incubated at 37˚C, with shaking 
at 180 r.p.m. until desired growth was achieved. 



















PAO1 None Mini-Tn7 transposon marker 
inserted at a neutral and site-
specific location on 
chromosome. Expresses green 









PAO1 None Mini-Tn7 transposon inserted 
at a neutral and site-specific 
location on chromosome. 
Expresses DsRed-Express 




Constructed by Dr. 
Chloe James 
(unpublished) 






PAO1 None Mini-Tn5lux transposon 
mutant (tetracycline 
resistance). Insertion in pilA 
gene results in absence of 
typeIV pili. 
(Taylor & Buckling, 
2010) 




strain (He et al., 
2004) 
PLPLφ2 PAO1 LESφ2 LESφ2 lysogen Winstanley strain 
collection. 
Constructed by Chloe 













PAO1 LESφ2 Marker as for PAO1 DsRed-
Express. LES φ2 lysogen 
PLPLφ3 PAO1 LESφ3 LESφ3 lysogen Winstanley strain 
collection. 
Constructed by Chloe 
James (James et al., 
2012). 









PAO1 LESφ3 Marker as for PAO1 DsRed-
Express. LESφ3 lysogen 
PLPLφ4 PAO1 LESφ4 LESφ4 lysogen Winstanley strain 
collection. 
Constructed by Chloe 
James (James et al., 
2012). 









PAO1 LESφ4 Marker as for PAO1 DsRed-
Express. LESφ4 lysogen 
PLPLφtriple PAO1 LESφ2, 3 and 4 Triple LES phage lysogen Winstanley strain 
collection. 
Constructed by Chloe 




PAO1 LESφ2, 3 and 4 Marker as for PAO1 GFP. 
Triple LES phage lysogen 
Winstanley strain 
collection. 





PAO1 LESφ2, 3 and 4 Marker as for PAO1 DsRed-
Express. Triple LES phage 
lysogen 
LESB58 LES LESφ1:6 (full 
complement) 
Clinical strain; CF isolate Winstanley strain 
collection 
(Winstanley et al., 
2009) 
LESB65 LES LESφ1:4, 6 Clinical strain; CF isolate Winstanley strain 
collection (Fothergill 
et al., 2007; Jeukens 
et al., 2014) 
LES400 LES LESφ1:6 (full 
complement) 
Clinical strain; CF isolate Winstanley strain 
collection (Jeukens et 
al., 2014; Parsons et 
al., 2002) 
LES431 LES LESφ1,3:6 Clinical strain; Isolate from 
non-CF parent of child with 
CF 
Winstanley strain 
collection (Jeukens et 
al., 2014; McCallum 




2.1.1 Quantification of viable bacteria in a sample 
Bacterial cultures were serially diluted 10-fold and 6 x 20 µl spots pipetted onto 
Columbia agar for each dilution and allowed to dry. Plates were incubated overnight, 
the resulting colonies counted, and the colony forming units (c.f.u.) ml-1 calculated. 
If bacterial colonies were required for further processing, then a spread-plate method 
was used, to ensure numerous, well-separated colonies. 75 µl of a dilution was 
spread evenly across the surface of the plate with a sterile L-shaped spreader and 
allowed to dry. All platings were conducted in triplicate. 
2.1.2 Determination of the minimal inhibitory concentration (MIC) of 
antibiotics on bacterial strains 
Antibiotic powders were purchased from Sigma-Aldrich (unless otherwise stated) 
and dissolved in 1 ml sterile distilled water (SDW), with the exceptions of 
norfloxacin, which was dissolved in 1% (v/v) glacial acetic acid and water, and 
nitrocefin and rifampicin, which were dissolved in 100 mg ml-1 dimethyl sulfoxide 
(DMSO). SDW was added and the antibiotic solution sterile filtered through a 0.2 
µm syringe filter (Millipore). The concentrated stocks (100, 10 or 1 mg ml-1) were 
frozen at -20˚C until required, or made fresh, depending on the manufacturer’s 
recommendations. Stocks were diluted in Mueller Hinton broth (MHB (Oxoid)) to 
obtain required working concentrations. 
2.1.2.1 Broth microdilution method 
Two-fold serial dilutions of MHB/antibiotic were dispensed into rows of a sterile 96-
well clear, flat-bottomed microtitre plate (50 µl per well). Overnight liquid bacterial 
cultures were diluted to the turbidity equivalent of a McFarland standard 0.5 
(Beckton Dickinson), followed by a further 10-2 dilution, and 50 µl of this was added 
to each well and pipetted up and down to mix thoroughly. A growth control (MHB 
and bacteria only) and a sterility control (MHB only) were included on each plate. 
Plates were incubated for 18 hours at 37 ˚C and the MIC (i.e. lowest antibiotic 
concentration at which growth is inhibited) was determined by manual inspection of 
wells. Four wells per strain were tested on each plate, and each strain was tested on 
three individual plates. 
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2.1.2.2 Determination of the MIC for two antibiotics used in conjunction 
The MICs of two antibiotics when used in combination may differ due to synergism 
or antagonism. To determine the MICs of two antibiotics used together, the 
checkerboard broth microdilution method was used. As in (2.1.2.1), all dilutions 
were performed in MHB. Two-fold serial dilutions of antibiotic 1 were dispensed 
into the rows of a 96 well plate, and two fold serial dilutions of antibiotic 2 were 
dispensed into the columns. Each well contained 25 µl of each antibiotic. Bacteria 
were added to the wells and controls included on each plate (2.1.2.1). The 
combination MIC was determined as the lowest concentration for each antibiotic at 
which no bacterial growth was observed. One strain was tested per plate, and nine 
replicate plates were tested for each strain, necessary because of the inherent 
unreliability of this test (White et al., 1996).  
2.1.2.3 Disk diffusion method 
For high-throughput testing of multiple isolates, the standardised disc diffusion 
method was used, according to the British Society of Antimicrobial Chemotherapy 
(BSAC) guidelines (Andrews & Howe, 2011). Antibiotic susceptibility was 
determined by referring to the published breakpoints for P. aeruginosa (EUCAST, 
2013). All isolates were tested in duplicate. 
2.2 Use of artificial sputum medium (ASM) to culture bacteria 
2.2.1 Preparation of ASM 
ASM was prepared as described in (Kirchner et al., 2012)(Appendix A) and stored at 
4˚C for a maximum of eight weeks. 
2.2.2 Bacterial culture in ASM 
To set up initial cultures, 50 µl mid-exponential phase bacteria were inoculated into 5 
ml ASM in a glass universal. Cultures were incubated at 37 ˚C with slow shaking (65 
r.p.m.) for 96 hours.  
2.2.3 Degradation of ASM biofilms 
Biofilms were homogenised with Sputasol (Oxoid), a sputum liquefying agent. To 
prepare, 7.5 ml of Sputasol was diluted in 92.5 ml SDW. This was added in equal 
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volume to the bacterial culture, and the tube vortexed for 30 seconds, followed by 30 
minutes incubation at 37 ˚C with rapid shaking (200 r.p.m.), to disrupt the biofilms. 
Unused Sputasol was stored at 4˚C for a maximum of 4 days. 
2.3  General PCR methodology 
2.3.1 Crude DNA preparation using boiled bacterial colonies 
A small portion of a single colony was transferred into 50 µl SDW in a 0.2 ml PCR 
tube. The suspension was heated to 100˚C for 5 minutes and the resulting template 
used immediately in the standard PCR. 
2.3.2 Standard polymerase chain reaction (PCR) 
Standard PCR was carried out in 96 well PCR plates or 0.2 ml PCR tubes, depending 
on the number of samples. Each reaction contained: 1X Green GoTaq Flexi Buffer, 
2.5 mM MgCl2, 0.5 U GoTaq DNA polymerase (all Promega), 10 µM each dNTP 
(Bioline), 300 nM each primer and 5 µl crude DNA template. SDW was added to a 
final volume of 25 µl. Green GoTaq Flexi Buffer contains two dyes that migrate 
during gel electrophoresis, so addition of loading dye for gel electrophoresis was not 
required. All primer sequences and PCR cycling conditions are described in Table 
2.2. PCR cycling was carried out in an Eppendorf MasterCycler Gradient. 
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Table 2.2. Oligonucleotide primers used in this study 





Cycling conditions Study Reference 
P2F CTCCACTTCTCGGTTGCTTC 206 LES phage 2 95°C, 4 min then 30 
cycles: 95°C, 30 s; 
58°C, 30 s; 72°C, 30 s; 
final extension step, 
72°C, 7 min 
Any PCR assay 
involving detection of 






P3F TCAGGAAAACCTTGCCATTC 384 LES phage 3 
P3R GTCTTCTGGTGGTCGGTGAT 
P4F AGTTACGCCTGCTGGTGAGT 506 LES phage 4 
P4R CCTCAGTCGTGCCTTCTTTC 
2totF AGTAGCCGACCCAGACCTTT 141 LES phage 2 95°C, 10 min; then 
40 cycles: 95°C, 10 s; 
60°C, 15 s; 72°C 30s 
qPCR to detect relative 
copies of free LES 
phages 
(James et al., 
2012) 2totR ATGGAAGCAACCGAGAAGTG 
3tot1F CGCAGGTACCACCAGACTTT 122 LES phage 3 
3tot1R CATGTCCAGCAGGTTCAAAA 
4tot1F GCTCATGAGTGGCTGACAAC 105 LES phage 4 
4tot1R TCTTGGGCAGAGAACCATTC 
PS1 ATGAACAACGTTCTGAAATTCTCTGCT 249 P. aeruginosa oprI 
lipoprotein gene 
94°C, 5 min then 30 
cycles: 94°C, 1 min; 
60°C, 1 min; 72°C, 2 
min; final extension 
step, 72˚C, 5 min. 




(De Vos et al., 
1993) PS2 CTTGCGGCTGGCTTTTTCCAG 
lasRF GTGCCGAATCCATATTTG 854 lasR gene 95°C, 4 min then 30 
cycles: 95°C, 30 s; 
48°C, 30 s; 72°C, 30 s; 
final extension step, 
72°C, 7 min. 
Amplification and 
Sanger sequencing of 
lasR gene 
(Fothergill et al., 
2007) lasRR CCTTCCCTATATATCTGC 
7leftF TTCGAGTTGGATCCGGCC  247 fimU LJ (left 
phage-host 
junction) 
95°C, 4 min then 30 
cycles: 95°C, 30 s; 
55°C, 30 s; 72°C, 30 s; 
final extension step, 
72°C, 7 min. 
Confirmation of 
LESφ4 integration 
sites in PAO1 
This study 
7leftR GTCGTGCTGTGCTGATCTTT 
7fimUrF CGCTCATTCCGTGCCAATTA 358 fimU RJ (right 
phage-host 
junction)  
7fimUrR TCAATGCGATGCTGCAGTAC  
7leftF  328 fimU intact 
insertion site 7fimUrR  
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11leftF CTTCTTCAAGGCCAAGGGGT 458 pilV LJ    
11leftR CGATGGCGATACGGTGATGA 
11rightF GACGAGGTGCTTAGACGGAG 610 pilV RJ 
11rightR ATCATGGACAGGCCCGATTG 
11leftF  349 pilV intact 
integration site 11rightR  
Nar1F GTATCCGATTCCATCCTGGGGAA Variable 5̍ end of LES 
phage 4 
94°C, 3 min then 30 
cycles: 94°C, 1 min; 
60°C, 2 min; 72°C, 4 
min; final extension 
step, 72°C, 7 min. 








2.3.3 Visualisation of PCR products 
PCR products were visualised by agarose gel electrophoresis. Molecular grade 
agarose (Bioline) was dissolved in 0.5X TBE buffer (Appendix B). A 2% (w/v) 
agarose gel was used for PCR products below 650 bp, and a 1% (w/v) gel used for 
larger DNA fragments, or visualisation of intact genomic DNA. The agarose was 
melted by heating and cooled (to avoid vapour formation) prior to the addition of 
ethidium bromide to a final concentration of 0.1 µg ml-1. 4 µl of PCR product was 
added to each well, and a 1 KB+ marker (Invitrogen) was run alongside for size 
determination of products. For PCR reactions using the colourless GoTaq Flexi 
Buffer, 5 parts DNA were mixed with 1 part loading dye (Invitrogen), prior to 
loading. Electrophoresis was performed for 45-90 minutes at 100V and DNA was 
visualised under an UV transilluminator (Syngene InGenius). 
2.3.4 DNA extraction and purification from gels 
After agarose gel electrophoresis, required bands were cut from the gel using a 
disposable scalpel. DNA was extracted from the gel slice using the Qiaquick gel 
extraction kit (Qiagen). The gel slice was weighed and dissolved in buffer QG (3 
volumes buffer to 1 volume gel) by heating to 50˚C for 10 minutes. Isopropanol was 
added (1 volume isopropanol to 1 volume gel) and the mixture added to a spin 
column to bind the DNA. The column was centrifuged at 13 000 r.p.m. for 2 minutes 
and 500 µl buffer QG added to remove traces of agarose. The column was 
centrifuged again and 750 µl buffer PE (contains ethanol) was added to wash the 
DNA. The column was allowed to stand for 2 minutes before centrifugation at 
13,000 r.p.m. for 1 minute. The column was centrifuged for a further minute to 
remove traces of buffer PE and DNA was eluted by pipetting 30 µl buffer EB 
directly onto the centre of the membrane and allowing to stand for 2 minutes, 
followed by centrifugation at 13 000 r.p.m. for 1 minute. 
2.3.5 Determination of DNA concentration and quality 
DNA quality was assessed by spectrophotometric analysis, using a Nanodrop ND-
1000 spectrophotometer. The A230, A260 and A280 of 2 µl of DNA were measured, and 
the A260/280 and A260/230 ratios calculated. DNA was deemed acceptable quality if the 
A260/280 was 1.8 (±0.1) and the A260/230 was above 1.6. DNA quantity in the sample 
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was estimated by fluorimetric analysis, as this measures only DNA, and is not 
influenced by other nucleic acids that may be present in the sample. The double-
stranded DNA broad range assay (Invitrogen) was used to estimate DNA 
concentration. 10 µl DNA was added to 190 µl Qubit buffer (prepared according to 
the manufacturer’s instructions), which contains a dye that binds to DNA and emits a 
fluorescent signal. Samples were vortexed for 2-3 seconds and incubated at room 
temperature for 2 minutes. The fluorimetric signal was measured using the Qubit 
fluorometer and DNA concentration was estimated by comparison to known 
standards. 
2.4 Bacteriophages used in this study and general protocols 
All bacteriophages used in this study were initially isolated from P. aeruginosa strain 
LESB58 and purified. LESφ2, LESφ3 and LESφ4 were the only free LES phages 
used in this study as they were the only LES phages to be successfully isolated on 
strain PAO1 (James et al., 2012). Where phage production by bacterial strains is 
investigated, the bacterial strains used are detailed in Table 2.1. 
2.4.1 Separation of free infective bacteriophages from bacterial host 
Bacterial cultures were filtered through a 0.2 µm filter (Millipore) to remove cells 
and debris, unless otherwise stated. The phage-containing filtrate was stored at 4˚C. 
2.4.2 Preparation and storage of high titre phage stocks 
High titre phage stocks were prepared previously (James et al., 2012) and were 
stored at 4 ˚C. The titre was checked regularly. To achieve very high titre phage 
stocks, 500 µl sterile 4X PEG/NaCl solution (Appendix B) was added to 1500 µl 
high titre phage stock in a sterile 2 ml microfuge tube and inverted slowly to mix. 
Tubes were incubated overnight at 4˚C before centrifugation at 13,000 g for 15 
minutes at 4 ˚C, and the supernatant discarded. The pellet was resuspended in 120 µl 
PBS with overnight incubation at 4˚C. 
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2.4.3 Determination of bacteriophage titre 
2.4.3.1 Standard plaque assay 
100 µl mid-exponential phase (OD600 0.5) P. aeruginosa PAO1 was added to 100 µl 
of diluted bacteriophage suspension and vortexed. 5 ml of molten top agar (LB + 
0.4% agar (w/v)) was added, and the tube inverted three times, slowly so as to 
minimise bubble formation. The mixture was overlaid onto a standard LB agar (1% 
w/v) plate and allowed to set, before incubation overnight at 37˚C. Plaques were 
counted and plaque forming units (p.f.u.) ml-1 calculated as an estimate of the 
number of infective phages present. Three technical replicates were performed per 
bacteriophage dilution. 
2.4.3.2 Spot assay  
Where a more high-throughput method was required, a modification of the 
traditional plaque assay was used. PAO1 was mixed with top agar and overlaid onto 
LB agar. 20 µl spots of phage dilutions were pipetted onto the surface and allowed to 
dry, before overnight incubation. 
2.4.3.3 Quantifying levels of each phage separately 
The methods described in section 2.4.3.1 allow an accurate estimate of the total 
number of infective virions present in a sample, but cannot distinguish between 
bacteriophages. To obtain counts and differentiate between the different phages, two 
approaches were taken, quantitative real-time PCR (qPCR), and direct PCR of 
plaques. qPCR gives relative, rather than absolute numbers of phages present and 
does not indicate phage viability. Direct PCR of plaques was used when phage copy 
number was too low to be accurately estimated by qPCR. This method allows direct 
quantification of the number of infective phages of each type present in a sample but 
is time consuming and labour intensive. 
2.4.3.3.1 Quantitative real-time PCR (qPCR) method 
2.4.3.3.1.1 DNase I treatment of phage supernatants 
 Phage were separated from bacteria and DNase treated to remove contaminating 
bacterial/ prophage DNA. 17 µl phage supernatant was mixed with 2 µl incubation 
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buffer and 1 µl DNAse I recombinant (Roche) and incubated at 37 °C for 10 minutes. 
The reaction was stopped by the addition of EDTA to a final concentration of 8 mM, 
and heating to 75 °C for 10 minutes. A PCR assay was carried out using primers 
targeted to the bacterial outer membrane lipoprotein gene (oprI); a negative result 
confirmed total degradation of bacterial DNA. The phage supernatant was then 
heated to 100˚C for 5 minutes in order to burst the phage capsids and release the 
phage DNA. 
2.4.3.3.1.2 qPCR assays 
Copy numbers of each phage were estimated by comparison to a standard curve. 
Standards were produced by PCR amplification of bacteriophage supernatants 
(2.3.2). The amplified DNA was separated by gel electrophoresis and the correct 
sized DNA fragment extracted from the gel and purified (2.3.4). DNA concentration 
was estimated (2.3.5) and copy number calculated using the following formula: 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑝𝑖𝑒𝑠 =
(𝑎𝑚𝑜𝑢𝑛𝑡 𝐷𝑁𝐴 (𝑛𝑔) ∗ 6.022 ∗ 1023)
(𝑎𝑚𝑝𝑙𝑖𝑐𝑜𝑛 𝑙𝑒𝑛𝑔𝑡ℎ (𝑏𝑝) ∗ 6.6 ∗ 1011)
 
A 10-fold dilution series of each standard was prepared for each primer pair, ranging 
from a concentration of 102 – 107 copies µl-1. The set-up of the qPCR reaction was 
automated with the Qiagility liquid handling robot (Qiagen). Each reaction 
contained: 1X SYBR green mastermix (Qiagen), 1 µM each primer, 1 µl DNase-
treated phage supernant (or standard) and DEPC-treated water, to a final volume of 
25 µl. Reactions took place in 0.1 ml strip-tubes (Qiagen), which were placed in a 
Rotor-Gene 6000 (Corbett). Cycling conditions are detailed in Table 2.2. Data were 
analysed with the accompanying software. Negative controls and standards were 
included in each run, with 2 replicates per concentration. Three technical replicates 
per sample were performed each run and averaged, and each sample was tested on 3 
separate runs. 
2.4.3.3.2 PCR amplification from plaques 
A plaque assay was performed to obtain numerous, well separated plaques. To 
identify the phage responsible for each plaque, crude DNA was prepared from the 
plaque using a modification of the bacterial colony boil preparation; a pipette tip was 
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placed directly into the centre of the plaque and the material transferred into SDW, 
prior to boiling. The resulting template was used in a standard PCR reaction with 
primers targeted to the phage genomes (Table 2.2). The p.f.u. ml-1 per phage was 
calculated as the total p.f.u.ml-1, multiplied by the proportion of plaques caused by 
the phage. 76 plaques were tested for each biological replicate, with a total of three 
biological replicates. 
2.4.4 Factors affecting phage production in original bacterial host strain 
To test the effect of substances on phage production by bacterial strains, mid-
exponential phase cultures were exposed to a sub-inhibitory concentration of the 
substance for 1 hour (2.4.4.1, 2.4.4.2, 2.4.4.3). Cultures were then diluted 1:10 into 
fresh media and incubated for a further two hours, to allow bacterial recovery and 
phage lysis. Phages were separated from bacteria and quantified.  Norfloxacin 
(known to induce the lytic cycle of the phages used in this study) was used as a 
positive control and added at the MIC for the bacterial strain (2.1.2.1). Four 
biological replicates were carried out for each strain/ substance combination. 
2.4.4.1 Antibiotics 
Antibiotics were added singly, or in combination, at the MIC for the bacterial strain. 
2.4.4.2 Ethylenediaminetetraacetic acid (EDTA)  
EDTA was dissolved in water and autoclaved, and added to a final concentration of 5 
mM, both alone, and in combination with norfloxacin. 
2.4.4.3 Hydrogen peroxide 
Hydrogen peroxide solution (Sigma-Aldrich) was added to a final concentration of 0, 
2.5, 5 or 50 mM. To verify that hydrogen peroxide did not affect bacterial viability at 
the concentrations used, bacterial viable cell counts were calculated after 1 hour 
incubation with hydrogen peroxide and compared to the control. 
2.4.5 Phage one-step growth curves 
1 ml mid exponential phase PAO1 was mixed with a 1 ml aliquot of purified phage 
preparation, at a concentration of 2 x 105 p.f.u. ml-1 (an approximate MOI of 2 x 10-
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3), inverted slowly to mix, and incubated at 37 ˚C for 5 minutes to allow phage 
adsorption. The mixture was centrifuged at 6,000 g for 2 minutes and the pellet 
resuspended in 20 ml LB, pre-warmed to 37 ˚C. The bacterial suspension was 
incubated at 37 ˚C, with shaking at 180 r.p.m., and every 10 minutes, 200 µl was 
removed, centrifuged at 6,000 g for 2 minutes to pellet the bacteria, and the phage in 
the supernatant quantified. The unadsorbed phage in the discarded supernant from 
the first step were quantified, and the frequency of infected bacteria calculated as the 
MOI multiplied by the proportion of phage adsorbed. The number of phage per 
infected cell was calculated for every time point by dividing the total number of 
phages by the number of infected cells. The growth curve for each phage was 
repeated 4 times, on separate days. 
2.4.6 Measurement of the frequency of lysogeny of bacteriophages upon 
bacterial infection 
A single colony of PAO1 was inoculated into 5 ml ASM and incubated for 24 hours 
and the culture was homogenised. The OD600 was adjusted to 1.0 (5 x 10
8 c.f.u.ml-1) 
and bacteriophage added to a multiplicity of infection (MOI) of 10. The mixture was 
incubated on ice for 30 minutes, with regular inversions, to allow phage adsorption. 
It was then transferred to 37˚C for 20 minutes, with shaking at 65 r.p.m. to allow the 
cells to make the lysis/ lysogeny decision. The mixture was then transferred to ice for 
5 minutes, followed by centrifugation at 4˚C at 12,000 g for 2 minutes. The 
supernatant was discarded and the pellet washed twice with ice cold 10 mM MgSO4. 
The pellet was resuspended in 1 ml ice-cold LB and the cells serially diluted down to 
10-5, on ice. Dilutions were plated onto a P. aeruginosa PAO1 soft-agar overlay 
(2.4.3.2) for infective centres (ICs). An IC is observed as a plaque, and is defined as 
any cell that has been infected by a phage, regardless of the decision made by the 
cell. Both lytic and lysogenic infections result in plaques; when a cell becomes a 
lysogen, the high rate of spontaneous entry into the lytic cycle results in lysis of 
surrounding cells, hence a plaque is formed. In addition, dilutions were plated onto 
Columbia agar for colony forming units. Only uninfected cells and lysogens formed 
colonies; cells that entered the lytic cycle lysed. The colonies observed were then 
screened for the presence of prophage to determine the number of lysogens; colonies 
were patched onto a PAO1 soft agar lawn and incubated overnight. Spontaneous 
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lysis of the surrounding area was indicative of a lysogen (Figure 2.1). The frequency 
of lysogeny was calculated with the following equation: 
Frequency of lysogeny = (Number of lysogens/infective centres)*100 
 
 
Figure 2.1 Screening of colonies for the presence of prophage. Single colonies were patched onto the PAO1 
soft agar lawn (1 per grid-square) and incubated overnight. PAO1 was used as a negative control, and the 
corresponding PLPL as a positive control. The zone of lysis surrounding the positive control can be easily 
distinguished. 
 
2.4.7 Phage amplification efficiency in different bacterial growth media 
25 ml glass universal tubes containing 5 ml LB or ASM were each inoculated with 
strain PAO1 and incubated for 24 hours at 37°C with shaking at 180 r.p.m. (LB) or 
65 r.p.m. (ASM). Phage were added to the stationary phase cultures to a final titre of 
1 x 105 p.f.u. ml-1 (M.O.I. = 5 x 10-5) and cultures incubated for a further 24 hours. 
Cultures were homogenised and the bacteriophages separated and enumerated. The 
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fold change in titre (day-1) was calculated for each phage under each condition. Six 
replicates were performed for each phage in each bacterial growth medium. 
2.5 Experimental coevolution of P. aeruginosa and bacteriophages in ASM 
2.5.1 Experimental design 
Replicate populations were set up, with each population defined as a culture of P. 
aeruginosa PAO1 in ASM (2.2.2). Six populations were assigned to each of two 
main treatments; a control treatment (PAO1 alone) and a LES phage treatment 
(PAO1, plus the three LES phages (LES φ2, LES φ3 and LES φ4)). Three additional 
control treatments (each with addition of a single phage) were included in the 
experimental design, but were not subjected to the same follow-up experiments as 
the two main treatments (sections 2.5.3 to 2.5.7.5). Bacteria were incubated for 24 
hours prior to addition of the phages. Phage were added to a MOI of 0.1 (with equal 
numbers of each phage), and were added only once, at the beginning of the 
experiment. The cultures were incubated for a further 3 days and the biofilms 
homogenised. 50 µl of the homogenate was transferred into 5 ml ASM and the 
process was repeated, for a total of 30 transfers. Every transfer, 1 ml of homogenate 
from each population was stored at -80 ˚C in 25 % (v/v) glycerol-LB. The 
experimental design is summarised in Figure 2.2. 
2.5.2 Quantification of bacterial and phage numbers throughout the 
experiment 
At every other transfer, the numbers of viable bacterial cells and total free phages in 
the biofilm homogenate were quantified. In addition, at every 5th transfer, bacteria 
were screened for the presence of prophage, using multiplex PCR with three sets of 
primers (Table 2.2), targeted to each phage. Free phage levels were measured 





Figure 2.2 Bacteria-phage coevolution in ASM: experimental design 
2.5.3 Endpoint assessment of colony morphology diversity 
After 30 transfers, cultures were spread-plated to obtain >300 well-separated 
colonies. Colony morphology was independently classified by two researchers into 
one of five morphologies: Smooth and straw-coloured, small (<0.5mm) and straw-
coloured, raised centre, fuzzy spreader or wrinkly spreader. Simpson’s dominance 
index, D (the complement of Simpson’s diversity index) was calculated for each 
population as a measure of the morphological diversity within a population (Hill et 
al., 2003) using the following formula: 
𝐷 =
1 − (∑n(n − 1))
N(N − 1)
 
where n = number of colonies displaying a particular morphology, and N = the total 
number of colonies (all morphologies).  
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2.5.4 Endpoint isolation of individual colonies 
Forty colonies were selected randomly from each population, by dividing plates into 
portions with a grid, and picking all colonies within each square, moving in a 
predetermined direction across the plate, until the quota was reached. Isolates were 
streaked onto Pseudomonas isolation agar (Appendix A) to confirm that they were 
Pseudomonas spp. and stored in sterile 96-well plates, in 25% (v\v) glycerol-LB. 
Each isolate was characterised with multiple phenotypic tests (2.5.5). 
2.5.5 Phenotypic characterisation of endpoint isolates 
The ancestral PAO1 strain was used as a negative control for all phenotypic tests. All 
phenotypic tests were performed in duplicate. 
2.5.5.1 Auxotrophy 
A single colony was patched onto M9 minimal media (Appendix A) and incubated at 
37 °C. Isolates displaying no growth after 18 hours were classed as auxotrophic. 
2.5.5.2 Biofilm formation 
Overnight cultures were diluted 1:100, and 150 µl added to each well (n=8 per 
isolate) of a clear-bottomed 96 well plate. Plates were incubated statically for 24 
hours at 37 ˚C. Liquid was removed and the wells washed gently with PBS (3 times) 
to remove all planktonic bacteria. Plates were dried at 60 ˚C for 90 minutes to fix the 
biofilms, and biofilm mass stained by addition of 200 µl of 0.25 % crystal violet 
(w/v) for 10 minutes at room temperature. Crystal violet was removed by gentle 
washing with tap water, and the crystal violet stain resolubilised in 125 µl 95% 
ethanol. The absorbance of each well was measured at a wavelength of 590 nm. The 
mean A590 was calculated for each isolate on the plate, and normalised to the ancestor 
by dividing by the A590 value for PAO1 on that plate. Two independent biological 
replicates were performed for each isolate. Only the first 10 isolates were tested per 
population, due to time constraints. 
2.5.5.3 Hypermutability 
10-fold serially diluted overnight cultures grown in LB were spotted onto LB agar 
plates containing 300 µg ml-1 rifampicin. Plates were incubated overnight at 37 °C. 
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Isolates were classed as hypermutable if growth on rifampicin was comparable to 
PAOΔmutS, a known hypermutator. 
2.5.5.4 Motility 
2.5.5.4.1 Swarming 
A small portion of a colony was lightly touched onto the surface of a swarming plate 
(Appendix A). Plates were incubated for 16 hours at 37 ˚C and the diameter of the 
swarm measured at the widest point. An isolate with a diameter <6 mm was 
considered swarming deficient. 
2.5.5.4.2 Swimming 
A small portion of a colony was lightly touched to the surface of a swimming plate 
(Appendix A).  Plates were wrapped loosely in clingfilm to prevent dehydration, and 
incubated without inversion for 14 hours. The visible diameter of bacterial growth 
was measured at the widest point. An isolate with a diameter <20 mm was 
considered swimming deficient. 
2.5.5.4.3 Twitching 
A colony was stabbed through to the bottom of a LB agar plate and incubated for 24 
hours. The agar was removed with forceps and 10 ml 0.25 % (w/v) crystal violet 
added to the plate for 30 minutes, to stain the area of bacterial growth. The crystal 
violet was removed and plates rinsed with water. The diameter of bacterial growth 
was measured at the widest point. An isolate with a diameter <10 mm was 
considered twitching motility impaired. 
2.5.5.5 Phage resistance 
To test bacterial resistance to the phages used in this study, a modified version of the 
phage spot assay was used. 20 µl of 10-fold diluted overnight culture was mixed with 
200 µl agar overlay and poured into a well containing 1 ml bottom agar, in a 25 well 
square petri dish (Fisher Scientific).  High titre (>1x1010 pf.u. ml-1) preparations of 
each phage were spotted on top. Isolates were classed as resistant to a phage if there 
was no evidence of bacterial lysis after overnight incubation at 37 ˚C. 
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2.5.5.6 Prophage complement 
Isolates were tested for the presence of the three prophages with a multiplex PCR 
assay (2.3.2, primers described in Table 2.2), using crude DNA templates (2.3.1). 
2.5.5.7 Growth in LB 
Overnight cultures were diluted 1:100 and 200 µl added to wells (n=4 per isolate) of 
a clear-bottomed 96 well plate. The plate was held at 37 ˚C, with shaking at 100 
r.p.m. in an Omega fluostar plate reader. The OD600 was measured every 5 minutes 
and the doubling time in the exponential phase of growth calculated for each well. 
Two biological replicates were performed per isolate. Only the first 10 isolates were 
tested per population, due to time constraints. 
2.5.5.8 Antibiotic susceptibility 
Antibiotic susceptibility was determined using the disc diffusion assay (2.1.2.3) to 
six anti-pseudomonals, chosen because they are core components of the CF treatment 
regime. They were: piperacillin/ tazobactam, ceftazidime, meropenem, ciprofloxacin, 
tobramycin and colistin. 
2.5.6 Detection of clinically antibiotic resistant isolates at a low abundance in 
whole populations 
To investigate the possibility of the existence of clinically antibiotic resistant isolates 
at a low abundance in a population, a modified version of the agar dilution method 
for testing MICs was developed. Clinical antibiotic resistance is defined as the ability 
to grow in the presence of antibiotics that are in clinical use, at concentrations higher 
than the breakpoint levels of clinical resistance, which are updated regularly 
(EUCAST, 2013). Whole population cultures were adjusted to the turbidity 
equivalence of a McFarland standard 0.5 (Beckton Dickinson), and plated onto MHA 
to obtain c.f.u.ml-1. 100 µl of undiluted culture was plated directly onto MHA plates 
containing antibiotics at the breakpoint levels for clinical resistance (EUCAST, 
2013). After overnight growth at 37 °C, colonies growing on antibiotic-containing 
media were calculated as a proportion of total population counts. PAO1 grown in 
ASM was included as an additional negative control, to control for any effects 
caused by growth in a biofilm. 
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2.5.6.1 Beta-lactamase assay of beta-lactam resistant isolates 
Isolates were passaged twice through antibiotic free media to ensure basal (as 
opposed to induced) beta-lactamase levels were being studied. Cultures were grown 
to an OD600 0.3, and nitrocefin (Merck-Millipore) was added to a final concentration 
of 51.6 µg ml-1. As the λmax of nitrocefin changes from 390 nm (in the absence of 
beta-lactamase) to 486 nm upon hydrolysis, the absorbance at both wavelengths was 
measured every 5 minutes, for 35 minutes. The A486/390 ratio was calculated for every 
time point as an indicator of beta-lactamase production. Five biological replicates 
were performed for each isolate. 
2.5.7 Genotypic characterisation of endpoint populations 
2.5.7.1 DNA extraction and pooling 
DNA was extracted from all 40 isolates within each population, normalised and 
pooled, and the pooled DNA from each population was sequenced, allowing an 
estimation of the frequency of variants in the population. DNA was extracted from 
overnight cultures using the Wizard genomic DNA extraction kit (Promega) and 
eluted in Qiagen elution buffer. DNA for each isolate was quantified in triplicate 
(2.3.5) and normalised to the lowest concentration in the pool, resulting in equal 
amounts of DNA for isolates across the population. 
2.5.7.2 DNA sequencing 
Library preparation (500 bp paired-end) was done by the Liverpool Centre for 
Genomic Research (CGR). Samples were sequenced on a HiSeq 2000 (Illumina), 
with multiplexing of 3 samples per flow cell lane. 
2.5.7.3 Bioinformatics analysis 
Bioinformatics analysis was performed by Dr. Sam Haldenby, CGR. Briefly, single-
nucleotide variants (SNVs) were called by mapping to the reference strain PAO1-
UW. Pre-existing variants in our PAO1 strain were filtered out after resequencing of 
this strain, as PAO1 is known to demonstrate substantial diversity between 
laboratories (Klockgether et al., 2010). Prophage positions in the PAO1 genome 
were determined by examination of contig ends.  
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2.5.7.4 PCR confirmation of single nucleotide polymorphisms (SNPs) in the 
lasR gene 
An 854 bp region, encompassing the entire lasR gene (719 bp) and a small region of 
the adjacent rsaL gene was amplified using standard PCR, using the LasRF and 
LasRR primer pair (Table 2.2). Amplified DNA was purified using the QIAquick 
PCR purification kit (Qiagen), according to the manufacturer’s instructions, and 
Sanger sequenced (Source Bioscience) using the reverse primer. Sequence quality 
was assessed by inspection of the sequence chromatogram using Finch TV 
(Geospiza). Good quality sequence was similarity searched using the nucleotide 
basic local alignment search tool (BLASTn), against P. aeruginosa PAO1 sequences 
in the non-redundant nucleotide database. All other parameters were set to the 
default. Alignments were inspected to identify variants. 
2.5.7.5 PCR confirmation of phage integration sites 
PCR amplification was conducted to confirm phage integration sites, and quantify 
the exact frequency at which a specific integration site occurred in a population. Dual 
PCR amplification was used to amplify both the left and right phage-bacterial 
chromosomal junctions, and the principle is summarised in Figure 2.3. Primer pair 1 
targeted the left bacterial-phage junction, with the forward primer designed to bind to 
the bacterial gene and the reverse primer to the 3ʹ end of the phage. Primer pair 2 was 
designed to target the right junction, with the forward primer designed to bind to the 
5ʹ end of the phage and the reverse primer to the bacterial gene. Positive 
amplification yielding two products confirmed occupation of the locus by LESφ4. 
Positive amplification between the forward and reverse primer of primer pair 1 and 
2, respectively, yielding a single product, indicated an intact integration site. If an 
isolate was PCR positive for prophage, but had an intact integration site, the phage 
was assumed to have integrated elsewhere in the PAO1 genome. Primers were 
designed to span the fimU integration locus in population 7, and the pilV integration 
locus in population 11. All 40 endpoint isolates were PCR screened to obtain each 
integration frequencies, in addition to 20 isolates per time point, per population, at 




Figure 2.3 Diagram to illustrate the concept of PCR confirmation of LES φ4 integration sites in the PAO1 
genome. 
 
2.5.7.6 Inverse PCR to determine LES φ4 phage integration site 
Inverse PCR (IPCR) was used to determine LESφ4 integration sites in the single-
phage control treatment (as sequence data was not available), allowing a comparison 
of phage integration sites in the presence and absence of other LES phages. The 




Figure 2.4 Diagram to illustrate the concept of inverse PCR to determine LESφ4 integration sites in the 
PAO1 genome. 
2.5.7.6.1 Restriction endonuclease digestion 
Genomic DNA was extracted (2.5.7.1) and digested with NarI restriction enzyme 
(New England Biolabs), selected as it was known to cut 775 bp into the 5̍ end of 
LESφ4, and also at numerous points throughout the PAO1 genome. Digestion was 
performed according to manufacturer’s recommendations. The enzyme was 
inactivated by heating to 65 ˚C for 20 minutes, and the digested DNA purified using 
the QIAquick PCR purification kit (Qiagen), and quantified.  
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2.5.7.6.2 Recircularisation of DNA fragments 
Ligation is favoured at low DNA concentrations and large reaction volumes. To this 
end, DNA was diluted to <1 ng µl-1 and 45 µl diluted DNA mixed with 5 µl 10X 
ligase buffer and 3 µl T4 DNA ligase (Stratagene). The mix was incubated at 18 ˚C 
overnight, then heated to 100 ˚C for 3 minutes, to introduce nicks in the circularised 
DNA. The DNA was purified again, as before, and eluted in a small (30 µl) volume 
to ensure the DNA was as concentrated as possible.  
2.5.7.6.3 PCR amplification of DNA 
Primers were designed using the free software FastPCR, which has a tool to allow 
design of primers for IPCR. Primers were designed to face outwards (as opposed to 
conventional primers which face inwards) at the 5̍ end of the phage, in the region 
between the end of the phage and the first restriction enzyme cut site. Each PCR 
reaction contained: 500 nM each primer, 10 µM each dNTP (Bioline), 10 µl Q5 
reaction buffer, 10 µl high GC enhancer, 1 U Q5 high-fidelity DNA polymerase (all 
New England Biolabs), 5 µl ligated DNA and DEPC treated water, to a final volume 
of 50 µl. Q5 DNA polymerase was selected due to its low error rate and its improved 
ability to amplify long and difficult sequences, relative to other polymerases. Primers 
and cycling conditions are described in (Table 2.2). 
2.5.7.6.4 Sanger sequencing of DNA amplicons to determine phage integration 
site  
The entire PCR reaction was subjected to agarose gel electrophoresis. The most 
visible band was selected and the DNA extracted (2.3.4). The amplicon was Sanger 
sequenced (Source Bioscience) using the reverse primer. BLASTn analysis revealed 
a small portion of sequence with high similarity to the end of the phage (c repressor 
gene), and the remainder of the sequence matched to the phage integration locus in 
the PAO1 genome.  
2.6 Direct competition of evolved populations with ancestor in ASM 
Endpoint evolved populations were competed against antibiotic labelled PAO1 
strains, so that the competitors could be easily separated. Whole-populations were 
competed, rather than individual isolates, as it is known that in genetically diverse 
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populations, the fitness of individual isolates are not representative of population 
level-fitness (Wong et al., 2012). Populations were competed against their 
“ancestor”, PAO1::GmR, and to control for the competitive effect of phages, 
populations were also competed against a strain that does not produce the receptor 
required for phage infection, PAO1 pilA-::TetR. To confirm the absence of any fitness 
costs of the antibiotic gene cassette, wild-type PAO1 was competed against both 
antibiotic marked strains in LB. 
Prior to initiation of the competition, both competitors were acclimatised to the 
competition medium (ASM). Biofilm homogenate from endpoint populations, and 
stocks of the ancestral competitor strains, stored at -80 ˚C, were defrosted. 
Approximately 5 x 105 bacterial cells were inoculated into 1 ml of ASM in a sterile 
24 well tissue culture plate and incubated for 24 hours. Cultures were homogenised 
with Sputasol and diluted 5-fold. The OD600 for each competitor was measured and 
adjusted to 0.4. Competitions were initiated with a 50:50 starting ratio of each 
competitor; 50 µl of each competitor was inoculated into 5 ml ASM and incubated 
under conditions identical to 1 cycle of the coevolution experiment (2.5.1). The exact 
input cell density of each competitor was quantified by plating onto Columbia agar. 
After 4 days, biofilms were homogenized and diluted cultures plated onto both non-
selective media (LB agar) and the appropriate antibiotic media (LB agar containing 
10 µg ml-1 gentamicin or 50 µg ml-1 tetracycline), in order to quantify the density of 
each competitor. The density of the evolved PAO1 population was calculated by 
subtracting the density on antibiotic media from the density on non-selective media. 
Five independent biological replicates were performed for each competition. 
2.6.1 Estimation of bacterial fitness and calculation of the selection rate 
constant 
 The Malthusian parameter was calculated for each competitor, and describes the 
average rate of increase per day. The following equation was used: 
mi = (ln(final cell density/initial cell density))/ number of days 
and has units of day-1. The selection coefficient (Sij) is routinely used to compare the 
relative fitness of one strain to another, when in competition, by comparing the ratio 
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of the competitors’ Malthusian parameters. However, the selection coefficient relies 
on an increase in competitor density over the course of the competition. Due to the 
natural bacterial growth curve in ASM, cell densities were lower at the end of the 
competition than at the beginning, hence the selection coefficient could not be 
calculated. An alternative method is to calculate the selection rate constant (rij), 
which measures the subtractive difference of the Malthusian parameters of the two 
competitors: 
rij = mi – mj 
where i is the evolved competitor population and j is the ancestral PAO1 competitor, 
with units of day-1. 
2.7 Experimental coevolution of P. aeruginosa and LES bacteriophages in a 
rat model of chronic lung infection 
The rat model of chronic lung infection is a well established model for P. aeruginosa 
infection (Kukavica-Ibrulj et al., 2008b; Van Heeckeren & Schluchter, 2002), and 
involves infection (by intubation) with agar beads that contain the strain(s) of 
interest. This experiment was done in collaboration with Irena Kukavica-Ibrulj, in the 
lab of Professor Roger Levesque, at Laval University, Québec. The experimental 
design consisted of two groups of rats: a control group, which were infected with 
PAO1 only, and a phage-treated group, which were infected with PAO1, plus LES 
phages φ2, φ3 and φ4. 
2.7.1 Agar bead preparation 
PAO1::SmR was grown to an OD600 of 1.0 in tryptone-soy broth (TSB, Difco). 2 x 
1010 cells were centrifuged at 7,200 r.p.m. for 3 minutes, and washed 3 times in 
sterile PBS. Cells were resuspended in 1 ml PBS (controls), or in 1ml PBS 
containing LES φ2, φ3 and φ4, each at a concentration of 6.7 x 108 (phage 
treatment). The phage suspension in PBS was prepared according to (2.4.2), and 
gave an approximate total MOI of 0.1. The bead-making protocol results in some 
loss of both bacterial and phage titre (approximately 3 logs), hence it was necessary 
to determine the actual MOI once the beads had been made. However, we 
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determined that the loss of bacteria and phage throughout the process was 
proportional. 
The bacterial suspension was added to 10 ml molten 2% (w/v) agar-PBS, preheated 
to 48 ˚C, and vortexed vigorously. The mixture was poured slowly into the centre of 
an Erlenmeyer flask containing 200 ml sterile mineral oil (Sigma) held at 48 ˚C, with 
constant magnetic stirring. Ice was added to the sides of the flask to cool, and the 
stirring continued for 5 minutes. The stirring was ceased and the flask left at room 
temperature for 10 minutes to allow the beads to settle at the bottom of the flask. 
The mineral oil was siphoned off using a vacuum pump, and the beads washed with 
an equal volume of PBS, followed by centrifugation at 10,000 r.p.m at 4 ˚C for 20 
minutes. Residual mineral oil was removed, and this wash-step repeated a further 
two times to remove all the mineral oil. All but 50 ml of the PBS was removed, and 
the remaining PBS-bead suspension transferred into a sterile falcon tube and allowed 
to settle for 10 minutes. The majority of the PBS was removed, to leave 
approximately 7.5 ml of beads, suspended in an equal volume of PBS. The beads 
were stored at 4˚C prior to infection. 
2.7.1.1 Quantification of bacteria in the beads 
1 ml of the bead suspension was diluted into 9 ml PBS and homogenised (on ice) for 
30 seconds, using a PTA 20S Polytron homogeniser (Kinematica). Bacterial counts 
in the bead suspension were determined by plating on TSA containing 300 µg ml-1 
streptomycin. 
2.7.1.2 Quantification of bacteriophages in the beads 
Bacteriophages were quantified without centrifugation or filtration of the sample, to 
ensure that all bacteriophages were detected, even those that may have adsorbed to 
bacterial cells/ agar. The actual MOI was calculated by calculating the ratio of phage 
to bacterial counts in the beads. 
2.7.2 Rat infection 
Ethical approval for animal experiments was obtained from the Animal Care 
Committee, Laval University. Male Sprague-Dawley rats, weighing between 300-
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350 g, were housed in individual cages, with food and water ad libitum. Rats were 
weighed, and anaesthetised with 2% (v/v) isofluorane-oxygen, followed by an intra-
peritoneal ketamine injection to maintain anaesthesia. Rats were intubated using an 
18-gauge venous catheter, and a 1 ml tuberculin syringe used to deliver between 2 x 
107 and 4 x 107c.f.u.s into the lungs (in a volume of between 100 and 120 µl). Rats 
were sacrificed after 10 days, or earlier if showing signs of morbidity, with 0.2 ml 
Euthanyl (Bimeda-MTC), administered by intra-peritoneal injection. Lungs were 
removed and suspended in 10 ml sterile PBS, on ice. Lungs were homogenised as 
described for the beads (2.7.1.1), and the c.f.u.s in the lungs determined by plating 
onto TSA containing 300 µg ml-1 streptomycin. Total free infective phages in the 
lung homogenate were quantified using the methods described in 2.4.1 and 2.4.3.2. 
The phage to bacterium ratio was calculated as the total number of p.f.u.s in the 
lungs, divided by the total number of c.f.u.s. 
2.7.3 Characterisation of multiple endpoint isolates 
40 bacterial isolates were selected from each rat (as for the coevolution experiment in 
ASM (2.5.4)) and characterised for the presence of prophage (2.5.2) and twitching 
motility phenotype (2.5.5.4.3). 
2.8 In vitro bacterial invasion assays 
2.8.1 Experimental design 
PAO1 LES Phage Lysogens (PLPLs) are isogenic to PAO1 but contain 
bacteriophage(s) integrated into their genome i.e. they are lysogens (Table 2.1). The 
ability of bacteria harbouring prophages to both invade, and resist invasion to a 
population of phage susceptible bacteria was tested using fluorescently labelled 
PLPLs and non-lysogenic PAO1 (termed PAO1φ-). Each strain was labelled 
separately with both a green fluorescent protein (GFP) (Chalfie, 1995) and red 
fluorescent protein (DsRed-Express) marker (Lambertsen et al., 2004), to allow the 
effect of marker to be controlled. We tested three single prophage PLPLs (LESφ2, 
LESφ3 and LESφ4), and the PLPL harbouring all three prophages (PLPLφtriple), 
against PAO1φ-. Bacteria were competed from initial starting ratios of 1:9 (PLPL to 
PAO1φ-, and vice versa), and bacterial densities of each competitor were calculated 
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every 8 hours, over a period of 24 hours. At the end of the experiment, bacteria were 
plated and colonies were PCR screened for the presence of prophage.  
2.8.2 Growth in fluorometer and estimation of bacterial densities 
Both competitors were grown to mid-exponential phase (OD600 0.5) in LB. Cultures 
were centrifuged at 12,000 g for 2 minutes, the supernatant discarded and the pellet 
resuspended in 10 times the initial volume of prewarmed M9-CaGlu (Appendix A),  
selected for its lack of autofluorescence, relative to other media. Competitions were 
carried out in black polystyrene, clear-bottomed, 96-well microtitre plate (Corning), 
to minimise cross-talk between wells and background fluorescence. PAO1φ--GFP 
and PLPL-DsRed-Express were added to a well in the correct ratio, to a final volume 
of 200 µl, and the mixture pipetted up and down to mix well. This repeated in 
another well for the reverse markers, with 6 technical replicates for each mixture. 
The plate was incubated at 37˚C with shaking at 200 r.p.m. in a Fluostar Omega plate 
reader (BMG Labtech). Fluorescence intensity (FI) of both GFP and DsRed-Express 
in each well was measured every 8 hours using  485 nm and 544 nm excitation filters 
and 520 nm and 590 nm emission filters, for GFP and DsRed-Express, respectively. 
Readings were normalised to an unlabelled PAO1 negative control to control for 
bacterial autofluorescence. To allow non-destructive sampling of bacterial densities 
over the 24 hour period, densities were estimated by comparing FI of each well to a 
standard curve of FI against bacterial density. To produce the standard curve, PAO1 
GFP and PAO1 RFP were mixed together, with different ratios in each well (i.e. 10 
µl GFP/ 190 µl DsRed-Express, 20 µl GFP/ 180 µl DsRedExpress etc.). Standards 
were included on every plate. At each time point, the FI for each set of filters was 
plotted against the bacterial cell densities (predetermined for each time point by 
plating for c.f.u.s), and the line of best fit was calculated using Sigma plot.  
Three independent biological replicates were performed for each competition. The 
Malthusian parameters of each competitor and the selection rate constant (2.6.1) 
were calculated separately for each marker in each competition, at t24 only. 
2.8.3 Estimation of prophage fitness (i.e. frequency) in bacterial population 
At the end of the competition (t24), mixture were plated onto Columbia agar and 
incubated overnight at 37 ˚C. Single colonies were patched onto fresh Columbia agar 
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and PCR tested for prophage complement following overnight incubation. 23 
colonies were tested per competition. 
2.8.4 In vivo bacterial invasion assays 
Bacterial invasion assays were conducted in vivo using the rat model of chronic 
infection, as described previously (2.7). Using a similar experimental design to the in 
vitro invasion assays, PLPLφtriple was competed with PAO1φ-, but the competitors 
were labelled with antibiotic resistance instead of fluorescence markers. Two groups 
of rats were used, with a competitive ratio of 1:9 (lysogen to non-lysogen) in one 
group, and a ratio of 1:1 in the second. The protocol followed was as described in 
(2.5), except for the differences outlined below: 
2.8.5 Agar bead preparation 
PAO1φ-SmR and PAO1φtripleGmR were each grown to an OD600 of 1.0. For the first 
group (1:9 competitive ratio), 2 x 109 cells PAO1φtriple GmR and 1.8 x 1010 cells 
PAO1φ- SmR were centrifuged and washed separately, and the cell suspensions 
pooled together and mixed thoroughly, just prior to the addition to the agar-PBS. 
This was repeated for the second group (1:1 competitive ratio), but using 1 x 1010 
cells of each competitor. 
2.8.6 Determination of bacterial cell counts 
To determine the counts of each competitor, in both the beads and in the lungs, 
dilutions were plated on TSA containing 300 µg ml-1 streptomycin or 10 µg ml-1 
gentamicin, in addition to TSA containing no antibiotic. Selection rate constants 
were calculated as described in section 2.6.1, using cell densities in the bead 
inoculum and lungs as start and end densities, respectively. 
2.9  Statistical analysis 
2.9.1 Basic statistical tests 
All statistical analyses were performed in R (R, 2013), unless otherwise stated. 
Parametric tests were used where possible; data were checked for homogeneity of 
variance by examination of a box-plot, and for normality by examination of a 
quantile-quantile (QQ) plot. Non-normal data were transformed (using a log10 or 
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arcsine transformation) and re-checked for normality. Data that still violated the 
assumptions of the parametric test were analysed using the non-parametric 
equivalent. 
2.9.2 Principal component analysis (PCA)  
Phenotypic data from the host-phage coevolution experiment resulted in large, 
multivariate datasets. To explore the underlying structure of the data and elucidate 
the factors that are responsible for much of the variance, PCA was used as an 
exploratory data analysis tool, using the ade4 package (Dray, 2007) in R. Complete 
datasets (i.e. data for all 40 isolates within each population) were available for all but 
two of the variables (biofilm formation and doubling time in LB). For the incomplete 
variables, only the first 10 isolates of every population were tested, due to the large 
amount of time and work required to test these specific phenotypes. PCA in R cannot 
proceed with missing values, but numerous methods exist to allow missing values to 
be ignored or replaced. Multiple imputation was chosen as a method to replace the 
missing data, using the mi package (Su et al., 2011) in R, as it enables existing data 
to be retained. Data were plotted with dudi PCA scatter plots, and the independent 
variables (phage-treatment and population) overlaid, using the s.class function. 
2.9.3 Analysis of molecular variance 
Analysis of molecular variance (AMOVA) involves partitioning the diversity 
between various genetic haplotypes (where a haplotype is defined as a collection of 
specific alleles) into within and between population components. The diversity is 
defined as the average distance between two randomly chosen haplotypes. Whilst 
such an approach has traditionally been applied to genetic data, it is possible to apply 
this statistical method to phenotypic data (Mowat et al., 2011), by defining 
haplotypes as a collection of specific phenotypic traits. This was applied to the 
dataset of phenotypic traits produced from the host-phage coevolution experiment. 
Isolates were classified as different haplotypes based on the combination of 
phenotypic traits displayed. For each trait, isolates were scored a 0 if they displayed 
the same phenotype as the ancestor, or a 1 if they displayed a mutant phenotype. A 
haplotype in this instance was defined as a unique combination of phenotypic traits, 
and the frequency of each haplotype in each population was determined. An 
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Euclidean distance matrix was created to determine the evolutionary distance 
between the various haplotypes. AMOVA was performed using the ade4 package in 
R (Dray, 2007). The distance matrix was partitioned into sub-matrices for the various 
subdivisions of the data, including treatment (control or phage-treated), population 
and individual isolates. The sums of squares were computed and analysed in a nested 
ANOVA framework, termed AMOVA. This yielded φ statistics (analogous to the F 
statistic of ANOVA). Significance was tested by Monte-Carlo permutation tests (49 
permutations). 
2.10 Reannotation of LES phage genomes 
2.10.1 Assigning protein functions using PSI-BLAST 
Predicted protein sequences within the LESφ2,φ3 and φ4 prophage regions of 
LESB58 were subjected to protein similarity searches using the Position-Specific-
Iterated-BLAST (PSI-BLAST) algorithm, with the aim of improving the functional 
annotation of the prophage genomes.  Predicted open-reading frames (ORFs) were 
obtained from the supplementary data of the LESB58 published genome paper 
(Winstanley et al., 2009). Protein sequences were subjected to BLASTP and PSI-
BLAST searches against the non-redundant protein sequences database, using the 
default parameters. Only hits to proteins with an annotated function were considered. 
If the initial BLASTP search revealed only hits to hypothetical proteins, an iterative 
search was carried out using the position-specific scoring matrix (PSSM) derived 
from the initial BLASTP search and subsequent multiple sequence alignment of 
significant protein hits. Iterations were continued until either detection of multiple 
sequences with a similar function, or convergence. All BLASTP hits were critically 
analysed by manual inspection of alignments. As PSI-BLASTING can give false 
positives, a reverse PSI-BLAST strategy was employed to indicate whether 
relationships were likely to be meaningful; the hit sequence was subjected to a PSI-
BLAST search, and if the phage protein sequence was not returned as a hit, then it 
was assumed to be a false positive. For hits to more divergent proteins, multiple 
related sequences in a protein family plus the query protein were aligned with 
COBALT and Clustalx and visualised in Jalview, to search for conserved domains 
and residues. The likelihood of homology was assessed by considering numerous 
factors, including the quality of alignment, PSI-BLAST scores, presence of 
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conserved domains, and the context of the gene function with regards to its location 
on the phage genome. Phage genes were grouped into gene modules according to 
function, and the phage genome visualised using DNA plotter (Carver et al., 2009). 
2.10.2 Identification of phage-encoded anti-CRISPR genes 
Protein sequences with known anti-CRISPR (clustered regularly interspaced short 
palindromic repeats) activity were obtained from (Bondy-Denomy et al., 2013; 
Pawluk et al., 2014). A tblastn search was conducted for each anti-CRISPR protein 
sequence against the translated (in all 6 reading frames) genome sequence of 
LESB58. In addition, the nucleotide sequences of LES prophage 2, 3 and 4 were 
blastn searched against P. aeruginosa PA14 genome, to identify putative CRISPR 
spacers. Exact matches were searched against the CRISPRdb database (Grissa et al., 
2007) to determine whether PA14 harbours spacers from previous phage infection 
that would potentially confer immunity to the LES phages. 
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Chapter 3 Characterisation of the LES phages 
3.1 Introduction 
3.1.1 The Liverpool epidemic strain 
The Liverpool epidemic strain (LES) was the first transmissible strain of 
Pseudomonas aeruginosa identified, and is associated with a worsened morbidity 
and mortality, relative to infection with other P. aeruginosa strains (Al-Aloul et al., 
2004). The LES was discovered after multiple patients in a CF children’s centre were 
found to be infected with a common beta-lactam- resistant strain (Cheng et al., 
1996), and challenged the previous notion that all P. aeruginosa strains were 
acquired from the environment and unique to each CF individual. The LES has an 
unusual phenotype, with premature expression of quorum sensing (QS) -related rhl 
and las regulatory genes, and subsequent overproduction of secreted virulence 
factors related to QS such as pyocyanin and elastase (Fothergill et al., 2007; 
Salunkhe et al., 2005).  LES is a biofilm hyperproducer (Kukavica-Ibrulj et al., 
2008b), displays enhanced survival on dry surfaces (Panagea et al., 2005), is capable 
of superinfection (McCallum et al., 2001), and displays enhanced antimicrobial 
resistance (Ashish et al., 2012b; Fothergill et al., 2007; Salunkhe et al., 2005). These 
factors may have contributed to its successful spread; in 2004, LES was identified as 
the most common clone in CF centres in England and Wales in 2004 (Scott & Pitt, 
2004), and a recent UK-wide study of P. aeruginosa isolates using variable number 
tandem repeat (VNTR) analysis found that it is still the most common clone in CF 
patients (Martin et al., 2013). The LES has even spread as far as North America 
(Aaron et al., 2010). 
3.1.2 LES bacteriophages 
Genome-sequencing of LESB58, the first isolate of LES identified, revealed some 
clues as to how the LES has established itself as such a successful pathogen. The 
LES genome contains six prophages (named LESφ1-6), of which four are not found 
in strain PAO1. Table 3.1 describes the main characteristics of the six LES phages. A 
signature-tagged mutagenesis approach demonstrated that insertions in three of the 
prophages (LESφ2, LESφ3 and LESφ5) greatly reduced LES competitiveness in a rat 
model of chronic lung infection (Winstanley et al., 2009). These were in genes 
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encoding the DNA replication protein DnaC of LESφ2, a hypothetical protein of 
LESφ3, and a putative lytic enzyme of LESφ5, suggesting that perhaps active phage 
replication is necessary for bacterial competitiveness.  
LES phagesφ2-5 are novel, but display a degree of mosaicism, with regions of 
similarity to other known phages, and to each other (Figure 3.1). LESφ2 has a large 
region that is homologous to part of bacteriophage F10, of which a small part is also 
homologous to a small region of LESφ3. LESφ3 also displays similarity to LESφ5, 
sharing a 7.5 kb region with 99.8% identity. LESφ4 and LESφ5 are similar to the 
sequenced phages D3112 (Wang et al., 2004) and D3 (Kropinski, 2000), 
respectively. All of the active LES phages encode integrases, and therefore integrate 
by site-specific replication, with the exception of LESφ4, which encodes a 
transposase, rendering it capable of replication by transposition, and therefore able to 
integrate at multiple locations throughout a bacterial genome. Although LESφ4 is 
transposable, like the well characterised Escherichia coli phage Mu (Morgan et al., 
2002), its genome organisation is more reminiscent of E. coli phage λ. LESφ2 and 
LESφ3 also appear similar to lambdoid phages. 
Examination of the phage genomes does not reveal any obvious genes that may be 
involved in bacterial virulence or competitiveness, but the phage genomes are poorly 
annotated and the annotations have not been updated since the LES genome was 
published, despite the fact that a lot of phage functional proteomics data has since 
become available. 
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Figure 3.1 LESB58 prophages and regions of genome similarity to other known phages. Duplicated regions 
between the phages are labelled. Black arrows denote mutations that were found to significantly reduce 
competitiveness of LESB58 in a model of chronic infection. Figure adapted from (Winstanley et al., 2009). 
A recent study characterised three of the LES phages (LESφ2, 3 and 4), and found 
that they can all successfully infect the laboratory reference strain PAO1 (James et 
al., 2012). Moreover, the LES phages could integrate into the PAO1 genome and 
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form stable lysogens, although the level of spontaneous phage lysis was higher than 
in the native bacterial host LESB58. It was observed that the phages each produce 
characteristic plaques on PAO1. LESφ2 produces very small, clear plaques, LESφ3 
produces large plaques with a turbid centre, and LESφ4 produces small, clear 
plaques with a turbid halo. All three phages were found to require the type IV pili of 
the bacterial cell for infection, which is required for twitching motility and surface-
attached biofilm formation. Examination of the host range of the phages observed 
that 6/32 clinical isolates of P. aeruginosa were susceptible to LES phage infection. 
Interestingly, several clinical isolates, as well as the laboratory reference strain 
PA14, were resistant to LESφ2 and LESφ3, but susceptible to LESφ4, yet the 
mechanism underlying this difference was not explored. 
3.1.3  LES isolates have different prophage complements 
Since the LES was discovered, numerous isolates have been identified, all exhibiting 
differences in phenotype, virulence, and prophage complement. The best 
characterised are the recently sequenced LES400, LESB65 and LES431 (Jeukens et 
al., 2014), alongside LESB58, which is the oldest LES isolate, and the first to be 
genome sequenced. LES400 has retained all six prophages, but is a lasR mutant 
(Parsons et al., 2002), resulting in low virulence in mouse and Caenorhabditis 
elegans models of infection (Carter et al., 2010a). LES431 is missing LESφ2 and 
demonstrates high virulence in both infection models. Interestingly, LES431 was 
first isolated from the lungs of a parent of a child with CF, an unusual occurrence 
(McCallum et al., 2002). LESB65 is missing LESφ5 (Fothergill et al., 2007), and 
displays moderate virulence in the mouse model, capable of actually establishing 
stable colonisation in the lungs and nasopharynx (Fothergill et al., 2014). However, 
the presence (or absence) of the prophages is not necessarily responsible for the 
phenotypes and virulence levels observed.  
Studies that involve collection of large numbers of LES isolates in multiple patients 
over time, have observed that loss (Mowat et al., 2011) or degradation (Williams et 
al., unpublished) of one or more of the prophages are common phenomena. A 
screening of 26 LES isolates found that LESφ5 was missing in 69% of isolates, and 
that LESφ2 was missing in 3 isolates (Winstanley et al., 2009). A similar pattern was 
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observed for sequenced LES and LES-like isolates, with loss LESφ5 and LESφ2 in 
multiple isolates, loss of LESφ5 being the most common (Jeukens et al., 2014). 
3.1.4 Phage contribution to bacterial fitness 
3.1.4.1 Phage-encoded fitness factors 
Prophages often encode genes that are not directly involved in viral replication and 
that can confer a benefit to their bacterial host. Such genes are often found in regions 
of DNA termed morons, defined as independent transcriptional units of DNA that are 
not part of the essential phage genome, and are expressed whilst the phage is in the 
prophage state (Juhala et al., 2000). One example is genes that encode superinfection 
exclusion proteins, which block incoming phage DNA, hence enabling avoidance of 
lytic phage infection and consequent cell death. Such as system has been observed in 
multiple phage-host systems, including Salmonella phage P22 (Hofer et al., 1995), E. 
coli T-even phages (Lu & Henning, 1994), lactococci (Akçelik, 1998) and 
streptococci  (Sun et al., 2006). LES phagesφ2, φ3 and φ4 are known to display a 
hierarchy of superinfection exclusion, with LESφ2 lysogens resistant to infection by 
LESφ3 and  LESφ4, but not vice versa (James et al., 2012), suggesting that LESφ2 
encodes at least one protective superinfection exclusion gene.  
Morons can contain genes that enhance the virulence of their bacterial host, either 
directly e.g. phage-encoded toxins, or indirectly, by enhancing the fitness of bacteria, 
which may result in increased virulence (Hacker & Carniel, 2001). For example, the 
bor gene of E. coli phage λ plays an important role in bacterial immune evasion; it 
encodes an outer membrane protein that aids cell survival in animal serum 
(Barondess & Beckwith, 1990; Barondess & Beckwith, 1995). Another example is 
the gipA gene found in the late operon of the Gifsy-1 bacteriophage of Salmonella 
enterica serovar Typhimurium. gipA was observed to be massively upregulated in 
the small intestine in a mouse model of infection, and was identified as important for 
survival and/or growth in the Peyer’s patches (Stanley et al., 2000). Both of these 
phage-encoded fitness factors were identified as probable morons based on their 
expression whilst in the prophage state, and the presence of terminator stem loops 
(Hendrix et al., 2000).  
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Prophages frequently encode multiple morons; phage 933W, isolated from the 
pathogenic E. coli strain O157:H7, harbours the aforementioned bor gene, as well as 
the stk gene, which encodes a serine/ threonine kinase that is predicted to affect the 
signal transduction pathways of eukaryotic cells (Plunkett et al., 1999). It also 
posseses a lom homologue, a gene that encodes an outer membrane protein necessary 
for adhesion to human epithelial cells (Vaca Pacheco et al., 1997). 
3.1.4.2 Phage virulence factors expressed upon prophage induction 
Some prophage-encoded virulence factors are only expressed/released when the 
prophage enters the lytic cycle, whereas others are increased, through an increase in 
phage replication and/ or increased release in virulence proteins through cell lysis. 
Shiga-toxin production in E. coli Stx phage lysogens is massively upregulated upon 
phage induction (Wagner et al., 2001b), and substances that cause prophage 
induction, such as quinolone antibiotics, are associated with increased toxin 
production and disease in the mammalian host (Zhang et al., 2000). A recent 
experiment with an E. coli Stx phage mutant incapable of induction and cell lysis 
observed that toxin production whilst in the prophage state was very low; phage 
induction and lysis was necessary for virulence in a mouse model of infection (Tyler 
et al., 2013).  
The prophage-encoded PblA and PblB platelet binding proteins of Streptococcus 
mitis strain SF100 play an important role in the pathogenesis of this strain, which 
causes endocarditis (Bensing et al., 2001). A study found that deletion of prophage 
genes necessary for cell lysis (holin and lysin genes) resulted in reduced platelet 
binding. It was observed that prophage-mediated cell lysis was necessary for release 
of the proteins from the cell cytoplasm, allowing them to bind to the outer membrane 
of other bacteria (Mitchell et al., 2007). Furthermore, phage lysin interacts with 
fibrinogen, further enhancing platelet binding (Seo et al., 2010). 
3.1.5 Phage classification and genomics 
In the absence of a universal gene in bacteriophages, and the pervasive genetic 
mosaicism that is observed between phages, bacteriophage classification is difficult 
(Lawrence et al., 2002), and is currently based on nucleic acid type, and morphology 
(Di Serio et al., 2014). LES phages φ2, 3 and 4 are all of the order Caudovirales, and 
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have been classified by their morphology into the Siphoviridae family, due to the 
presence of long, non-contractile tails.  
3.1.5.1 Phage genome organisation 
The Siphoviridae are notorious for their genetic mosaicism, and demonstrate high 
levels of horizontal transfer (Brüssow & Desiere, 2001). This can be observed by 
comparison of bacteriophage genome sequences, where blocks of homologous 
sequences are often interspersed with regions of low sequence similarity (Casjens, 
2005). LES phages φ2, φ3 and φ4 are all λ-like, based on their modular genome 
organisation, and the similarity of these modules to λ. Like many bacteriophage 
genomes (Hatfull, 2008), there are a large number of genes that are of unknown 
function. 
3.1.5.2 Using protein similarity searches to reannotate phage genomes 
When the LES genome was published in 2009, details of phage genomes were 
included in the supplementary data. The coding sequences (CDS) were predicted 
using Glimmer3 and genes that were not present in PAO1 or PA14, which would 
include the phage genes, were manually annotated using BLASTP. Since the LES 
genome was published, the amount of information in the databases has increased 
substantially, including characterisation of several transposable P. aeruginosa 
bacteriophages, a category to which LESφ4 belongs. Genomes require regular 
reviewing and re-annotation every 3-5 years, in line with knowledge and database 
expansion. Such an approach has been taken for several bacterial genomes (Camus et 
al., 2002; Dandekar et al., 2000) and has identified novel virulence factors in an 
uropathogenic strain of E. coli (Luo et al., 2009). A similar approach applied the 
LES phage genomes would be useful to further our understanding of the genome 
architecture of the phages, and to potentially identify genes that may contribute to 
bacterial fitness. 
3.1.6 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
system 
The CRISPR-Cas system of bacteria is a recently discovered form of adaptive 
immunity to bacteriophages and other mobile genetic elements (MGEs), such as 
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plasmids (Marraffini & Sontheimer, 2008). The CRISPR genes consist of repetitive 
sequences, interspersed with short regions of DNA that are homologous to MGEs 
(Bolotin et al., 2005; Mojica et al., 2005), termed spacers. These spacers were found 
to confer resistance to bacteriophages harbouring a similar sequence (Barrangou et 
al., 2007). Spacers are acquired after infection of the cell with foreign DNA; the 
DNA is incorporated into the CRISPR region, and the bacteria are thereafter able to 
mount a defence to incoming DNA with the appropriate protospacers (i.e. regions of 
foreign DNA that match the spacer sequences in the bacterial chromosome). Spacers 
are acquired preferentially from MGEs (as opposed to host chromosome) via 
multiple mechanisms, including a preference for replicating DNA and stalled 
replication forks, with bacterial confinement of stalled replication forks by Chi sites 
to avoid self-acquisition (Levy et al., 2015).  
The CRISPR genes are usually found in close proximity to the cas (CRISPR 
associated) genes. The spacers are transcribed and cleaved by the Cas protein(s) to 
form small CRISPR RNAs (Brouns et al., 2008; Carte et al., 2008), and the CRISPR-
Cas complex targets and cleaves the foreign DNA (Garneau et al., 2010). Such as 
system is analogous to the RNA interference system of viral defence in eukaryotic 
cells (Makarova et al., 2006). 
3.1.6.1 Anti-CRISPR phage proteins 
Given the widespread nature of CRISPR-Cas systems, it seemed highly likely that 
bacteriophages would have a counter defence strategy. Indeed, metagenomic analysis 
of the phage population obtained after experimental coevolution between 
Streptococcus thermophilus and phage 2972 revealed SNPs in or near the proto-
spacer adjacent motif region in the phage genome, rendering the phage immune to 
one of the bacterial CRISPR-Cas systems (Sun et al., 2013). However, this is likely a 
poor strategy, as it is known that upon recognition of imperfectly matching DNA (i.e. 
mutated phage proto-spacers), the CRISPR-Cas acquisition system is “primed”, and 
moves along the phage DNA, selecting multiple spacers, hence counteracting phage 
resistance (Datsenko et al., 2012) . 
Recently, a more sophisticated phage resistance mechanism has been observed in 
numerous related transposable Pseudomonas phages. These phages produce anti-
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CRISPR proteins that allow them to successfully infect P. aeruginosa strain PA14, 
which has an active type I-F CRISPR system. When these genes were cloned into a 
high copy plasmid and overexpressed in the bacterial strain, CRISPR-sensitive 
phages were then able to infect. The mechanism by which the anti-CRISPR proteins 
act was not elucidated, although the effect was thought to occur after the formation 
of the CRISPR-Cas complex (Bondy-Denomy et al., 2013). A more recent study 
identified more anti-CRISPR proteins, this time active against the type I-E CRISPR 
system, that inhibit the CRISPR-Cas complex (Pawluk et al., 2014). These are recent 
studies, and it is thought that there are many more phage anti-CRISPR genes that 
have not yet been discovered. 
3.1.7 Phage growth characteristics 
Bacteriophages have innately different growth characteristics, and upon lytic 
infection of a bacterial host will display a characteristic growth curve. The growth 
characteristics of a bacteriophage impact on its fitness and evolutionary success, and 
are likely to also affect host ecology.  
The growth characteristics of bacteriophages can be assessed using one-step growth 
curves, whereby the phage lytic cycle is observed from the beginning (initial 
adsorption to bacteria) to the end (release of phage virions by bacterial cell lysis) by 
measurement of free phage over time. Two important characteristics can be 
determined using such can approach; the latent period, and the burst size (Ellis & 
Delbrück, 1939). The latent period refers to the time spent in the bacterial host, 
between adsorption to the bacterium, and lysis of the cell. The burst size is the 
number of virions released per infected cell.  The longer the phage latent period, the 
more time available to accumulate virions within the cell, hence the larger the burst 
size, but with this comes the cost of less time available to find and infect new hosts. 
When attempting to maximise fitness, there exists a clear trade-off between latent 
period and burst size. Theoretical models predict an optimal latent period exists, one 
that is intermediate, resulting in an intermediate burst size (Wang et al., 1996). 
Experiments with isogenic E. coli λ lysogens, that differ only in their lysis time (a 
proxy for latent period), support the theoretical work. There was a clear, positive 
relationship between lysis time and burst size, and experimental support for the 
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trade-off; an intermediate lysis time was associated with higher phage fitness (Wang, 
2006). 
Trade-offs exist for other aspects of the phage life-cycle. For example, there is a 
trade-off between phage adsorption rate and latent period, although, interestingly, 
competition experiments between phages revealed that adsorption rate has a greater 
impact on phage fitness than the latent period (Shao & Wang, 2008). There is also a 
trade-off between the multiplication rate in the bacterial host and survival outside the 
host (De Paepe & Taddei, 2006), most likely because building virions capable of 
surviving for lengthy periods in the environment is more metabolically costly. 
Phage growth characteristics and the optimal strategy are hugely influenced by the 
bacterial host(s) and growth environment. Host availability, and the quality of those 
hosts (i.e. the metabolic status of the cell) both affect the optimal lysis time (Abedon 
et al., 2001; Abedon et al., 2003). Host physiology is also known to affect phage 
burst size. Bolger and colleagues measured the burst size of phages upon infection of 
cultures that had been in stationary phase for different lengths of time. Burst size 
varied with time in stationary phase. Unexpectedly, the burst size was larger in five 
day versus three day old cultures, a fact that was attributed to the cells transitioning 
to a biofilm mode of growth (Bolger-Munro et al., 2013). It is important to note that 
what appears optimal in a laboratory environment may not be optimal in the natural 
environment. For example, a high adsorption rate can be detrimental in a biofilm 
mode of growth (Gallet et al., 2009), presumably due to adsorption to cellular debris 
etc.  
Most studies looking at phage life-history traits have been performed with obligately 
lytic phages. Temperate phages have an added dimension of complexity in that they 
have the option of integrating into the host chromosome and delaying the lytic cycle 
until a later date. This is the equivalent of having a longer latent period, and also of 
increasing the burst size, as phage progeny are produced by vertical transmission (i.e. 
binary fission of bacterial cell, resulting in prophage replication), as well as when the 
cell enters prophage-mediated lysis (Abedon, 2009).  
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3.1.8 Lysis / Lysogeny decision and phage fitness 
Upon infecting a host cell, temperate phages usually take one of two routes, and 
enter the lytic cycle, or, alternatively, integrate into the host chromosome as a 
prophage. Ultimately, the decision should be based upon what is likely to maximise 
phage fitness. Extensive research has been conducted with E. coli λ into what factors 
affect the lysis/lysogeny decision, as the regulation of it is well understood. Briefly, 
lysogeny results when the CII lysogenic regulator accumulates within the cell to 
above a certain threshold, switching off the default lytic cycle and stimulating the 
synthesis of Int, which is required for phage integration (Oppenheim et al., 2005). 
The regulation is more complex than this, but that is sufficient information for the 
purposes of this chapter. Conditions that prevent CII degradation favour lysogeny. 
For example, nutrient starvation increases the frequency of lysogeny (FOL), as 
starving cells lack the enzymes that degrade CII (Lieb, 1953). MgSO4 starvation has 
a similar effect, although the molecular mechanism for this was not determined 
(Kourilsky 1973). A high multiplicity of infection also increases the FOL (Lieb, 
1953); Kourilsky concluded that this was due to an unknown phage-encoded pro-
lysogeny factor, and the more phage that infect the cell, the more likely it is that the 
critical threshold concentration will be reached (Kourilsky, 1973). The lysis/ 
lysogeny decision appeared to be quite stochastic in λ, but a recent study suggested 
that it may simply be the result of pre-existing variation in bacterial cells; smaller 
cells are more likely to become lysogens, as the necessary regulatory molecules, such 
as CII, reach the threshold concentration faster when in a smaller volume (St-Pierre 
& Endy, 2008). 
3.1.9 Factors affecting phage production by lysogens 
3.1.9.1 Induction 
It is known that DNA-damaging agents that induce the SOS response in the bacterial 
cell, such as UV light and mitomycin C can cause prophage induction. The focus of 
research has now shifted to other, more biologically relevant inducers, as well as 
prophage induction via SOS independent pathways.  
Los et al. studied phage production in different E. coli Stx lysogens under a range of 
conditions. The DNA-damaging antibiotic norfloxacin and mitomycin C both caused 
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prophage induction, but sodium chloride did not. Temperature affected the efficiency 
of induction (Łoś et al., 2009). Hydrogen peroxide (H2O2), a DNA damaging agent 
that is present in the CF lung (Jobsis et al., 2000), resulted in a rapid, but more 
limited induction, occurring in only a fraction of the population (Łoś et al., 2009). 
Stx lysogens produce increased levels of toxin when in the presence of H2O2, and 
also when co-cultured with human neutrophils, which produce H2O2 (Wagner et al., 
2001a). A transcriptomics study of Burkholderia cenocepacia (another CF pathogen) 
growing as a biofilm found that exposure to high doses of H2O2 led to upregulation 
of multiple phage-related genes (Peeters et al., 2010). A similar finding was observed 
for P. aeruginosa strain PAO1 (Chang et al., 2005). 
One study proposed a role for the quorum-sensing molecules, acyl homoserine 
lactones (AHLs) in prophage induction (Ghosh et al., 2009). They observed that 
when added to soil samples, AHLs caused an increase in the total viral abundance of 
the sample. They then tested this on the E. coli - λ model system, and found that 
AHLs cause an increase in the numbers of free λ, although with no significant 
decrease in bacterial cell counts. This was true for a recA mutant, suggesting that this 
is SOS independent. However, a recent study challenged the conclusion that the 
increase in phage-production was due to induction; in fact, AHLs cause a 
downregulation of bacterial phage receptors, leading to reduced superinfection and a 
subsequent build-up of free phages (Høyland-Kroghsbo et al., 2013). 
EDTA and citrate are found in many pharmaceuticals due to their role as chelating 
agents, and increase phage and toxin production in E. coli lysogens. This is not SOS-
dependent, but occurs due to disruption of the cell membrane through magnesium ion 
chelation. This effect is synergistic with the known inducer norfloxacin, resulting in 
much higher levels of phage production than with norfloxacin alone (Imamovic & 
Muniesa, 2012). Interestingly, the effect of EDTA on phage production was greater 
in wild-type STEC strains than with mitomycin C. 
3.1.9.2 Repression  
Sub-inhibitory concentrations of certain antibiotics have been found to reduce 
spontaneous phage production in certain lysogens, including the LES (Fothergill et 
al., 2011). Inhibitors of protein translation, including azithromycin, and the cell wall 
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inhibitor fosfomycin, reduce Shiga toxin production in E. coli (McGannon et al., 
2010). Similarly, azithromycin (among other antibiotics) decreases both phage and 
toxin production in strain O104:H4 (Bielaszewska et al., 2012). A study involving a 
panel of 4 LES isolates and six commonly used anti-pseudomonals found that 
azithromycin suppresses phage production in two of the isolates, as does tobramycin, 
an aminoglycoside that inhibits protein synthesis (Fothergill et al., 2011).  
3.1.10 Factors affecting phage amplification 
When estimating phage fitness, the traditional approach is to measure phage 
amplification (growth) in a naïve bacterial host, under laboratory conditions. 
However, this is never representative of the actual environment of the phage and 
host, and there are numerous factors that affect phage fitness in the natural 
environment. The CF lung environment in which the LES phages are found is 
nutritionally rich, viscous (Denton, 1960) and contains high concentrations of free 
DNA (Chernick & Barbero, 1959) and mucin glycoproteins (Boat et al., 1976). P. 
aeruginosa grows as a biofilm and this may affect susceptibility to phage infection, 
through the simple physical protection afforded by the biofilm substratum. In 
addition, as P. aeruginosa becomes adapted to the CF airways in chronic infection, 
common phage receptors are lost (Smith et al., 2006b), although chronic isolates are 
not always more resistant to phage (Friman et al., 2013). 
3.2 Objectives: 
1. To use protein sequence similarity searches to update the annotation of the 
LES phage genomes. 
2. To measure phage production by the original bacterial host strain (LES) in 
the presence of environmental factors common to the CF lung. 
3. To assess the lytic growth of the LES phages in a novel host background, and 
factors that affect this, including bacterial growth environment. 
4. To assess the frequency of entry into the lytic or lysogenic cycle for the LES 




3.3.1 Reannotation of LES phage genomes  
3.3.1.1 LESφ2 
Using BLASTP, it was possible to assign a putative function to a further 5 ORFs 
(Appendix C). A large number of ORFs return only hits to hypothetical proteins, a 
common issue when annotating phage genomes. PALES_08001, previously 
annotated only as a phage-related protein, returned significant hits to several DNA 
binding proteins. It possessed a conserved domain at its C terminus that is 
characteristic of the phage pRha superfamily of DNA binding proteins. ORF 
PALES_08061 shared 100% identity to an antitermination protein Q in P. 
aeruginosa, and returned a hit to a superfamily of such proteins (PF06530), as well 
as significant hits to multiple bacteriophage proteins in the same superfamily. 
PALES_08161 returned a hit to a bacterial recombinase in the initial BLASTP 
search, and subsequent PSI-BLAST iterations returned hits to multiple recombinases 
across different bacterial species, some phage encoded. 
Two ORFs in the late gene region returned BLASTP hits to structural phage proteins, 
and an iterative search using PSI-BLAST indicated that a further three ORFs in the 
late gene region are homologous to phage structural and tail proteins, including those  
from phages of P. aeruginosa, Burkholderia spp. and Raoultella planticola. Based on 
their position in the phage genome, it is likely that this is their function.  
3.3.1.2 LESφ3 
PSI-BLAST analysis, as well as identification of some conserved protein domains of 
the LES φ3 genomes, enabled us to assign a putative function to a further 11 ORFs. 
PALES_13341 had a specific CDD hit to ParBc (Pfam02195), a ParB-like nuclease 
domain. The ParB protein domain is known to cleave single-stranded DNA, but can 
also nick super-coiled plasmid DNA and act as an exonuclease. PALES_13381 had 
high scoring hits to P. aeruginosa proteins labelled as transcriptional regulators, due 
to the presence of a multi-domain transcriptional regulator COG2932. A specific 
CDD hit was also obtained for the peptidase S24 LexA-like protein, responsible for 
repair of single-stranded DNA in bacterial cells upon activation of the SOS response, 
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suggesting that this is a LexA-like transcriptional regulator. The top hit of the ORF 
next to this, PALES_13391, was a DNA-binding protein, yet further analysis using 
the CDD revealed specific hits to two conserved domains; at the N terminus of the 
protein to the phage regulatory protein Rha (pfam09669), and at the C terminus to 
the phage anti-repressor (KilAC domain) protein (pfam03374).  
3.3.1.3 LESφ4 
Using BLASTP and PSI-BLAST, it was possible to assign a putative function to a 
further 13 ORFs, in addition to a confident prediction of function for a further 3 as 
anti-CRISPR genes (3.3.2.2), based on the recently published protein sequences of 
known anti-CRISPR genes (Bondy-Denomy et al., 2013; Pawluk et al., 2014). The 
majority of newly-annotated ORFs were structural or phage-tail proteins. Several 
proteins were annotated based on their high levels of similarity (≥90%) to the 
recently characterised Pseudomonas phage LPB1 that was originally isolated from 
hospital sewage (Ceyssens et al., 2009a). Using the new functional annotations, 
genes were classed into modules. Two clear functional regions of early and late 




Figure 3.2 Genome organisation of LES phage 4. Circles represent (from inside out): GC content, 
classification according to timing of gene expression and classification according to predicted function. 
3.3.2 Identification of anti-CRISPR phage-encoded proteins 
3.3.2.1 Putative spacers targeted to LESφ4 observed in PA14 genome 
As LESφ4 is known to be capable of infection of PA14, a strain which possesses two 
CRISPR systems, we searched for evidence that (a.) PA14 has been exposed to LES 
φ4 or a similar sequence in the past, and had spacers present in its genomes capable 
of recognising the phage and (b.) that LESφ4 encodes proteins capable of protecting 
itself from the PA14 CRISPR response. The LESφ4 genome was BLASTN searched 
against the PA14 genome to identify potential spacers present in the PA14 CRISPR 
region. The result was positive; a short sequence matching exactly (E = 4e-11) to one 
of the 2 known CRISPR regions of PA14 (between 2936004 and 2936036 bp) was 
observed, suggesting that PA14 has had prior exposure to a LESφ4-type phage.  
Despite their inability to infect PA14, no putative spacers were identified in the 
PA14 genome matching to LESφ2 or 3, suggesting that an alternative bacterial 
resistance mechanism is preventing phage infection. 
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3.3.2.2  LESφ4-encoded anti-CRISPR proteins 
Two recent publications identified numerous anti-CRISPR proteins in Pseudomonas 
transposable phages that show activity against either the type I-E or type I-F CRISPR 
system of P. aeruginosa, including phage D3112, which is known to share similarity 
with LESφ4. BLASTP searches of these protein sequences against the LESφ4 
genome revealed that four of the anti-CRISPR proteins are highly similar to proteins 
predicted to be encoded by the LES φ4 genome. These include protein ACR3112-3, 
active against the type I-E CRISPR system (94% identity, E = 9e-25), as well as 
three that are active against the type I-F CRISPR system, gp33 (88% identity, E = 
8e-84), gp35 (96% identity, E = 8e-96) and gp36 (92% identity, E = 2e-20). It is 
worth noting that gp33 and gp35 both match to either end of PALES_15761 (known 
as orf29b). 
3.3.3 Phage production by original host LES in the presence of various 
environmental factors relevant to the CF lung environment 
The effect of various environmental conditions on LES phage production was 
investigated. Such conditions were chosen because they are known to affect phage 
production in other bacterial species, and are conditions that bacteria are likely to 
experience in the CF lung environment. Phage production after treatment was 
compared to a control, as there is a low level of spontaneous phage production. 
3.3.3.1 H2O2 increases LES phage production 
The presence of H2O2 significantly increases phage production in isolate LESB58, 
(One-way ANOVA; F3,12 = 45.43, p < 0.001). The mean PFU ml
-1 values of H2O2 
treated cultures are significantly higher than the control at all concentrations used 
(Dunnett’s post-hoc test: 2.5 mM, p < 0.05, 5 mM and 50 mM, p < 0.001). The effect 
is dose-dependent; as the concentration of H2O2 increases, so do the numbers of 
phage produced (Figure 3.3). Bacterial viability was not affected at the doses used 




Figure 3.3 Effect of increasing H2O2 concentration on production of free plaque-forming phages by isolate 
LESB58. Error bars ±1 SEM. Asterisks denote statistical significance. 
3.3.3.2 EDTA does not affect phage production and does not act synergistically 
with norfloxacin 
EDTA has no effect on phage production (Figure 3.4); no difference was observed 
between the control and EDTA treated cultures (Mann-Whitney: W = 13, P > 0.05).  
Norfloxacin, a known inducer, increased phage production. However, no synergy 
was detected between norfloxacin and EDTA, as evidenced by no significant 
difference in phage production between norfloxacin alone, and norfloxacin in 




Figure 3.4 Effect of EDTA, both alone, and in combination with the known inducer norfloxacin, on 
production of free, plaque-forming phages by isolate LESB58. Error bars ± 1 S.E.M. 
3.3.3.3 Antibiotics 
3.3.3.3.1 Commonly used antibiotics suppress LES phage production 
Certain antibiotics used in the management of CF are known to increase or decrease 
phage production in 4 LES isolates (Fothergill et al., 2011). However, this previous 
dataset did not include the antibiotics fosfomycin and ceftazidime, or any 
combination of antibiotics. The effect of these antibiotics on phage production was 
tested in 4 LES isolates, using the same methodology as described previously 
(Fothergill et al., 2011), so that the results may be directly comparable. In addition, 
the effect of the antibiotics ceftazidime and colistin in combination was determined; 
colistin is known to greatly suppress phage production (Fothergill et al., 2011), but 
whether this effect is additive when in combination with another antibiotic was 
unknown. The MICs were determined for isolate LESB58, and were found to be: 100 
µg ml-1 for fosfomycin, 64 µg ml-1 for ceftazidime, and 192 and 3.4 µg ml-1 for 
ceftazidime and colistin, respectively, when used in combination (determined using 
the checkerboard method). Data were analysed separately for each isolate with a 
Kruskal-Wallis test, and post-hoc pair-wise comparisons performed using the 
Nemenyi test with Chi-squared approximations, with the PMCMR package (Pohlert, 




Figure 3.5 Effect of antibiotic treatment on phage production by a panel of clinical LES isolates. (A.) 
Control treatment (spontaneous phage induction), (B.) Ceftazidime monotherapy, (C.) Fosfomycin 
monotherapy and (D.) Ceftazidime and colistin combination therapy. Antibiotics were at added at the MIC 
to exponentially growing cultures (n = 7) and incubated for 1 hour, followed by 1 hour recovery and phage 
enumeration. Error bars + 1 S.E.M. Asterisks denote a statistically significant difference compared to the 
control value for that isolate. 
The effect of the different antibiotics varied between the different LES isolates 
(Figure 3.5); all three treatments resulted in significantly less phage production (p < 
0.05) in just one of the four isolates; fosfomycin suppressed phage production in 
isolate LES431, and ceftazidime supressed phage production in isolate LES400, both 
when used alone, or in combination with colistin. There were no obvious additive 
effects on phage production when two antibiotics were used in combination. 
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3.3.3.3.2 Individual LES phage suppression with colistin 
Colistin is known to suppress total LES phage production (i.e. numbers of virions 
capable of causing plaques on the indicator host PAO1). However, it is not known 
whether the effect varies between phages. To determine this, we PCR-tested plaques 
and calculated the relative proportion of plaques caused by each phage, both after 
colistin treatment, and in untreated controls.  The proportion of plaques caused by 
each phage varied between the phages, even in the absence of antibiotics (Figure 
3.6). Approximately equal proportions of plaques were caused by LESφ2 or LESφ4, 
with relatively few caused by LESφ3. Colistin greatly reduced the numbers of free 
phages produced (data not shown), in line with previous findings (Fothergill et al., 
2011). However, the relative frequencies of plaques caused by each phage was not 
significantly different in the colistin treatment compared to the control (χ2=0.06, d.f. 
=2, P > 0.05), suggesting that the LES phages are affected equally by colistin 
treatment. 
 
Figure 3.6 The proportion of plaque-forming virions produced by LESB58 (in the presence of absence of 
colistin) that can be attributed to each LES phage. Plaques were PCR tested using a multiplex PCR assay. 




3.3.4 LES prophages in a novel host background 
3.3.4.1 One-step growth curves of LES phages in PAO1 
The lytic growth of LESφ2-4 on the naïve bacterial host PAO1 was measured under 
laboratory conditions, using a one-step growth curve. This allowed determination of 
two major growth parameters, latent period and burst size, and for comparisons to be 
made between the phages. 
 LESφ2 has a mean (±1 S.E.M) latent period of 88(±6) minutes and a burst size of 
27(±4) (Figure 3.7). 
 
Figure 3.7 One step growth curve of LESφ2 on exponentially growing P. aeruginosa strain PAO1. Each 
data point represents the mean of 4 separate experiments. Error bars denote ±1 S.E.M. 
LESφ3 displays both the shortest latent period, and the largest burst size of the three 





Figure 3.8 One step growth curve of LESφ3 on exponentially growing P. aeruginosa strain PAO1. Each 
data point represents the mean of 4 separate experiments. Error bars denote ±1 S.E.M. 
LESφ4 displays a long latent period of 93(±12) minutes and a relatively small burst 
size of 13(±2) (Figure 3.9). 
 
Figure 3.9 One step growth curve of LESφ4 on exponentially growing P. aeruginosa strain PAO1. Each 
data point represents the mean of 3 separate experiments. Error bars denote ±1 S.E.M. 
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3.3.4.2 LES phage amplification in different growth media 
The majority of phage growth experiments are performed with exponentially 
growing cells in rich, liquid media. However, it is known that growth rate and the 
potential for phage amplification is dependent on many factors, including the 
physiological state of the cell, and the bacterial growth environment. A simple assay 
was performed to test the ability of the LES phages to replicate in two different 
growth media: LB, the simple laboratory broth, and ASM, a medium designed to 
mimic cystic fibrosis sputum in order to simulate the lung environment as much as 
possible. From a small starting MOI of 5 x 10-5, free phage were enumerated after 24 
hours of co-incubation with PAO1, and the amplification (fold change in titre day-1) 
of each phage was calculated. There were large differences, both between the 
different LES phages, and between the different media (Figure 3.10). A log10 
transformation was applied to the data, and after the interaction term was found to be 
non-significant (P = 0.69), a simple, additive model was fitted to the data, with phage 
type (3 levels) and media (2 levels) as the 2 main factors. A significant effect was 
observed for both phage type (F2,32  = 44.2, MSE = 43.7, P < 0.001) and media (F1,32 
= 30.7, MSE = 30.4, P < 0.001). Post-hoc comparisons with TukeyHSD tests 
revealed that LESφ2 had a lower fold change in titre than LESφ3 (P < 0.001) and 
LESφ4 (P < 0.001), and LESφ3 amplified less than LESφ4 (P < 0.05). LESφ2 was 
unable to amplify over the 24 hour period; a loss of virions was actually observed in 
LB, possibly through non-specific binding to bacterial debris. LESφ3 amplified quite 
poorly in LB, yet interestingly showed a huge increase in titre in ASM, making it 
comparable to LESφ4. Of the three phages, LESφ4 was the most successful, 




Figure 3.10 Fold change in free phage titre (p.f.u. ml-1) after 24 hours co-incubation with strain PAO1, in 
different media. LES phages were added to bacteria that had already reached stationary phase. Error bars 
±1 S.E.M. 
3.3.4.3 Frequency of lysogeny upon infecting PAO1 is high in ASM 
Upon infecting a bacterial cell, temperate phages tend to follow one of two routes: 
lysis, or lysogeny. In order to quantify how frequently this decision is made either 
way upon infection of PAO1 with the LES phages, we used a modified assay to 
determine the frequency of lysogeny (FOL). The FOL is defined as the frequency of 
infections of PAO1 that result in phage integration into the bacterial genome, as 
opposed to entry into a lytic infection. The limitations of the assay mean that a FOL 
of below 10% cannot be detected. The FOL of the three LES phages was determined 
for single-phage infection of exponentially growing PAO1, at an MOI of 0.1, and 
was below the limit of detection (i.e. <10%) for all three phages. The FOL was 
subsequently determined in conditions designed to mimic the CF lung environment 
i.e. bacteria in the stationary phase of the growth cycle, and a high MOI. Such 
conditions are known to increase the FOL for E. coli λ (Kobiler et al., 2002; 
Kourilsky, 1973; Lieb, 1953), and it was hypothesised that this would also be the 
case for the LES phages. Indeed, this is what was observed. The FOL was high for 
all three LES phages (Table 3.2), but the highest was for LESφ3, with on average 
over half of cell infections resulting in lysogeny. Because of the substantial variation 
between replicates, it is difficult to determine whether the FOL is significantly 
different between the phages, but the fact that the FOL is for all three is high in a 
simulated CF lung environment is an important finding.  
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Table 3.2 The frequency of lysogeny of LES phages 2, 3 and 4, upon infection of stationary phase P. 
aeruginosa, with a MOI of 10. 
 Phage 
LES φ2 LESφ3 LESφ4 
Frequency of 
lysogeny (mean) 
33 56 34 
Range 11-47 36-81 10-47 
Standard deviation 17 17 14 
 
3.4 Discussion 
In this study, the genomes of the LES phages φ2-4, originally published in 2009, 
were revisited, and reannotated using protein sequence similarity searches. This 
method was reliant on new data being made available in the time elapsed since the 
LES genome was published, and was very successful for LESφ4, due to functional 
proteomics studies with similar phages (Ceyssens et al., 2008; Ceyssens et al., 
2009a).  In all three phages, several structural proteins were identified; these tend to 
be well conserved at the amino acid level in many phages (Proux et al., 2002), even 
those infecting different host species (Brüssow & Desiere, 2001).  
The majority of the ORFs with newly-assigned functions in the LESφ2 and LESφ3 
genomes were involved in lysis/ lysogeny and control of replication. An 
antitermination protein Q was identified in both: this was initially identified in λ 
(Yang & Roberts, 1989), and prevents termination of host RNA polymerase at the 
terminator, therefore enabling expression of the next set of genes. This protein 
regulates both early and late phage gene operons. LESφ2 also encodes a putative 
recombinase protein. Phage recombinases are required for genome replication 
(Mosig et al., 2001) and DNA repair (Stahl et al., 1997) and are quite common: a 
2010 study used Hidden Markov Models of known phage recombinases to screen 
465 phage genomes for the presence of homologues and found them in 133 genomes 
(Lopes et al., 2010). Phage recombinases play a key role in horizontal gene transfer, 
allowing shuffling of genes, even between functional temperate and defective phages 
(De Paepe et al., 2014), and so may play an important role in driving phage (and 
consequently bacterial) evolution. Given the high degree of mosaicism between the 
LES phages, it is possible such phage-mediated recombination between the LES 
phages occurred in the past.  
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A cluster of ORFs in LESφ3 (PALES_13431 – PALES_13461) were newly 
annotated and appear to be part of the lysis/ lysogeny module; they include the 
antiterminator protein Q, a transcriptional regulator and a holin. Interestingly, 
PALES_1345, in the middle of this block of genes, shares 100% identity with an 
mRNA interferase of present in multiple  Pseudomonas spp., and 73% amino acid 
identity with HicA, an mRNA interferase first identified in P. fluorescens (Silby et 
al., 2009), and the bacteriostatic toxin component of a toxin-antitoxin system that is 
found in many prokaryotes (Jørgensen et al., 2009). Many hypotheses for their 
function have been put forward to explain their prevalence, including a stress 
survival response for bacteria (Christensen et al., 2003; Wang et al., 2011) and 
stabilisation of genetic elements (Wozniak & Waldor, 2009), among others.  
A further two ORFs in the LESφ3 genome that were of previously unknown 
function, PALES_13381 and 13391, were annotated as a LexA-like transcriptional 
regulator, and phage regulatory/ anti-repressor protein, respectively. Work with 
Salmonella Gifsy phages observed that the phages are induced by binding of phage 
anti-repressor protein, rather than cleavage of the repressor molecule, as in λ, and 
that this anti-repressor protein is under control of LexA. Even more interestingly, the 
anti-repressors could bind to the repressors in other phages; the authors speculated 
that this could lead to co-ordination of phage induction in polylysogenic strains 
(Lemire et al., 2011). Clearly, the mechanism by which the LES phages are induced 
and the interactions between the phages are of future interest. 
Reannotation of LESφ4 identified mainly structural genes, but also one ORF 
involved in host lysis, encoding the Rz protein. LESφ2 also carries a putative gene 
for an Rz protein, located in the same relative position as in the genome of λ, next to 
the holin genes. The Rz protein forms a protein complex that completes host cell 
lysis by fusing the inner and outer bacterial membrane (Berry et al., 2008). However, 
arguably the most significant finding was the three ORFs that encode putative anti-
CRISPR proteins; this may explain the ability of LESφ4 to infect PA14, as well as 
several clinical strains of P. aeruginosa (James et al., 2012), where LESφ2 and 
LESφ3 could not, despite using the same receptor to infect cells. Anti-CRISPR 
proteins were found in a large group of transposable Pseudomonas phages (Bondy-
Denomy et al., 2013; Pawluk et al., 2014), and the high sequence similarity and 
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conservation of their location in the genome between phages is suggestive of a 
fitness benefit to the phages. This finding also raises important questions regarding 
polylysogeny; anti-CRISPR proteins are expressed whilst the phage is in the 
prophage state, thereby silencing the host CRISPR response; would this then allow 
infection by other phages that would be typically CRISPR sensitive? This is a new 
and fascinating field of research and warrants further study.    
A recently published study by our group used qPCR to measure the levels of free 
LES phages in the sputa of LES-infected patients, as well as bacterial density. The 
levels of free phage were found to be very high, outnumbering bacteria 10-100 fold, 
and the free phage to bacterium ratio negatively correlated to bacterial density, 
suggesting a role for the LES phages in the control of P. aeruginosa densities in the 
CF lung (James et al., 2014). Given that the P. aeruginosa populations are dominated 
by, if not exclusively, LES in these patients, this suggests that the phages are 
produced by prophage induction, rather than lytic infection of susceptible strains. We 
investigated the influence of various aspects of the CF lung environment on phage 
production, in an attempt to elucidate what might be causing such high levels of 
phage production in the lung. H2O2, a known inducer of E. coli phages (Łoś et al., 
2010) increased phage production in LES φ2-4 in a dose-dependent manner. 
However, selecting the correct dosage of H2O2 to use for this study (i.e. a 
biologically realistic concentration) was difficult, because there are (to my 
knowledge) no studies accurately quantifying reactive oxygen species (ROS) 
concentrations in CF sputum. Some studies even question the common belief that 
H2O2 (and other reactive oxygen species) are elevated in the CF lung, finding no 
difference in H2O2 concentration in the breath condensate of CF and non-CF 
individuals (Ho et al., 1999; Worlitzsch et al., 1998). Another study found that 
during exacerbations, children with CF have abnormally high levels of H2O2 that 
subsequently decrease after antibiotic treatment (Jobsis et al., 2000), yet there was no 
comparison with healthy control subjects. All these studies rely on H2O2 in breath 
condensate as a reliable proxy for levels in the lower lung, yet obstructive mucus 
plugs may trap air in the lower lungs and prevent in being exhaled. However, if H2O2 
(and probably other ROS also) cause dose-dependent phage induction, elevated H2O2 
levels (for example, during exacerbations) could have an effect on the host-phage 
dynamics in the CF lung. Despite this, a recent study by our group found no increase 
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in LES phage densities during patient exacerbations {James, 2014 #475}. There is 
also evidence that H2O2-mediated prophage induction is a form of interspecific 
competition; Streptococcus pneumoniae is able to displace Staphylococcus aureus by 
producing H2O2, causing prophage induction and cell lysis (Selva et al., 2009). 
Previous work studying the effect of anti-pseudomonals on phage production in LES 
isolates observed that whilst quinolone antibiotics, such as ciprofloxacin, increase the 
levels of free phage, many others, including azithromycin and colistin actually 
suppress phage production. The range of anti-pseudomonals used was extended in 
this study, and it was found that both fosfomycin and ceftazidime suppress phage 
production, each in only one of the four LES isolates tested. Fosfomycin blocks a 
critical enzymatic step in cell wall biosynthesis (Kahan et al., 1974) and ceftazidime 
inhibits penicillin binding proteins, causing cell filamentation and subsequent lysis 
(Hayes & Orr, 1983). Whilst these mechanisms of action would have no obvious 
inhibitory effects on phage production, antibiotics have global effects; sub- inhibitory 
concentrations of antibiotics with different modes of action are capable of 
modulating transcription of multiple genes in several bacterial strains (Goh et al., 
2002). 
The CF lung is a complex environment, and there are likely to be many factors, other 
than antibiotics and H2O2, that affect phage production. One candidate is cigarette 
smoke, as it contains many known mutagens. A study showed that benzo(a) pyrene 
diol epoxide, a chemical detected in the vaginal secretions of female smokers, causes 
prophage induction in lactobacilli, although other chemicals in the panel, including 
nicotine and tar, did not (Pavlova & Tao, 2000). The effect cigarette smoke may have 
on phage production on bacteria in the CF lung has not been investigated, and is 
potentially important, given that the lungs will have the highest exposure to cigarette 
chemicals (relative to other organs) in smokers, or individuals exposed to passive 
smoking. 
Given that mutations in prophage genes encoding proteins involved in cell lysis 
affect the competitiveness of LES, it is likely that environmental factors that affect 
phage production will also affect bacterial dynamics, potentially influencing disease 
progression. In Shiga-toxigenic E. coli, the relationship between toxin production 
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and disease is clear (Boerlin et al., 1999; Zhang et al., 2000). As antibiotics affect 
toxin production, the choice of antibiotic has an impact on disease progression; the 
phage suppressing antibiotic azithromycin had a protective effect, whilst the phage 
inducing-agent ciprofloxacin worsens disease in gnotobiotic piglets infected with 
O157:H7, compared to untreated controls (Zhang et al., 2009). Similarly, clinical S. 
aureus isolates from CF patients undergo prophage induction upon exposure to 
ciprofloxacin, leading to the upregulation of phage-related virulence factors (Goerke 
et al., 2006). Regardless of the effect on bacterial virulence/ competitiveness, 
antibiotics or environmental conditions that cause phage induction should still be 
viewed with caution, given their potential for mediating horizontal gene transfer.  
The fitness of LESφ2-4 in both laboratory and CF-like (ASM) environments has 
been considered. The three phages display quite different lytic growth curves when 
infecting PAO1 in the exponential growth phase. One-step growth curves are a 
method used frequently to estimate phage growth, and LESφ4 showed the lowest 
growth rate, having both the longest latent period and smallest burst size. However, 
this was not predictive of its fitness and ability to amplify in stationary phase cultures 
over an extended period of time; LESφ4 amplified more than LESφ2 and LESφ3 in 
LB, and more than LESφ2 in ASM. LESφ2 did poorly in both media, but actually 
decreased in titre in LB. There are likely many explanations for the differences 
observed; ability to infect and replicate in stationary phase cultures, ability of phages 
to penetrate the biofilm (in ASM), and the phage adsorption coefficient. Whilst 
phage must be able to adsorb to bacteria to initiate an infection, a high adsorption 
coefficient can be detrimental, especially in a biofilm environment (Gallet et al., 
2009). A study of lytic phages infecting Pseudomonas biofilms found that one of the 
phages adsorbed to both the biofilm substratum and culture plate walls, reducing its 
initial infection efficiency (Pires et al., 2011). Conversely, adhering reversibly to 
surfaces can be advantageous; lytic bacteriophages are known to be able to adhere to 
mucus, and by doing so may form part of the mammalian immune system; by 
adhering to mucosal surfaces, phage have greater access to incoming bacteria (Barr 
et al., 2013). This is a relatively new idea, and has not been empirically tested in 
temperate phages, or lytic phages in the lung. However, a recent metagenomic 
analysis of the temperate phage populations of P. aeruginosa from CF and non-CF 
bronchiectasis found that phage-encoded Ig-like domains were very prevalent. Phage 
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binding to human glycoproteins was proposed as a mechanism to enable phage 
infection and propagation within the lung (Tariq et al., 2015), a hypothesis that was 
supported by a previous finding that Ig-like domains were widespread in both lytic 
and temperate phages, across all three families of Caudovirales (Fraser et al., 2006). 
Attempts to assay mucin and DNA binding for the LES phages, using a modified in 
vitro assay of the one described by Barr et al. were unsuccessful, due to large inter-
assay variation.  
The fitness of the LES phages has only been considered in isolation, on a short-term 
basis. Given the poly-lysogenic nature of the LES, there are likely to be phage-phage 
interactions. Co-infecting bacteriophages face competition for resources; phage 
fitness is seriously impaired when co-infecting for E. coli lambdoid phages (Refardt, 
2011). A study of the levels of free LES phages in the sputa of LES-infected patients 
found that although LESφ2 and LESφ4 usually dominate and are found at high 
numbers, when LESφ2 was not present in one patient, high levels of free LESφ3 
were found (James et al., 2014). In addition, there is a superinfection hierarchy 
between the LES phages (James et al., 2012), which could affect the fitness of 
phages when infecting naïve bacterial strains.  
Many theories as to the role of bacteriophages focus on their lytic activity. For 
example, bacteriophages can control bacterial densities (Shapiro et al., 2010) and act 
as allelopathic agents, lysing phage-susceptible competitors (Brown et al., 2006; 
Gama et al., 2013; Joo et al., 2006). However, in a model CF-lung environment, the 
frequency of LES phage infections resulting in lysogeny is very high, suggesting that 
this is perhaps the norm in the CF lung. This finding is similar to that observed in λ. 
There is evidence that environmental conditions can select for a more or less 
responsive lytic switch in λ; Refardt & Rainey coevolved E. coli and λ under two 
different regimes, designed to favour either lysis or lysogeny. λ evolved under the 
latter had a significantly higher probability of lysogeny than the ancestor, or phage in 
the former regime (Refardt & Rainey, 2010). Furthermore, the issue of polylysogeny 
remains to be explored. It is known that for λ, a high number of infecting phages per 
cell increases the likelihood of lysogeny, due to phage-encoded pro-lysogeny factors 
(Kourilsky, 1973; Lieb, 1953) However, studies with the E. coli – λ model system 
only ever consider a single phage, but there are multiple LES  phages. It remains to 
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be determined what effect would multiple phage genotypes have on the probability 
of lysogeny, if any. 
3.5 Summary 
 Reannotation of the published genomes of LESφ2, LESφ3 and LESφ4 
enabled the functionality of more ORFs in each of the LES phage genomes to 
be predicted, in particular for LESφ4. 
 LESφ4 encodes putative anti-CRISPR proteins, which in related phages are 
active against the type I-E and I-F CRISPR immunity systems of P. 
aeruginosa. 
 H2O2, a chemical present in the CF lung causes an increase in LES phage 
production, but EDTA, a chemical found in many pharmaceuticals, does not. 
 Two commonly used anti-Pseudomonas drugs, fosfomycin  and ceftazidime, 
suppress LES phage production, but only in one isolate from four tested. 
Antimicrobial combination therapy with two phage-suppressing drugs does 
not have an additive effect. Colistin, a strong phage suppressor, has an 
equally negative effect on each of the LES phages, φ2, φ3 and φ4. 
 LES phages φ2, φ3 and φ4 each have a characteristic growth curve upon lytic 
infection of naïve strain PAO1, with LESφ4 displaying the lowest fitness. 
However, over an extended period of time, LESφ4 demonstrates the highest 
amplification in both LB and ASM. 
 The frequency of phage infections resulting in lysogeny is low in 
exponentially growing cultures, but high in a model CF lung environment.   
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Chapter 4 The role of the LES phages in driving bacterial 
phenotypic diversification in ASM and in vivo 
4.1 Introduction 
4.1.1 P. aeruginosa growth in the CF lung 
4.1.1.1 Biofilm formation 
Microscopy of CF sputa, as well as analysis of quorum sensing (QS) signals support 
the widely accepted hypothesis that P. aeruginosa grows as a biofilm in the CF lung 
(Singh et al., 2000). Schwab et al. observed biofilm-like masses of P. aeruginosa 
cells in CF lung tissue (Schwab et al., 2014), but Bjarnsholt et al. performed a more 
detailed analysis of the spatial distribution; by examining different regions of lung 
tissue from explanted lungs, as well as lungs from deceased individuals, they found 
that P. aeruginosa aggregates were common in the conductive zone of explanted 
lungs, and had spread to the respiratory zone in those individuals who died as a result 
of the infection (Bjarnsholt et al., 2009). 
P. aeruginosa biofilm growth in vivo is clearly very difficult to study, but many 
studies have used artificial sputum to model the CF lung environment. Interestingly, 
P. aeruginosa forms biofilm-like structures in this media that are not surface attached 
(Haley et al., 2012; Sriramulu et al., 2005), and it is thought that this is how it may 
exist in the CF lungs. When grown in a biofilm for a short period, P. aeruginosa 
undergoes rapid diversification, giving rise to subpopulations that have a specific 
role in the biofilm structure (Boles et al., 2004).  
4.1.1.2 Chronic infection 
P. aeruginosa initial airway colonisation follows a distinct pattern: transient/ 
intermittent detection, followed by continuous culture positive detection of non-
mucoid, antibiotic-susceptible strains, followed by progression to chronic infection 
(Burns et al., 2001) and the appearance of mucoid colonies (Li et al., 2005), at which 
stage the infection is almost impossible to eradicate. Chronic infection is usually 
diagnosed by continuous culture-positive sputum samples and the presence of 
antipseudomonal antibodies in patient sera (Brett et al., 1992), although this is not 
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definitive. Chronic infection is associated with a worsened clinical status (Lee et al., 
2003) and the emergence of certain phenotypes that are common to chronic CF 
infections but not environmental or acute infection isolates of P. aeruginosa, 
presumably representing the adaptations to a uniquely challenging environment. 
4.1.2 Phenotypes of P. aeruginosa isolated from chronic CF infections 
Isolates obtained from chronic P. aeruginosa infections often have characteristic 
phenotypes, including  auxotrophy, hypermutability, resistance to anti-
pseudomonals, loss of motility, quorum–sensing deficiency and mucoidy (Hogardt & 
Heesemann, 2010), all representing a divergence from the so called “wild-type” 
which causes acute infections. Indeed, such chronic infection isolates actually have a 
reduced ability to cause acute infections (Lorè et al., 2012). Some of the most 
commonly affected phenotypes are discussed in the following subsections: 
4.1.2.1 Auxotrophy  
An auxotroph is a mutant microorganism that has nutritional requirements that differ 
from the wild-type from which it is derived.  The most common example of 
auxotrophy is the inability of cells to grow in the absence of certain amino acids. CF 
sputum is especially rich in amino acids (Barth & Pitt, 1996), so amino acid 
synthesis may become unnecessary or even undesirable, as it is metabolically 
expensive. The presence of auxotrophic mutants has been correlated with the severity 
of disease (Taylor et al., 1993; Thomas et al., 2000), although this may occur 
indirectly through an increase in the sputum amino acid content in severe disease. 
However, a correlation between amino acid concentration and the numbers of 
auxotrophic mutants was not observed (Thomas et al., 2000). A recent study 
investigated the metabolic adaptation of P. aeruginosa isolates in more detail, and 
found that whilst isolates developed more efficient use of the majority of compounds, 
it was largely dependent on the cost of synthesis, with a correlation between the cost 




4.1.2.2 Biofilm formation 
Biofilm production is often altered in chronic CF isolates; some display enhanced 
biofilm formation (Head & Yu, 2004), whereas other non-mucoid isolates display 
reduced surface biofilm formation in comparison to PAO1, in addition to an altered 
biofilm architecture (Lee et al., 2005a). However, mucoid isolates, which over-
produce the polysaccharide alginate and are considered a hallmark of chronic 
infection, are associated with enhanced biofilm formation; upon examination of CF 
sputum, the mucoid cells in a mixed population of P. aeruginosa can be observed in 
aggregates, surrounded by an extracellular matrix (Yang et al., 2008). Production of 
another biofilm-associated exopolysaccharide, Psl, is increased early on in chronic 
infection (via multiple pathways), resulting in enhanced biofilm formation (Huse et 
al., 2013). Biofilm formation is a clinical concern, not least because isolates can be 
more resistant to antimicrobials when growing as a biofilm (Aaron et al., 2002; Hill 
et al., 2005; Kirchner et al., 2012). Such tolerance is likely due to a combination of 
factors, including anaerobic conditions that make many antipseudomonals ineffective 
(Borriello et al., 2006), and upregulation of the blrR gene, a regulatory gene that 
mediates antimicrobial resistance in biofilms (Liao & Sauer, 2012). 
4.1.2.3 Hypermutability 
Hypermutable strains have an elevated mutation rate, due to a defect in DNA repair 
or error avoidance, most commonly the methyl-directed mismatch repair system 
(Oliver et al., 2000). Mutations in the mutS, mutL, mutH or uvrD genes can all cause 
this phenotype (Oliver et al., 2002). Hypermutators are rare in acute P. aeruginosa 
infections (Oliver et al., 2000), but common in chronic infections such as CF, with 
frequencies as high as 42% of isolates (Feliziani et al., 2010). However, there is 
certainly variation between patients; one study found 38% of isolates to be 
hypermutable in one individual, whereas in another individual, only one 
hypermutator was isolated at the beginning of the study. Isolates obtained from this 
individual at later timepoints were all non-mutators (Cramer et al., 2011). Similar 
variation is observed in LES-infected patients; whilst the majority of LES isolates are 
non-mutable, in some individuals, hypermutable LES isolates are found at high 
frequency (Mowat et al., 2011). 
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A high mutation rate is often considered detrimental (Giraud et al., 2001b), due to the 
risk of accumulating deleterious mutations; indeed, when mutator and non-mutator 
strains are competed in vitro and in vivo, in a mouse model of chronic lung infection, 
the mutator strains display lower fitness (Montanari et al., 2007). However, when 
additional selective pressures are present, a hypermutable phenotype can be 
advantageous, enabling quicker adaptation to antibiotic pressure (Alcalá-Franco et 
al., 2012) or a change in nutrient source (Le Bars et al., 2014). The CF lung is a 
heterogenous environment, and a high mutation rate can confer increased fitness in 
novel or diverse environments (Weigand & Sundin, 2012). Similarly, experimental 
evolution with E. coli mutator strains  revealed the mutator phenotype to be 
important for colonising and adapting to a new environment (Giraud et al., 2001a), 
and they have a selective advantage in an in vivo infection (Labat et al., 2005).  
The prevalence of hypermutators has clinical significance; they are strongly 
correlated with increased antibiotic resistance (Maciá et al., 2005; Plasencia et al., 
2007) and increased morbidity (Ferroni et al., 2009). There is some evidence that 
hypermutators become more common as chronic infection progresses; they are more 
common in lengthy infections/ older patients (Ciofu et al., 2005) and are at a higher 
frequency in end-stage chronic infections (Ciofu et al., 2010). 
Phage pressure is a possible reason for the high frequency of hypermutators in 
chronic P. aeruginosa infections; bacteria evolving in the presence of lytic phage are 
more likely to be hypermutable, and, consequently, more likely to develop resistance 
to phage (Pal et al., 2007).  
4.1.2.4 Motility 
Environmental isolates of P. aeruginosa are usually motile, yet chronic CF isolates 
have frequently lost motility (Lee et al., 2005a; Mahenthiralingam et al., 1994; Smith 
et al., 2006b); a recent study found approximately half of CF isolates to be motility 
mutants (Workentine et al., 2013). Similarly, a study of end-stage mutator strains 
found that approximately 1/3 of chemotaxis genes were downregulated, suggesting 
reduced motility (Hoboth et al., 2009). 
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Piliation and flagellation are proposed to be important for colonisation:  type IV pili 
are necessary for twitching motility, biofilm development (Klausen et al., 2003b) and 
phage transduction (Craig et al., 2004); flagella are necessary for swimming and the 
multi-cellular swarming motility (Verstraeten et al., 2008), enabling rapid host 
colonisation. However, once infection is established, such appendages become 
disadvantageous, as they require energetic investment and are targets of 
bacteriophages (Ceyssens et al., 2009b; Chibeu et al., 2009) and the immune system 
(Patankar et al., 2013; Patel et al., 1991). The LES phages are known to require the 
type IV pili for infection (James et al., 2012), and the lytic pilus-specific phage PP7 
is known to drive loss of twitching (Hosseinidoust et al., 2013a) and swimming 
motility in P. aeruginosa  (Brockhurst et al., 2005; Hosseinidoust et al., 2013a). 
Bacteriophages can also drive loss of motility in alternative ways; temperate P. 
aeruginosa bacteriophages are known to inhibit  motility through CRISPR-Cas 
mediated interactions with the host cell (Zegans et al., 2009) and through the 
expression of phage proteins that prevent pilus biogenesis (Chung et al., 2014).  
4.1.2.5 Antibiotic resistance 
Antibiotic resistance is a particularly problematic phenotype that is associated with 
chronic infection. Patients are constantly exposed to high levels of antimicrobials, 
but without clearance of the infection. This presumably exerts strong selective 
pressures on the P. aeruginosa populations residing in the lung, leading to the 
development of antimicrobial resistance.  
P. aeruginosa naturally has a high level of intrinsic antibiotic resistance and is 
resistant to many beta-lactams, fluoroquinolones and aminoglycosides. However, 
there are several antipseudomonals that the “wild-type” is susceptible to, but to 
which resistance will often develop in chronic CF infection. Resistance occurs by 
two mechanisms: adaptive and acquired.  
Adaptive resistance  involves changes in patterns of gene expression and can be 
induced by the environmental conditions, such as presence of extracellular DNA 
(Mulcahy et al., 2008) and antibiotics (Daikos et al., 1990; Fernández et al., 2010), 
or behaviour e.g. biofilm mode of growth (Høiby et al., 2010a) or swarming motility 
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(Overhage et al., 2008b). However, adaptive resistance is not heritable and will not 
persist long-term after removal of the stimulus. 
Acquired resistance, in contrast, is heritable, and can be mutational or transferred 
horizontally on genetic elements, such as plasmids and phages. There is a strong link 
between hypermutability and mutational resistance (Plasencia et al., 2007), and it 
may help explain why CF isolates demonstrate such high levels of antibiotic 
resistance. Mutations in genes associated with efflux pumps or target enzymes are 
common, as are mutations leading to over production of beta-lactamases; all lead to 
clinically meaningful resistance. 
4.1.2.6 Loss of social behaviour 
Many cooperative behaviours in bacteria are controlled by quorum sensing (QS), but 
“cheats”, that either do not produce, or respond to the signalling molecules can arise. 
They benefit from “public goods” produced by non-cheats, and by not producing 
these costly molecules themselves, may gain a fitness advantage and invade the 
population (Diggle et al., 2007a). Given that QS regulates the expression of multiple 
virulence factors, loss of QS is associated with attenuated virulence (Pearson et al., 
2000). Loss of social behaviour is common in chronic CF isolates; they are often QS 
mutants (Marvig et al., 2014; Mowat et al., 2011; Smith et al., 2006b), and there is 
evidence that levels of QS molecules, and the associated reduced secretion of 
exoproducts, are reduced in accordance with the length of infection (Jiricny et al., 
2014; Lee et al., 2005a).  
4.1.3 Phenotypic diversity of chronic isolates 
There have been numerous studies characterising multiple isolates from sequential 
sputum samples, sometimes in multiple individuals, and it has become apparent that 
whilst there is a trend towards the phenotypes mentioned in the previous section, 
chronic P. aeruginosa populations display incredible phenotypic and genetic 
diversity, even within a host. Wilder et al. studied a panel of isolates from 8 
individuals, and found that whilst 7/8 had a large proportion of QS deficient isolates, 
they were also incredibly diverse, suggesting diverse selective pressures (Wilder et 
al., 2009). Indeed, a study of multiple LES isolates, in multiple samples, from 
multiple individuals, found huge phenotypic diversity, with greater diversity within 
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individuals than between them (Mowat et al., 2011), a finding that also holds true for 
non-LES isolates (Ashish et al., 2013a). Workentine et al. considered a larger range 
of phenotypes in multiple samples from just one individual, and observed huge 
phenotypic diversity within samples (Workentine et al., 2013). However, the route of 
evolution towards these “chronic” phenotypes is not well understood. 
One proposed explanation for P. aeruginosa diversity in the CF lung is the spatial 
heterogeneity of the environment. Sequencing of multiple isolates of the DK1 
lineage (commonly isolated in CF clinics in Denmark) obtained from a single patient 
over time suggested the presence of three sublineages, each with different mutation 
rates and phenotypic characteristics, and limited parallel evolution between them. 
The authors speculated that this was due to spatial separation of the lineages, a 
conclusion that was supported to some extent by analysis of fluids and tissues from 
different sites within the respiratory tract (Markussen et al., 2014). 
The phenotypic heterogeneity of the population in the lungs that occurs through 
adaptive radiation in chronic infections has important implications for the treatment 
of P. aeruginosa. For example, traditional antibiotic susceptibility testing based on 
one isolate will give little clue to the rest of the population and result in potentially 
ineffective antibiotic treatment being administered. There is a need to understand 
which factors drive this diversification and enable the long-term persistence of P. 
aeruginosa in the lungs. 
4.1.4 P. aeruginosa diversification in Artificial Sputum Media (ASM) 
ASM has been used previously to study bacterial diversification, but only in short-
term experiments. P. aeruginosa strain LESB58 undergoes extensive diversification 
when cultured through one cycle of growth (7 days) in ASM in the presence of 
antibiotics, including altered antibiotic sensitivity, colony morphology and 
pyocyanin production (Wright et al., 2013). PA14 has been studied in synthetic CF 
sputum (an alternative to ASM) in the presence of mucin (to change the viscosity) or 
ciprofloxacin. Evolved isolates, and whole-populations were each competed against 
the ancestor, but individual genotype fitness was not predictive of population fitness. 
This indicates diversity within the population, and suggests that that fitness of 
individual isolates would be a poor measure of assessing the fitness of a population 
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(Wong et al., 2012). Similarly, when grown as a biofilm for an extended period of 
time (although not in ASM), PAO1 undergoes genetic diversification, particularly in 
genes expected to confer a phenotypic change, including motility and alginate 
synthesis genes (McElroy et al., 2014). 
4.1.5 Bacteriophages as drivers of phenotypic diversity 
Bacteriophages are known to drive bacterial diversification through numerous 
mechanisms. Lytic bacteriophages obligately kill their hosts and so place a strong 
antagonistic selective pressure on bacteria to avoid infection. The “kill the winner” 
hypothesis posits that the competition specialists in a bacterial population (often, but 
not necessarily the most abundant) become targets of bacteriophages. The subsequent 
reduction in the “winners” selects for diversity in the population (Winter et al., 
2010). Experiments with the P. fluorescens/bacteriophage ф2 host – parasite model 
system (Brockhurst et al., 2007) have provided evidence of how bacteriophages can 
drive bacterial diversification through antagonistic coevolution, and how this can be 
influenced by the environment. The diversity between replicate populations is high 
when bacteria coevolve with phage, but the total diversity (including within 
population diversity) is not, a fact that is largely driven by the emergence of different 
phage-resistant variants in different populations (Buckling & Rainey, 2002b). 
However, phage can drive reduced diversity in spatially heterogenous (but not 
homogenous) environments, largely through reductions in bacterial densities, which 
results in less competition for resources and hence less diversification (Brockhurst et 
al., 2004). The effects of extreme environments and bacterial dispersal have also 
been investigated using this system; phage increase the diversity in stressful 
environments (Benmayor et al., 2008), but strongly reduce diversity when in 
combination with dispersal (compared to the effects of dispersal alone) (Vogwill et 
al., 2011). In addition, phage can drive the emergence of hypermutable variants (Pal 
et al., 2007); such a high mutation rate may further accelerate the process of 
diversification. 
Lytic phage can drive diversification through selection for resistant phenotypes. For 
example, phage-resistant mutants of P. syringae have defective type IV pili (Lythgoe 
& Chao, 2003), a common target of bacteriophages. When Escherichia coli and 
phage PP01 underwent coevolution, phage-resistant variants with altered cell 
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membranes, as well as some mucoid variants, were observed (Mizoguchi et al., 
2003). The colony morphology diversity of P. aeruginosa is increased when 
coevolved with the lytic pilus-binding phage PP7 because of the emergence of 
resistant variants. Phage-treated populations are also more diverse with regards to 
motility, phage resistance and preferred environmental niche (Brockhurst et al., 
2005).  
Most experiments focussing on phage-driven diversification have neglected the 
effect of temperate phages. Temperate phage can increase the diversity of a bacterial 
population through the carriage of additional genes during lysogeny, and may lessen 
the antagonistic selection pressure (relative to lytic phages) through the option of 
lysogeny. These factors will likely influence phage-driven host diversification. 
4.2 Objectives 
1. Establish an experimental evolution set-up, with the well-characterised 
laboratory reference strain P. aeruginosa PAO1, in the presence or absence of 
LES bacteriophages φ2, φ3 and φ4 in ASM. 
2. Evaluate the usefulness of ASM as a model of chronic CF infection by 
comparing the phenotypic trajectory of P. aeruginosa in ASM with that in CF 
lung infections. To achieve this, the phenotypes observed in evolved isolates 
from the endpoint of this experiment will be compared with those specific to 
chronic CF isolates, as described in the literature. 
3. Quantify and compare the phenotypic diversification of PAO1 in the presence 
and absence of the LES phages. 
4. Address whether end-point bacterial populations are better adapted than the 
ancestor to the ASM environment with in vitro competition experiments. 
5. Contrast the phenotypic evolution observed in ASM with an in vivo model of 
chronic P. aeruginosa infection. 
4.3 Results 
Six replicate microscosms (hereafter referred to as populations) were included per 
treatment. Replicate populations 1-6 were assigned to the control treatment (PAO1 
alone in ASM), and 7-12 to the phage treatment (PAO1 + LES φ2, φ3 and φ4). 
 111 
 
4.3.1 Bacterial / phage dynamics 
4.3.1.1 Bacterial and free phage counts are high and stable through time 
Colony forming and plaque- forming units (ml-1) in the biofilm homogenate were 
quantified at every other transfer. Bacterial counts were high (~108 c.f.u. ml-1) and 
very similar between treatments (Figure 4.1). Free, infective phages were detected at 
high levels in all populations, with a median phage to bacterium ratio of 1.3 
(interquartile range: 0.65 to 2.3). 
 
Figure 4.1 Bacterial densities and abundance of free phages over the course of the challenge 
experiment.(A.) Bacterial densities of the control (phage-free) populations, (B.) Bacterial densities of the 
phage-treated populations and (C.) Densities of free LES phages. Phage were enumerated by plaque assay, 
using ancestral PAO1 as the indicator host. Datapoints represent the nean of two technical replicates. 
Error bars ±1 S.D. 
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4.3.1.2 Prophage dynamics 
Every 5 transfers, 15 colonies per population (phage-treatment only) were screened 
for prophage complement (40 colonies at the final transfer), using a multiplex PCR 
assay targeted to each of the LES phages (φ2-4) (Figure 4.2). LESφ4 dominated; 
three of the populations were almost exclusively single LESφ4 lysogens, and a 
further two were mostly double lysogens, with LESφ4 in combination with LESφ2 or 
LESφ3. Population #9 showed a different trend over time, with a large number of 
non-lysogens, in addition to a small number of LESφ3 single lysogens, and some 
triple lysogens. The frequencies of the different lysogens remain relatively stable 
over time.  PCR sampling of each control population was negative for LESφ2-4 at 





Figure 4.2 Distribution of lysogens in phage-treated populations. A minimum of per 15 isolates per 
timepoint (every 5 transfers) were PCR screened for the presence of LES φ2, 3 and 4. Area plots (1 per 
population) show the percentage of isolates testing positive for LES phages, either singularly or in 
combination. 
4.3.1.3 Quantification of individual free phages in endpoint populations 
Free phage were quantified at every other transfer by plaque assay, yet this does not 
differentiate between the three phages.  To address this, a qPCR approach was taken 
to calculate the relative numbers of each LES phage in the DNAse-treated 
supernatant of end-point populations. LESφ2 was not detected in two of the 
populations (#7 and #11) but found at high levels in the remaining four populations. 
(Figure 4.3). LESφ4 and LESφ3 were detected in all populations and the density of 
LESφ4 was higher than the other phages in all populations. The level of LESφ3 was 
quite variable between populations, and did not correlate well with the prophage 
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complement data (i.e. a low frequency of LESφ3 in prophage form does not 
necessarily lead to a low level of LESφ3 in free form). 
 
Figure 4.3 Relative densities of each free LES phage in endpoint, phage-treated populations.Relative 
density is calculated as the log10(copies µl-1+1), as determined by qPCR. Copy numbers per µl were 
calculated by comparison to a standard curve of known concentrations. The thick horizontal line denotes 
the median for each population. 
4.3.2 Phenotypic diversity of endpoint isolates 
4.3.2.1 Exploratory principal component analysis (PCA) of multivariate 
phenotype data 
At the end of the challenge experiment, the 40 isolates selected from each population 
were characterised for multiple phenotypes. Given the multivariate nature of this 
dataset, a PCA was performed in order to visualise the data and identify any 
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relationships between variables, or any obvious differences between the two 
treatments (Figure 4.4). Data for seven phenotypes were included: swimming, 
swarming and twitching motility, hypermutability, growth rate, biofilm formation 
and auxotrophy. The first principal component (which represents the maximum 
variation in the data) is strongly associated with twitching motility, suggesting that 
this phenotype explains a large amount of variation in the data.  
Two phenotypes, swimming motility and growth rate in LB, are strongly 
diametrically opposed, suggesting that a slow growth rate is associated with less 
motility. When the independent variable (treatment) is overlaid on the PCA plot 
(middle panel), it is apparent that there is a large degree of overlap between isolates 
from both treatments. There is a degree of clustering for some populations (bottom 
panel, points coloured according to population), but for others, the isolates are spread 




Figure 4.4 Exploratory principal component analysis of multivariate phenotype data.(A.) variable factor 
map, (B.) individual factor map, labelled with experimental treatment and (C.) individual factor map, 
labelled with population number. Data for the biofilm and growth variables were incomplete and were 
predicted with a multiple imputation approach. The Eigenvalues for the first and second components were 
2.07 and 1.59, respectively. The “Biofilm” label is partially obscured by the “Auxotrophy” label on the 
variable factor map. 
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4.3.2.2 Loss of wild-type phenotype 
The PCA highlights the diversity that is seen between isolates in terms of different 
phenotypes. Scaled continuous measurement data were required for the PCA, but for 
certain phenotypes it is possible to easily categorise isolates in a dichotomous 
fashion i.e. wild-type (similar to ancestral PAO1) or mutant (loss/alteration of 
phenotype, similar to characterised mutant). To this end, we scored isolates as wild-
type or mutant (using defined cut-off measurements) for the following five 
phenotypes: twitching, swimming and swarming motility, ability to synthesise amino 
acids, and spontaneous mutation rate. Many isolates were impaired for multiple 
phenotypes, and there was considerable variation in the proportion of mutants in each 
population (Figure 4.5). There was no difference between the control and phage 





Figure 4.5 Boxplots of the proportion of isolates per population displaying the mutant phenotype. Thick 
black horizontal lines represent the median, the box represents the upper and lower quantiles, and the 
circles represent outliers. 40 isolates were tested per populations (6 populations per treatment). 
4.3.2.3 Colony morphology diversity  
300 isolates from each population were classified as one of 5 morphological sub-
types: smooth and straw coloured, small (<0.5mm) and smooth, raised centre, fuzzy 
spreader or wrinkly spreader. All populations showed evidence of morphological 
diversification, but whilst there were large variations in inter-population 
morphological diversity (Figure 4.6), there was no difference in overall diversity 





Figure 4.6  Boxplot of the morphological diversity of bacterial populations (n=6). Thick black horizontal 
lines represent the median, the box represent s the upper and lower quantiles, and the circles represent 
outliers. Colonies were assigned to 1 of 5 morphologies and Simpson's dominance index (1-(Simpson’s 
index)) calculated as an estimate of population diversity, where 0=no diversity and 1=high diversity. 40 
isolates were assessed per population. 
 
4.3.2.4 Phage resistance 
Endpoint isolates were tested for resistance to each of the LES phages. Phage 
resistance was widespread in both treatments (Figure 4.7). The majority of isolates 
were resistant to all three phages in all but one population (#5), in which 93% of 

































Figure 4.7 Phage resistance of endpoint isolates to LESφ2-4. (A.) Control and (B.) phage-treated 
populations. Bars are coloured according to the particular phage combination to which resistance was 
observed. High titre pure phage stocks were spotted onto a soft-agar lawn of each isolate and scored as 
resistant if no lysis was observed after overnight incubation at 37˚C. 
4.3.2.5 Biofilm formation 
In order to assess whether isolates evolved in ASM had altered in their capacity to 
form biofilms, a simple in vitro assay was used to measure surface-attached biofilm 
formation. Due to the inherent variability of this assay, a large number of replicates 
are required, so it was not feasible to test all the isolates; instead, the first 10 from 
each population were tested. After staining of the biofilm with crystal violet and 
solubilisation, the A590 was measured as a proxy of biofilm formation, and 
normalised to the ancestor. Overall, there was no trend towards increased or 
decreased biofilm formation (Figure 4.8). There was large variability within many 
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populations, most notably population #3, which has a median biofilm formation 1.5 
times that of the control, but included poor and hyperbiofilm producers in the 
population, resulting in a large range. 
 
 
Figure 4.8 Biofilm formation of isolates obtained from endpoint populations. Biofilm formation was 
assessed by crystal violet staining of a surface-attached biofilm, followed by solubilisation and 
measurement at A590. Technical replicates were normalised the PAO1 control on the same plate. Two 
biological replicates were performed for each isolates, and 10 isolates were assayed per population. Boxes 
represent the interquartile range of the population, the middle black line the median, the whiskers the 5th 
and 95th percentiles, and the black circles outliers. 
4.3.2.6 Antibiotic resistance 
Disc diffusion assays revealed all 40 isolates from every population to be as 
susceptible to the selected panel of antipseudomonals as the ancestor. The method 
was then adapted to look for clinically resistant isolates that may be present at a low 
frequency in the entire population, by plating entire populations on agar containing 
antibiotics at clinical resistance breakpoint levels.  
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The frequency of antibiotic resistant isolates varied according to population and to 
antibiotic, with certain populations containing a relatively high frequency of isolates 
displaying clinical  resistance (Figure 4.9); tazobactam-piperacillin resistance was 
displayed in 0.08% of the population in population 11. Resistance occurred in a 
higher frequency of cells in this population than in the mutator strain, PAO1ΔmutS. 
Resistance to ceftazidime and tazobactam-piperacillin arose more frequently than 
resistance to other antibiotics. No meropenem resistant isolates were identified. 
In order to assess the extent to which the mutator phenotype of the isolates is 
responsible for the high frequencies of antibiotic resistant cells, the proportion of 
hypermutators in a population was plotted against the (arcsine transformed) 
frequency of resistant isolates (Figure 4.10). This was done for ceftazidime and 
tazobactam-piperacillin, as these were the antibiotics to which the highest level of 
resistance was detected. A correlation was detected between the frequency of 
hypermutators and tazobactam-piperacillin resistance (Spearman’s rank correlation 
coefficient: ρ = 0.69, p < 0.05), and between the frequency of hypermutators and 




Figure 4.9 Frequency of bacterial cells in whole populations displaying clinical resistance to a panel of anti-
pseudomonals  (arcsine transformed).  Frequencies were calculated after plating endpoint populations onto 
antibiotic free media, and media containing antibiotics at the clinical resistance breakpoint level.  
Planktonic PAO1 and PAO1 grown in ASM were included as negative controls. PAO1 ΔmutS was included 





Figure 4.10 The correlation between the frequency of hypermutators  in a population and the frequency of 
isolates (arcsine transformed) demonstrating clinical resistance to the antibiotics ceftazidime and 
piperacillin/tazobactam (n=12). 
In order to further characterise the nature of the spontaneously occurring antibiotic 
resistance, resistant colonies growing on ceftazidime or tazobactam-piperacillin from 
population #11 were isolated and MICs to both antibiotics determined (n = 20). The 
MICs were at least two-fold higher than the clinical resistance breakpoints, and there 
was a high degree of cross-resistance; all isolates found to be resistant to one 
antibiotic were also resistant to the other (Table 4.1). This suggests a resistance 
mechanism common to both antibiotics. Ceftazidime and piperacillin are both beta-
lactam antibiotics, and certain beta-lactamase enzymes are capable of degrading 
both, even in the presence of tazobactam (an inhibitor). In order to clarify if beta-
lactmases were being produced by these isolates, a beta-lactamase assay was 
conducted on five randomly selected isolates from each antibiotic medium, using 
nitrocefin, a chromogenic substrate for beta-lactamases. 
 125 
 
Beta-lactamase production was observed in all the isolates tested, to varying degrees, 
with no clear difference between isolates originally isolated from media containing 
ceftazidime or tazobatam-piperacillin (Figure 4.11). 
Table 4.1 Minimum inhibitory concentrations (as determined by broth microdilution) of PAO1 isolates 
displaying resistance to ceftazidime or tazobactam-piperacillin, to each antibiotic. 
Isolated from  MICs CAZ (mg L-1)  MICs TZP (mg L-1)  
CAZ  32-128  128-256  
TZP  32-64  128  
 
 
Figure 4.11 Beta-lactamase production in ceftazidime and tazobactam-piperacillin resistant isolates. 
Activity was measured using nitrocefin, in a chromogenic assay by calculating the change in A486/390 per 
minute. The dashed line indicates the value of the negative control (PAO1). The MIC of CAZ required for 
all isolates tested that were originally isolated from CAZ was 64 µg ml-1. 
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4.3.2.7 Analyis of Molecular Variance (AMOVA) 
4.3.2.7.1 Haplotype diversity 
Isolates were classified as different haplotypes based on the combination of 
phenotypic traits displayed. For each trait, isolates were scored a 0 if they displayed 
the same phenotype as the ancestor, or a 1 if they displayed a mutant phenotype. A 
haplotype in this instance was defined as a unique combination of phenotypic traits, 
and the frequency of each haplotype in each population was determined. 
57 different haplotypes were identified in this study, based on 8 phenotypic traits 
(Figure 4.12). The haplotype of the ancestor (haplotype 5) was very rare in evolved 
populations; only 8/480 isolates shared the ancestral haplotype, all of which were in 
the control populations. The most common haplotype (haplotype 4) was found in 
almost a quarter (111) of isolates across all but one population, and was characterised 
by loss of all three types of motility and resistance to all three LES phages, but 
displaying WT phenotypes of normal mutation rate and ability to synthesise amino 
acids. 
 
Figure 4.12 eBURST diagram reflecting diversity of phenotypic isolates obtained from end-point 
populations. A haplotype was defined as a unique combination of 8 phenotypic traits (auxotrophy, 
resistance to each LES phage, hypermutability and swimming, swarming and twitching motility).  Each 
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dot represents a single haplotype and the size of the dot reflects abundance. The ancestral haplotype is 
labelled in red. Sub group founders are labelled in yellow. Haplotypes found only in the control treatment 
are labelled in black, haplotypes found only in the phage treatment are labelled in green, and haplotypes 
observed across both treatments are labelled in pink. Haplotype numbers are arbritrary.  
The ancestral haplotype (haplotype 5) is phenotypically identical to PAO1. It is 
relatively low in abundance and is found only in the control treatment. Haplotype 41 
is the most divergent to the ancestor in that it differs in every phenotype. 
4.3.2.7.2 AMOVA 
The phenotypic distance between haplotypes was calculated, and the distance matrix 
was partitioned into sub-matrices for the various subdivisions of the data, including 
treatment (control or phage-treated), population and individual isolates. The 
proportion of variance attributable to each sub-division was estimated. Treatment 
group explained only 2% of the total variance; the majority of the variance (74%) 
was within populations (Table 4.2). 
Table 4.2 Analysis of Molecular Variance of the phenotypic diversity of haplotypes identified in endpoint 
populations. Variance was partitioned into within and between populations, and between treatments. 
Significance was tested by Monte-Carlo permutation tests (49 permutations). 
Variance 
component 
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4.3.3 Competitive assays of evolved populations 
To deduce whether evolved (endpoint) populations had adapted to the ASM 
environment, whole populations were competed against the ancestral PAO1 isolates, 
in conditions identical to one transfer of the challenge experiment, and the selection 
rate constant (rij) was calculated for each competition. The rij was >0 for all 
competitions which indicates that the evolved populations are more competitive in 
ASM than the ancestor.  
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The mean rij of the phage-treated populations was higher than the controls (1.58 
versus 1.10 day-1). To remove the competitive effect conferred by the LES phages 
(through prophage-mediated lysis), populations were also competed against PAO1 
pilA-, which is resistant to the LES phages. (Figure 4.13).  
All evolved populations from both treatments were fitter relative both to PAO1 and 
pilA- (Figure 4.13; one-sample t-test of each treatment-competitor combination 
against an expected value of 0 (no selection); all significant at an alpha-level of 
0.0125). However, when PAO1 pilA- was the competitor, there was a reduction in the 
mean selection rate constant for both treatments. No difference was observed 
between PAO1 pilA- and ancestral PAOl (mean rij ± 1 SEM = 0.26 ± 0.31), 
suggesting that the observed difference is not due to an inherent adaptive benefit of 
the pilA mutation in ASM. A two way ANOVA was conducted to compare the effect 
of treatment (phage or no phage) and competitor (PAO1 or pilA-) on selection rate 
constant. There was no effect of treatment (F 1,20 = 2.64, MSE = 0.18, p = 0.12) but 
the main effect of competitor was significant ( F1,20 = 35.8, MSE = 2.46, p < 0.001). 
The interaction of the 2 factors was significant (F1,20 = 8.54, MSE = 0.59, p < 0.01), 
so one way ANOVAs were conducted to assess the effect of treatment in the 
presence of each competitor separately. At an α level of 0.025, the effect of treatment 
was statistically significant when the competitor was PAO1, (F1,10 = 7.12, MSE = 





Figure 4.13 Interaction plot displaying treatment and competitor effects on population fitness. The 
selection rate constant was determined as a proxy for population fitness for each population when in 
competition with either ancestral PAO1, or an isogenic phage-resistant competitor, PAO1pilA-. Data points 
represent the mean ± 1 S.E. 
 
4.3.4 In vivo coevolution of PAO1 and LESφ2-4 
In order to compare the trajectory of P. aeruginosa population evolution and role of 
temperate phages in an ASM biofilm model with behaviour in vivo, a well-
established rat chronic lung infection model was used.  The experimental set-up was 
replicated in two groups of 6 rats, which were infected by intubation with agar beads 
containing PAO1 and free LES phages φ2-4.  The experiment ran for 10 days before 
the rats were sacrificed. Levels of bacteria and free phages in the lungs were 
quantified.  There was a large inter-rat variation in bacterial numbers in the lungs, 
but the mean bacterial cell counts between the two treatments were quite similar 
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(geometric mean = 3.8 x 106 (control) and 5.4 x 106 (phage treatment)). Free phage 
were detected in the lung homogenate of all phage-treated rats, with the phage to 
bacterium ratio ranging from 0.004 to 0.4. There was no clear relationship between 
bacterial densities and the ratio of free phage to bacteria (Figure 4.14). No free phage 
were detected in any of the control rats. 
 
Figure 4.14 The relationship between log10 bacterial densities and the ratio of  p.f.u.s to c.f.u.s (PBR) after 
10 days in the rat lung. Each individual datapoint represents one replicate (rat) in the phage-treatment 
only. 
Bacterial colonies were screened for their morphology, but no diversity was 
observed, with all colonies retaining the “smooth” ancestral morphotype. Forty 
bacterial isolates were selected randomly from each rat and subjected to PCR 
analysis for prophage complement, and the twitching motility phenotype. LESφ2 and 
LESφ3 single lysogens were common, yet single LESφ4 lysogens were rare (Figure 
4.15). LESφ4 occurred more frequently as double lysogens, in combination with 
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LESφ2 or LESφ3. Indeed, polylysogeny was a common phenomenon, with double 
lysogens of all phage combinations, as well as triple lysogens, being detected. All 
isolates (from both treatments) retained full twitching motility, comparable to the 
ancestor. 
 
Figure 4.15 Prophage complement of  PAO1 isolates obtained after 10 days in vivo growth, in the presence 
of free LES φ2-4 bacteriophages. Bars are coloured according to the number of isolates carrying each 
specific prophage combination. 
4.4 Discussion 
In this study, the well-characterised reference strain PAO1 was evolved in two 
different models of the CF lung, ASM, and the rat model of chronic infection, both in 
the presence and absence of LES phages φ2, φ3 and φ4. Extensive phenotypic 
diversification was detected in endpoint populations evolved in ASM, with the 
emergence of many phenotypes that are common to chronic CF isolates, yet there 
was no difference between phage-treated and control populations, suggesting that 
this diversification can occur in the absence of bacteriophages. The majority of the 
diversity was actually within populations, something that has been observed in many 
studies of CF isolates (Ashish et al., 2013a; Mowat et al., 2011; Wilder et al., 2009; 
Workentine et al., 2013).  
The parallel phenotypic trajectories that are evident between P. aeruginosa evolving 
in the CF lung and in ASM suggest that ASM could have useful applications as a 
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model for bacterial behaviour in the CF lung. Despite the lack of antibiotic or 
immune system pressures in this model, similar phenotypes are detected, suggesting 
that a large majority of bacterial adaptation in the CF lung may simply be driven by 
growth in a biofilm. In contrast, no phenotypic diversification was observed in the rat 
model of chronic lung infection. This may be partly because only two phenotypes 
were tested (due to time constraints), reducing the likelihood that diversity would be 
detected. Twitching motility was chosen, as this had a strong correlation with the 1st 
principal component, in addition to colony morphology diversity, as this is used 
frequently to assess general diversity in a population (Brockhurst et al., 2004; 
Buckling & Rainey, 2002b; Korona et al., 1994; Rainey & Travisano, 1998). The 
lack of diversification is more likely due to the short timescale of the experiment (10 
days, in contrast to 120 days in ASM), but the high costs and ethical implications of 
animal models limit the length of evolution experiments. Despite being proposed as a 
model of chronic infection (Cash et al., 1979; Kukavica-Ibrulj et al., 2008a), there is 
no evidence that P. aeruginosa grows as a biofilm in the rat agar bead model, and the 
method of bypassing the host defences by implantation of the beads is unrealistic. In 
contrast, a novel mouse model of infection that involves a more natural intranasal 
administration of P. aeruginosa has demonstrated that LES isolate B65 can adapt to, 
and colonise, the nasopharynx, with subsequent “seeding down” to the lungs 
(Fothergill et al., 2014). It is though that the upper respiratory tract acts as a reservoir 
of P. aeruginosa in CF, allowing bacteria to “pre-adapt” to the lungs (Hansen et al., 
2012), which could be an important step in the establishment of chronic infection. 
The nasopharyngeal mouse model seems to be a more realistic process of infection 
than the rat model, and can be maintained for a longer period of time (28 days). 
However, our attempts at establishing colonisation with this model using strain 
PAO1 were unsuccessful, as mice either cleared the infection completely, or 
developed an acute infection. At present, ASM offers the best option for conducting 
long-term evolution experiments. 
Bacterial and phage numbers were monitored over time during coevolution in ASM. 
Bacterial densities were relatively stable, and similar between all populations. Total 
free phage densities also did not fluctuate markedly over time. The continued 
existence of phage suggested maintenance of susceptible bacteria (Schrag & Mittler, 
1996), allowing continued phage production through lytic infection, and/or phage 
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production through prophage-mediated lysis. PCR amplification of colonies revealed 
that LESφ4 was the most dominant prophage, and LESφ2 and LESφ3 lysogens were 
rare. Likewise, qPCR revealed that LESφ4 was the most abundant free phage in 
endpoint populations. Interestingly, LESφ2 densities remained relatively high in the 
populations in which it had not been driven extinct, suggesting continued lytic 
cycling of LESφ2, or the existence of a small sub-population of LESφ2 lysogens 
undergoing high rates of spontaneous lysis. Indeed, previous research has shown that 
PAO1 LESφ2 lysogens have higher rates of spontaneous phage production than the 
other LES phages (James et al., 2012) and that LESφ2 is frequently the most 
abundant free phage in the sputa of LES infected individuals (James et al., 2014). 
Despite the relatively short timescale of the in vivo infection, the LES phages were 
able to establish lysogeny at quite high frequencies. However, the comparative 
evolutionary successes of the LES phages in the rat model of chronic infection were 
in complete contrast to in ASM, with LESφ2 and LESφ3 lysogens common, yet 
LESφ4 lysogens rare. That the pattern of dominance is so different to ASM suggests 
that the environment plays an important role in the order that the LES phages can 
establish lysogeny. LESφ4 in particular does badly in vivo when compared to ASM, 
but there are a host of possible explanations for this. LESφ4 may confer an 
advantage to bacteria in the ASM environment, and not in vivo, or there may be an 
inhibitor of successful infection in vivo that is specific to LESφ4. It has previously 
been observed that insertions in the LESφ2 and LESφ3 prophages in isolate B58 
reduce bacterial competitiveness in this model, suggesting that they are beneficial in 
vivo (Winstanley et al., 2009), which could explain their prevalence in this 
experiment. How insertions in the prophages affect bacterial competitiveness, and 
whether these findings would be applicable to LESB58 infections in CF, remain 
unknown. 
Large numbers of ASM-evolved endpoint isolates were phenotypically similar to 
chronic CF isolates, demonstrating elevated mutation rate and loss of motility.  
Previous studies of CF isolates have found loss of swimming, swarming and 
twitching motility (Workentine et al., 2013), and it has been proposed that this is an 
immune avoidance strategy (Mahenthiralingam et al., 1994). However, the lack of 
any immune system in our model suggests that loss of motility may evolve, at least 
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in part, because of other selective pressures: maybe they are simply a waste of energy 
in a sessile environment? The CF lung chemical environment may also influence 
motility; when P. aeruginosa is grown in processed CF sputum, the large majority of 
cells are non-motile. The same effect in not seen when the sputum is heat-treated, 
suggesting that there is some heat-labile, inhibitory component of sputum (Palmer et 
al., 2005). However, the researchers did not identify it, and it is unknown if ASM has 
the same effect. 
Perhaps surprisingly, loss of motility in endpoint populations was equally frequent in 
the phage treatment as in the controls. The majority of isolates had greatly reduced 
swarming, a complex type of motility regulated by multiple genes. Swarming cells 
upregulate production of virulence factors such as proteases and the type III secretion 
system (including related effector proteins), and demonstrate resistance to several 
antipseudomonals (Overhage et al., 2008b). The logical conclusion is that loss of 
swarming motility will result in lowered virulence. Functional type IV pili and 
flagella are required for swarming motility (Köhler et al., 2000), and as most isolates 
were twitching and swimming motility deficient (suggestive of defective type IV pili 
and flagella, respectively), it is unsurprising that such high levels of swarming 
deficient mutants were observed.  
Given that the type IV pili act as a receptor for the LES phages, the antagonistic 
selection pressure (i.e. the threat of lysis) may drive loss of this receptor, as described 
for lytic phages (Hosseinidoust et al., 2013a). However, temperate phages do not 
obligately kill, and lysogeny offers an alternative phage resistance mechanism, albeit 
only to similar phages. Lysogeny can have the added benefit of enhancing the fitness 
of bacteria through prophage-encoded genes (Barondess & Beckwith, 1990; 
Barondess & Beckwith, 1995; Stanley et al., 2000; Vaca Pacheco et al., 1997; Wang 
et al., 2010b). The fact that pili are lost in the control populations suggests that this is 
not merely phage driven, although by studying populations through time, we could 
assess if the rate at which twitching motility is lost differs in the two populations. 
The loss of twitching motility explains the high levels of phage resistance detected 
across both treatments. Population 5 was the only one to retain a high frequency of 
motile isolates, and also had a high frequency of isolates fully susceptible to all three 
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phages. It is also interesting to note the 15% of isolates in population 9 that remained 
fully susceptible to all three phages; it is possible that the spatial structure of the 
ASM environment/ biofilm allows escape from phage predation (Schrag & Mittler, 
1996).  Such spatial heterogeneity is also a feature of the CF lung. 
Previous studies have suggested a role for type IV pili in biofilm formation (Klausen 
et al., 2003b; O'Toole & Kolter, 1998), yet they are defective or not produced in this 
model, in which PAO1 forms biofilms. However, despite the reported link between 
type IV motility and biofilm formation, a study examining clinical isolates observed 
no correlation between biofilm production and motility (Head & Yu, 2004), although 
the authors did not control for growth rate. Another comparison of chronic infection 
isolates observed reduced biofilm formation in microtitre plate assays, as well as 
differences in biofilm architecture to that of PAO1, and the more late-stage the 
infection, the more pronounced the differences. PAO1 formed a smooth biofilm, 
covering a surface, yet many isolates formed patchy aggregates that did not cover a 
surface. The heterogeneities were largely due to differences in motility, with motile 
isolates forming biofilms more akin in structure to PAO1 (Lee et al., 2005a).  
Despite high frequencies of non-motile isolates in this study, biofilm formation was 
not strongly negatively affected. There were huge heterogeneities between isolates in 
biofilm formation, but no overall trend towards increased or decreased biofilm 
formation. The natural assumption is that growth in a biofilm will result in adaptation 
towards increased biofilm formation, but this is not necessarily the case. In vivo, 
biofilm formation may protect cells from aggressor such as antibiotics, other bacteria 
and the immune system, but these are lacking in this in vitro model. Being a better 
biofilm producer in this model is not necessarily advantageous; in order for 
individuals to pass on their genes, they must survive the 4 days until the transfer into 
fresh media, and if biofilm formation is not necessary for this, it will not necessarily 
be selected for.   
A high frequency of hypermutators were observed in some evolved populations, but 
again, there were large differences between populations, ranging from 0 to over 90% 
hypermutators. A high mutation rate is thought to be detrimental due to the risk of 
deleterious mutations, but can sweep a population by hitch-hiking with beneficial 
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mutations (Chao & Cox, 1983), and can be advantageous in a novel environmental, 
accelerating adaptation. The long-term E. coli selection experiment in the laboratory 
of Richard Lenski observed that hypermutators arose in several populations and 
swept to a high frequency. This was attributed to hitch-hiking, but, surprisingly was 
not linked to increased fitness (Sniegowski et al., 1997). The mutator phenotype may 
confer intrinsic fitness benefits; PAO1 mutS and mutL-deficient mutator isolates 
form biofilms with significantly enhanced microcolony growth (Conibear et al., 
2009), and mutS mutants overproduce the H2O2-degrading enzyme catalase, 
increasing their resistance to oxidative stress (Torres-Barceló et al., 2013). The 
hypermutable phentotype is linked with antibiotic resistance (Plasencia et al., 2007; 
Waine et al., 2008), and a clear correlation was observed between the frequency of 
hypermutators in a population and the frequency of clinically resistant isolates. 
Characterisation of these isolates identified increased basal β-lactamase levels, a 
resistance mechanism that has been identified previously in mutator strains 
(Mandsberg et al., 2009). The finding that clinically resistant isolates are present at 
low frequency in hypermutable populations, even in the absence of antibiotic 
treatment, may be of concern in chronic CF infections. 
Hypermutators aren’t necessarily maintained in the long-term; once a population has 
become adapted to its environment, the focus is then on reducing the genetic load, 
with a lowering of the mutation rate (Wielgoss et al., 2013). Hypermutability through 
time was not recorded in this study, so it is unknown when the mutator phenotype 
first arose in each population, or whether mutator lineages were previously present in 
the non-mutator populations, although sequence data may go some way to answering 
those questions. 
Despite the emergence of many phenotypes associated with chronic infection 
isolates, no mucoid isolates, which are often noted as a hallmark of chronic infection, 
were identified. This may be due to the short timescale of this study and lack of other 
selective pressures, such as the host immune system, other microbes or antibiotics. 
The mucoid phenotype is associated with resistance to opsonisation (Baltimore & 
Mitchell, 1980) and increased antimicrobial resistance (Govan & Fyfe, 1978), but is 
rarely identified in non-CF P. aeruginosa (Govan & Deretic, 1996). Growth in a 
biofilm compounds this problem, as mucoid biofilms are much more difficult to 
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eradicate (in comparison to non-mucoid biofilms) (Hengzhuang et al., 2011; Hentzer 
et al., 2001). There is also evidence that alginate, the polysaccharide that is 
overproduced in mucoid strains, protects the biofilms from the immune system (Leid 
et al., 2005). 
The diversification observed in ASM over what is a relatively short timescale could 
be driven by growth in a biofilm. P. aeruginosa diversifies when grown as a biofilm, 
and this self-generated diversity helps protect against oxidative stress (Boles et al., 
2004). The authors suggested that this was due to the “insurance effect”, which posits 
that biodiversity has a buffering effect over time on productivity, as well as raising 
the overall mean productivity of an ecosystem (Yachi & Loreau, 1999).  However, 
the extent to which the data supported the insurance hypothesis was questioned by 
Cooper and colleagues (Cooper et al., 2005), and the insurance hypothesis with 
regards to bacterial biofilms has still not been fully tested.  
Aside from diversity, the heterogeneity observed between replicate populations is 
also striking, suggesting that they are following divergent evolutionary trajectories. 
This is often observed in experimental evolution (Buckling & Rainey, 2002a; 
Lythgoe & Chao, 2003), but also between patients (Ashish et al., 2013a; Mowat et 
al., 2011). This suggests that not all the diversity observed P. aeruginosa populations 
in different patients can be explained by the infecting genotype or innate host 
differences, and highlights our lack of understanding of the processes driving this 
diversification. 
It is interesting that no differences in diversity were detected between the two 
treatments. Phages have previously been shown to drive the development of 
phenotypes associated with chronic infection in P. aeruginosa. For example, when 
coevolved with the pilus-specific phage PP7, PAO1 displayed impaired twitching 
motility and reduced biofilm formation, although sequencing of an impaired isolate 
did not reveal SNPs in any genes known to be involved in twitching motility. Phage-
resistant isolates evolved with an additional, LPS-specific  phage also had lowered 
motility and a reduced growth rate, but a higher production of virulence factors such 
as pyoverdine and pyocyanin, when compared to single-phage or phage free controls 
(Hosseinidoust et al., 2013a). Further analysis of these phage resistant isolates 
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revealed that they were more resistant to nonopsonic phagocytosis, presumably due 
to loss of required receptors, and had increased resistance to oxidative stress 
(Hosseinidoust et al., 2013b). Clearly, selection for phage-resistance can have far-
reaching consequences for bacterial phenotypes, even affecting virulence; phage 
resistance in the fish pathogen Flavobacterium columnare, is associated with reduced 
virulence in vivo (Laanto et al., 2012). 
As the LES phages are temperate, they are unlikely to impose such antagonistic 
selection pressures on the bacteria, as are seen with obligately lytic phages. Sequence 
data may give us more information about the coevolutionary interactions between 
PAO1 and the LES phages, and this is something that will be addressed in the 
following chapter. 
Such phenotypic diversification is not necessarily a consequence of adaptation to the 
ASM environment, but when competed against the ancestral PAO1, all the evolved 
populations had equal or increased fitness, relative to the ancestor. Interestingly, 
phage-treated populations were more competitive than the controls, but only when 
competed against the phage-susceptible competitor. This suggests that the LES 
phages may confer a competitive advantage to their hosts that is dependent on 
prophage-mediated lysis of the competitor, again something that will be investigated 
further in Chapter 6. 
4.5 Summary 
 PAO1 and LES bacteriophages φ2, φ3 and φ4 can stably coexist in an ASM 
model of the CF lung, but there are differences in the evolutionary success of 
the phages, with LESφ4 largely dominating in prophage form. 
 PAO1 undergoes extensive diversification in ASM, with many isolates 
developing phenotypes commonly observed in chronic CF isolates. Crucially, 
this diversification is not LES phage-driven, but occurs in the presence or 
absence of phages. 
 Low frequencies of clinically antipseudomonal-resistant isolates were 
detected in hypermutable populations. Ceftazidime and piperacillin-
tazobactam resistant isolates produced high levels of β-lactamases. 
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 All evolved populations had equal or increased fitness relative to the 
ancestor. Phage treated populations were more competitive than controls, but 
only when the competitor was phage-susceptible. 
 The evolutionary success of the LES phages is very different in a rat model of 
chronic infection, with LESφ2 and LESφ3 prophages dominating. However, 
no bacterial phenotypic diversity was detected after 10 days. 
4.6 Declaration 
The coevolution experiment was initially designed by Dr. Chloe E. James (in 
conjunction with Prof. M. A. Brockhurst and Prof. C. Winstanley), and was carried 
out by myself and Dr. James. The majority of the phenotypic characterisation of 
endpoint populations and all data analyses were performed by myself. 
The in vivo work was done in collaboration with Dr. Irena Kukavica-Ibrulj at the lab 
of Prof. Roger C. Levesque, Laval University.  
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Chapter 5 The role of the LES phages in driving bacterial genetic 
diversification in ASM  
5.1  Introduction 
5.1.1 Evolution of P. aeruginosa in the CF lung 
Isolates of P. aeruginosa from the lung of chronically infected CF patients tend to 
display characteristic phenotypes, as discussed in the previous chapter, which are 
often underpinned by mutations in several key genes. In the era of low-cost, high 
throughput genome sequencing, numerous studies have attempted to characterise the 
evolutionary trajectory of P. aeruginosa over the course of infection, and identify the 
genetic changes that enable adaptation to the CF environment. 
Sequencing of the same lineage over the course of an infection can identify genes 
important for adaptation, as can examination of multiple lineages for parallel 
evolution. Taking a longitudinal approach, Smith et al. sequenced two isolates from 
one patient that were 7.5 years apart, in addition to PCR testing of intermediate 
isolates. Interestingly, the majority of mutations that occurred over time were loss of 
function (LOF) mutations, with virulence factors in particular a target; genes 
involved in the type III secretion system, twitching motility, biofilm formation and 
production of proteases (all known virulence factors) were altered (Smith et al., 
2006b). It is thought that these virulence factors are required for establishing 
infection, as a transposon mutagenesis study of PA14 found that insertions in 
virulence genes resulted in reduced fitness in a mouse colonisation model, and 
reduced systemic dissemination in neutropenic mice (Skurnik et al., 2013). However, 
the selective pressures of a chronic infection may be different; bacteria are under 
constant attack from the immune system and antibiotics, and subjected to oxidative 
stress and competition from co-infecting microorganisms. It is hypothesised that loss 
of virulence factors may be an immune evasion strategy (Smith et al., 2006b), but it 
is difficult to pinpoint the exact factors that are driving within-host evolution. 
Some researchers have attempted to shortlist genes involved in adaptation to the CF 
lung. Marvig et al. compared multiple isolates of the DK2 lineage of P. aeruginosa, 
a common transmissible clone that is widespread through CF centres in Denmark. By 
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identifying genes that underwent parallel evolution, they were able to identify 65 
“pathoadaptive” genes, which are defined as genes that maximise pathogen fitness. 
Broadly, these were genes involved in cell envelope formation (linked with immune 
evasion), antibiotic resistance, or regulation of other genes. Interestingly, when the 
researchers looked at lineages that has displaced others, they were found to have 
more pathoadaptive mutations (Marvig et al., 2013), suggesting that such mutations 
may be important to the evolutionary success of a lineage. In a follow up study, a 
similar approach was taken, but studying isolates from children (i.e. recent 
infections) to identify genes that are involved in early adaptation to the CF lung. This 
strategy identified 52 pathoadaptive genes, including genes involved in antibiotic 
resistance, motility, secreted products and transcriptional regulation. Again, most 
were predicted LOF mutations (Marvig et al., 2014).  
Mutations in regulatory genes are a common theme (Dettman et al., 2013; Jeukens et 
al., 2014; Marvig et al., 2014), and may be an obvious target because of their 
pleiotropic effects. The anti-sigma factor MucA regulates alginate production, and 
mutations in mucA can cause overproduction of alginate (Pulcrano et al., 2012), 
resulting in the mucoidy phenotype that is associated with chronic infection. 
However, MucA has pleiotropic effects, regulating motility, rhamnolipid production, 
QS signal production and production of virulence factors (Rau et al., 2010; Wu et al., 
2004), suggesting it may facilitate early adaptation to the CF lung environment. 
Similarly, the 2-componenet regulator RetS has been implicated in the switch from 
acute to chronic infection. Inactivation of the retS gene results in reduced expression 
of genes involved in initial colonisation and virulence, such as motility and type II 
and III secretion system genes, and upregulation of genes involved in biofilm 
formation, resulting in lowered virulence in an acute model of infection (Goodman et 
al., 2004). The QS regulatory gene lasR is another regulatory gene that is commonly 
mutated in chronic isolates (Ciofu et al., 2010; Smith et al., 2006b; Yang et al., 
2011), although it has been suggested that this doesn’t happen until the late stages of 
chronic infection (Bjarnsholt et al., 2010). The QS systems control expression of 
multiple virulence factors (Latifi et al., 1995; Passador et al., 1993), and mutants 
cause less severe lung pathology in a rat model of chronic infection (Wu et al., 2001) 
and reduced virulence in acute murine models of infection (Pearson et al., 2000; 
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Rumbaugh et al., 1999). lasR mutants rise in prevalence as an infection progresses, 
and are associated with increased decline in lung function (Hoffman et al., 2009). 
A recent study attempted to determine the genetic basis for the evolutionary success 
of the LES, using 32 North American P. aeruginosa isolates that had been typed as 
LES. By estimating the strength of selection acting upon individual genes, those that 
were involved in adaptation to the CF lung could be predicted, and they included 
regulatory, secretion and transport genes. The researchers then considered genes that 
contribute most to the divergence of LES from other non-LES strains, and that may 
explain its evolutionary success. Genes involved in biofilm formation, arginine 
metabolism, protein secretion and cation transport were highlighted as important, as 
they were overrepresented in the accessory genome of the LES (Dettman et al., 
2013). A comparison of various LES and LES-like isolates found that SNPs were 
overrepresented in regulatory and virulence genes, suggesting strong selection 
(Jeukens et al., 2014). 
Transcriptomics data can provide additional information on genes that might be 
important for CF lung adaptation. Huse et al. selected clonal isolates over the course 
of an infection in three individual patients, and measured changes in gene expression 
against length of infection, and also against other clones. Multiple genes were 
expressed differently in the different clones, including genes that are commonly 
mutated, such as those involved in motility and virulence. When tracking gene 
expression in a single clone over time, 24 genes were found to be up or down-
regulated in the same way in the different clones, and these similar patterns are 
indicative of parallel evolution. Five of the consistently down-regulated genes were 
involved in type-IV pilus formation, whereas genes involved in biofilm formation 
were among those consistently upregulated (Huse et al., 2010). This upregulation 
was linked to a phenotypic change in a follow-up study; strains demonstrated 
increased Psl production, and, consequently, increased biofilm production (Huse et 
al., 2013). 
Despite the trend towards evolution in particular genes, as with phenotypes, there 
exists extensive diversity within a P. aeruginosa population, and between patients. In 
a similar study to Smith et al., isolates from two patients that each harboured 
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different clones of P. aeruginosa were sequenced. The genes that were mutated in 
the Smith et al. study were not found to be under selection, and there were 
substantial differences between the two clones, with regards to phenotypic and 
genetic diversification (Cramer et al., 2011) . A recent study with hypermutators 
identified parallel evolution in multiple sub-lineages in antibiotic resistance and 
catabolic genes, but also huge genetic diversity (Feliziani et al., 2014). It has been 
argued that this genetic diversification occurs during initial adaptation to the lung but 
quickly plateaus; in 12 DK2 isolates, taken from 6 patients over 3 decades there were 
several mutations in key regulatory genes early on in infection, with limited change 
afterwards, suggesting that the bacteria had reached an adaptive peak in the fitness 
landscape (Yang et al., 2011). However, this observation may be a peculiarity of the 
DK2 lineage, as chronic LES infections display huge phenotypic and genetic 
diversity, with little stability over time (Mowat et al., 2011), something that is also 
observed in chronic non-LES infections (Ashish et al., 2013a; Workentine et al., 
2013).  
The spatial structure of the lung can influence the evolution of P. aeruginosa in the 
lung, and it is plausible that bacteria occupy different niches in the lung, potentially 
evolving independently. Multiple lineages do occur: a recent study of DK1 (another 
transmissible that infects multiple patients in Danish CF centres), found that despite 
showing little overall genetic change (a handful of SNPs over a 32 year infection), 
the DK1 population could still be classified into three sub-lineages, each differing in 
their evolutionary rates, prevalence of pathoadaptive mutations, and phenotypes. 
Limited parallel evolution was detected between the three sublineages, suggesting 
that perhaps they occupy different niches. Indeed, there was some evidence that the 
sublineages were spatially separated in the CF lung (Markussen et al., 2014). 
Likewise, a recent paper highlighted the existence of multiple sub-lineages in several 
LES-infected individuals, with greater genetic diversity within patients than between 
(Williams et al., 2015).  
5.1.2 Role of hypermutators in genome evolution and adaptation 
As discussed in the previous chapter, several of the replicate PAO1 populations 
evolved in ASM (across both treatments) had a high frequency of isolates displaying 
the hypermutator phenotype. Given the prevalence of hypermutators in chronic 
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infections (Oliver et al., 2000), and the fact that a high mutation rate is likely to have 
an effect on genome evolution and adaptation, several studies have attempted to 
address the effect of mutation rate on adaptation to the CF lung. A study using the 
same isolates from Smith et al. (2006) compared hypermutators and non mutators. 
Unsurprisingly, hypermutators had more mutations, but mutations were similarly 
distributed in adaptive genes between both hypermutators and non mutators, 
suggesting a generalised effect of adaptation (Mena et al., 2008). Most fixed SNPs in 
hypermutator lineages are neutral (Feliziani et al., 2014). Development of a 
hypermutator phenotype is often preceded by mutations in mucA and lasR (Ciofu et 
al., 2010), and hypermutators dominate towards the end stage of chronic infection 
(Hogardt et al., 2007), suggesting that a high mutation rate is more adaptive in the 
later stages of chronic infection, although they have been observed as early as 2 years 
after colonisation (Cramer et al., 2011). Hypermutators are associated with 
development of antibiotic resistance (Ferroni et al., 2009) and downregulation of 
several virulence-associated traits (Hogardt et al., 2007). 
5.1.3 Bacteriophages as drivers of genome evolution 
Bacteriophages drive the phenotypic evolution of their hosts, but the underlying 
genomic change can occur by multiple mechanisms. Bacteriophages can have a 
direct effect on the genome of their host, for example through carriage of extra genes 
(in the case of prophages), or indirectly, as seen in the emergence of phage resistance 
mutations that occur during antagonistic coevolution with lytic phage.  
Temperate bacteriophages (like the LES phages in this study) can drive host genome 
evolution through gene disruption, transduction or by acting as anchor points for 
major chromosomal rearrangements, in addition to the carriage of extra genes, as 
mentioned above.  
5.1.3.1 Phage-mediated gene disruption 
Gene disruption frequently occurs through insertional inactivation; Staphylococcal 
phage L54a inserts into the lipase- encoding geh gene, resulting in a loss of 
phenotype, termed negative lysogenic conversion (Lee & Iandolo, 1986). Another 
Staphylococcus aureus phage, φ13, integrates into the 5' end of the hlb gene by site 
and orientation-specific integration, causing a loss of hlb-encoded beta-toxin 
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expression (Coleman et al., 1991). Escherichia coli phage Mu (short for mutator) 
was the first identified example of a bacteriophage causing mutations in the host 
chromosome, after lysogens were observed to display differences in their nutritional 
requirements, through phage-mediated disruption in gene function (Taylor, 1963). As 
a transposable phage, Mu can integrate randomly (Bukhari & Zipser, 1972), unlike 
many other phages, including λ, which utilise a site-specific integration system. 
Transposable phages infecting Pseudomonas are commonplace, and include one of 
the subjects of this study, LESφ4, the closely related D3112 (Wang et al., 2004), and 
related phage B3 (Braid et al., 2004). A comparison of two recently sequenced 
phages to other P. aeruginosa transposable phages highlights a common genome 
architecture, similar to that of phage Mu, despite sharing a low sequence similarity 
(Cazares et al., 2014). D3112 has been shown to cause mutations in PAO1 through 
insertional inactivation (Rehmat & Shapiro, 1983), yet the potential impact of phage-
mediated gene disruption on bacterial evolution has been widely neglected. 
5.1.3.2 Phage transduction 
Transduction is the transfer of genetic material between bacterial genomes by a 
bacteriophage, of which there are two types, specialised and generalised. Specialised 
transduction is mediated by temperate phages, and occurs when the phage excises 
imprecisely from the bacterial genome, taking with it adjacent bacterial gene(s), 
which are transferred to another bacterial host upon phage infection and 
lysogenisation. Specialised transducing E. coli λ phages have been shown to 
transduce the gene for the β-subunit of RNA polymerase (Kirschbaum & Konrad, 
1973), genes involved in DNA replication (Hansen & von Meyenburg, 1979), genes 
encoding ribosomal proteins (Jaskunas et al., 1975) and recA (McEntee & Epstein, 
1977). Specialised transducing phages are not confined to E. coli, and have been 
identified in Salmonella enterica serovar Typhimurium  (Chan et al., 1972), Bacillus 
subtilis (Zahler et al., 1977) and P. aeruginosa (Cavenagh & Miller, 1986). 
Generalised transduction occurs during the lytic cycle of phages, so is not confined 
to only temperate phages. Prior to cell lysis, phage capsules are packaged with phage 
DNA, but bacterial DNA can be mistakenly incorporated. The fact that any part of 
the bacterial chromosome can be packaged gives rise to the name “generalised 
transduction”. Unlike in specialised transduction, the virions contain little or no 
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phage DNA. Upon infection of another cell, the DNA is released into the cell 
cytoplasm and can potentially recombine with the host chromosome. Temperate 
phage P22 in S. Typhimurium  is capable of generalised transduction (Ebel-Tsipis et 
al., 1972), like over 90% of temperate phages of the S. Typhimurium complex 
(Schicklmaier & Schmieger, 1995). Generalised transduction can affect bacterial 
evolution; the veterinary antibiotic carbadox-mediated phage induction of a multi-
drug resistant strain of S. Typhimurium causes generalised transduction of antibiotic 
resistance genes (Bearson et al., 2014). Generalised transducing phages of P. 
aeruginosa have been identified, including the recently characterised φPA3, 
originally isolated from sewage. It is capable of infection of clinical CF isolates, and 
can transduce mutations in las and rhl between PAO1 isolates (Monson et al., 2011). 
There is evidence that generalised transduction may play a role in the evolution of 
bacteria in natural P. aeruginosa populations; the environmental phage UTI can 
transduce DNA between environmental P. aeruginosa strains (Ripp et al., 1994). 
Furthermore, transduction can occur between lysogens in environmental freshwater 
test chambers, which are similar to the natural environment (Saye et al., 1990). The 
same study compared transduction frequencies between lysogenic and non-lysogenic 
P. aeruginosa, and found the transduction was highest between lysogen and non-
lysogen, as opposed to between two lysogens. 
5.1.3.3 Phage-mediated chromosomal inversions 
Prophages can act as anchor points for chromosomal inversions and other major 
genomic rearrangements. Sequencing of a pathogenic Streptococcus pyogenes isolate 
identified two major chromosomal inversions, one of which was caused by 
homologous recombination between two related prophages, and the other which the 
authors hypothesised occurred after a phage integration event which caused an 
“unbalancing” of the genome (Nakagawa et al., 2003). There is evidence of a 
prophage-mediated chromosomal inversion in Enterococcus faecium, but despite the 
notion that major chromosomal rearrangements would have a negative impact on 
fitness, no such effect was detected (Lam et al., 2012). 
Most studies look at isolates taken from one or more patients, at one or more 
timepoints, but it is impossible to determine the drivers of evolution. An 
experimental evolution approach can simplify things by removing factors (such as 
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immune system, antibiotic pressure etc.), and reintroducing in a controlled manner, 
comparing evolution in the presence or absence of such factors.  
Phages are found at high levels in the CF lung (James et al., 2014), yet their 
contribution to P. aeruginosa evolution is largely ignored. The populations generated 
in the previous study (Chapter 4) provide the ideal opportunity to study genetic 
diversification in an artificial sputum environment, in the presence or absence of 
temperate bacteriophages. 
5.2 Objectives  
1. Identify genetic variants occurring in endpoint ASM populations by 
sequencing pooled DNA of the 40 phenotypically characterised isolates for 
each population. 
2. Identify genes that are important for adaptation to the ASM environment by 
looking for those most commonly mutated, and those predicted to have an 
effect on amino acid sequence, in addition to those that are mutated between 
parallel populations. Contrast genes identified as adaptive in the presence and 
absence of LES phages. 
3. Identify integration sites of the LES phages in the evolved PAO1 isolates. 
5.3 Results 
In the previous chapter, PAO1 was cultured long-term in ASM, in the presence or 
absence of LESφ2-4, and the phenotypic diversity within and between populations 
was assessed by phenotypic characterisation of 40 isolates from each population. 
DNA was extracted for the same 40 isolates per population, pooled and sequenced. 
Using this pooling strategy, it is possible accurately determine the frequency of 
different variants within each population, which can then be compared with the 
phenotype data. Bioinformatics analysis was performed by Dr. Sam Haldenby, CGR.  
5.3.1 Single nucleotide variants (SNVs) across both treatments 
Deep sequencing of populations confirmed genetic diversification in both the phage-
treated and control populations, but there were no clear differences between the two 
groups. Between 21-185 single nucleotide variants (SNVs) or small insertion/ 
deletion polymorphisms (INDELS) were identified in each population. Most variants 
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were detected at a low frequency in a limited number of populations, but a scoring 
system of variants enabled identification of SNVs that are more likely to be 
biologically meaningful. Using this method (developed by Sam Haldenby), scores 
were weighted by predicted severity of effect on protein, the number of variants 
identified per gene and frequency of all variants across all populations. The highest 
scoring mutated genes are summarised in Table 5.1. There is a strong correlation 
between the frequency of isolates with the hypermutator phenotype at t30, and the 
number of SNVs detected in the population (Figure 5.1: Pearsons product-moment 
correlation coefficient; r = 0.94, P < 0.001).  
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Table 5.1 Detection of variants in pooled populations. The number of variants across all populations is reported, both as a total (all populations) and split according to 
treatment (control or phage). The frequency of each variant was estimated for each population (pool of 40). The most prevalent variant was defined as the variant observed 
in the highest number of isolates over all populations. Mutated genes were scored by frequency of variants detected, prevalence of each variant and severity of predicted 
effect on the resulting protein (scoring system developed by Sam Haldenby). Highest scoring mutated genes are located at the top of the table. Only SNVs scoring >3.5 are 
reported. “DEL” = deletion, “dN” = non-synonymous mutation. 
    Control treatment Phage challenged     




















in which observed 
Mean frequency of 
variant in populations 
where observed 
Predicted effect 
hutU Urocanate hydratase (role in 
histidine metabolism) 
1 70.0 1 4/6 1 3/6 DEL 7/12 1 Single nucleotide deletion 
and frameshift (severe) 
lasR Transcriptional regulator (role 
in regulation of quorum 
sensing)  
4 38.6 1 1/6 4 4/6 dN 3/12 0.91 Glutamic acid replaced with 
STOP codon – protein 
truncation (severe) 
glpR Glycerol-3-phosphate regulon 
repressor 
4 36.5 3 6/6 3 5/6 DEL 9/12 0.37 Deletion and frameshift 
(severe) 
PA4394 Conserved hypothetical 
protein 
1 30.0 1 2/6 1 1/6 DEL 3/12 1 Single nucleotide deletion 
and frameshift (severe) 
cysB Transcriptional regulator 18 26.7 11 6/6 8 6/6 dN 1/12 0.55 Glutamic acid → valine 
(moderate) 
PA3271 Probable sensory 
transduction histidine kinase 
12 24.4 6 6/6 6 6/6 dN 1/12 0.65 Phenylalanine →leucine 
(moderate) 
braB Branched chain amino acid 
transporter 
12 24.2 6 5/6 8 6/6 dN 6/12 0.40 Threonine → alanine 
(moderate) 
amrZ Alginate and motility 
regulator Z 
9 20.9 6 5/6 3 3/6 DEL 1/12 0.60 Single nucleotide deletion 
and frameshift (severe) 
fha1 Predicted component of 
typeVI secretion system 




Flagellar motor component 7 19.3 4 4/6 4 4/6 dN 2/12 0.38 Leucine → phenylalanine 
(moderate) 
mutS DNA mismatch repair protein 5 16.0 3 2/6 2 2/6 dN 1/12 0.93 Cysteine → arginine 
(moderate) 
C295R(37) 
pilY1 Type IV fimbrial biogenesis 
protein 
4 13.7 3 2/6 1 1/6 DEL 1/12 0.88 (severe) 
-992(35) 
mvfR Transcriptional regulator 6 12.2 1 1/6 5 4/6 dN 1/12 0.93 Alanine → threonine 
(moderate)  
A25T(37) 
aer Aerotaxis receptor 7 9.9 3 3/6 4 4/6 dN 1/12 0.58 G380S(23) 
opdE Membrane protein 1 9.3 0 0/6 1 1/6 dN 1/12 0.93 Tryptophan replaced with 
STOP codon (severe) 
W190*(37) 
PA5233 Predicted flagellar basal body-
associated protein 
4 8.3 3 3/6 1 1/6 dN 1/12 0.58 Glutamic acid replaced with 
STOP codon (severe) 
E109*(23) 
acsA Acetyl-coenzyme synthetase 4 7.8 0 0/6 4 4/6 dN 1/12 0.53 Asparagine → threonine 
(moderate) 
NS566T(21) 





rpoS Sigma factor 3 6.3 2 2/6 1 1/6 dN 1/12 0.75 Asparagine → serine 
(moderate) 
N129S(30) 
PA2229 Conserved hypothetical 
protein 
3 6.0 2 1/6 1 1/6 dN 1/12 0.95 Leucine → methionine 
(moderate) 
L167M(38) 
PA0671 Hypothetical protein 1 5.8 1 1/6 0 0/6 DEL 1/12 0.58 -160?(23) 
PA3521 Probable outer membrane 
protein precursor 
1 5.8 1 1/6 0 0/6 DEL 1/12 0.58 -469?(23) 
bifA Predicted signal transduction 
protein 
4 5.5 2 2/6 2 2/6 dN 1/12 0.48 Threonine → proline 
(moderate) 
T377P(19) 
motB Chemotaxis protein motB 4 5.1 2 3/6 3 3/6 dN 3/12 0.13 Deletion (moderate) 
VKR12-(15) 
PA0061 Hypothetical protein 1 5.0 1 1/6 0 0/6 DEL 1/12 0.50 FS? (severe) 
-84?(20) 
braC Branched-chain amino acid 
transport protein 
7 4.9 3 3/6 4 3/6 dN 1/12 0.30 Glutamic acid → lysine 
(moderate) 
E259K(12) 
PA1442 Conserved hypothetical 
protein 
2 4.8 2 2/6 0 0/6 DEL 1/12 0.40 -11?(16) 
PA5017 Conserved hypothetical 
protein 
3 4.8 1 1/6 2 2/6 dN 1/12 0.28 Serine → proline (moderate) 
S438P(11) 
PA2827 Conserved hypothetical 
protein 
1 4.6 0 0/6 1 1/6 dN 1/12 0.93 Proline → serine (moderate) 
P111S(37) 
PA1047 Probable esterase 1 4.5 1 1/6 0 0/6 DEL 1/12 0.45 (severe)-278(18) 
PA0690 Hypothetical protein 2 4.4 1 1/6 2 1/6 dN 1/12 0.35 Threonine → isoleucine 
(moderate) 
T597I(14) 
hutC Histidine utilization repressor  5 4.1 3 3/6 2 2/6 DEL 1/12 0.20 (severe) 
-81(8) 
vqsM AraC-type transcriptional 
regulator 





1 4.0 1 1/6 0 0/6 dN 1/12 0.80 Alanine → threonine 
(moderate) 
A341T(32) 
PA3157 Probable acetyltransferase 1 4.0 1 1/6 1 1/6 DEL 2/12 0.20 (severe) 
-372?(16) 
PA2462 Hypothetical protein 4 3.9 0 0/6 1 1/6 DEL 1/12 0.28 (severe) 
-5315(11) 
antB Anthranilate dioxygenase 
small subunit (anthranilate 
metabolism) 
1 3.9 1 3/6 1 2/6 dN 5/12 0.16 Threonine → methionine 
(moderate) 
T57M(31) 
pilT Twitching motility protein 3 3.9 3 4/6 0 0/6 dN 1/12 0.60 Leucine → proline 
(moderate)  
L193P(24) 






Figure 5.1 Correlation between the frequency of isolates displaying a hypermutator phenotype, and the 
number of SNVs in endpoint populations. 
There were several variants that occurred in more than one population. One example 
is a single variant in the hutU gene, coding for urocanate hydratase. The same 
frameshift mutation had reached fixation in 7/12 populations. A similar occurrence 
was observed for the QS regulatory lasR gene; four variants were detected in lasR, of 
which two had a predicted “severe” effect and were found at a very high frequency in 
the population. One of the variants was present in 3 populations (one in the control 
and two in the phage-treatment). To confirm that this was not an artifact of the 
sequencing, the lasR gene was PCR amplified in each of these populations (using 
pooled population DNA), and Sanger sequenced. This confirmed the Illumina data: a 
C to A transversion corresponded with a predicted change in the amino acid 
sequence, from a glutamic acid to a STOP codon. The lasR gene of population 11, in 
which the other high scoring variant was found, was also Sanger sequenced, and a 4 
base pair insertion was identified, resulting in a predicted frameshift. 
Many of the top scoring mutated genes were regulatory genes, including the 
aforementioned lasR, a transcriptional activator and key component of one of the 
major quorum sensing (QS) systems of P. aeruginosa. Other high scoring mutated 
regulatory genes included glpR, cysB, amrZ, vqsM and fleQ. Mutations in genes with 
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key roles in bacterial motility, including motA, motB, pilT and pilY1 were also 
common.  
As an additional approach to identify areas of the bacterial genome that may be 
under selection, the frequency of variants across all populations observed at each 
position in the PAO1 genome was plotted separately for each treatment (Figure 5.2). 
There is a clear peak in the frequency of mutations in the region of the endogenous 
filamentous prophage of PAO1 (Pf4), in both treatments. Other locations were 
identified as hot spots for mutations in both treatments, but to a lesser degree, 
including the regulatory genes rpoS and cysB, and the braB and braC genes, that are 
involved in the Na+ dependent and Na+ independent branched amino acid transport 
systems, respectively. There are some mutational hotspots present (above the 
threshold) in one treatment but not the other, most notably in the pilus-related genes 
pilY1 and pilA, only present in the control treatment. High frequencies of twitching 
impaired mutants were detected across populations in both treatments (Chapter 4), 





Figure 5.2 Variant position frequency across the PAO1 genome for (A.) control populations combined and 
(B.) phage-treated populations combined. Variant position frequency is the frequency of variants observed 
in a sliding window of 8 kb, but gives no information as to the number of times each variant is observed. 
Genes/ regions in the PAO1 chromosome with a variant position frequency >0.0005 are labelled. Data were 





Nucleotide position number (Mbp)







































































































Nucleotide position number (Mbp)























































































     A
    B.
154 
 
5.3.2 LES phage integration sites in the PAO1 genome 
The LES phages are always found at the same positions in different LES isolates, 
with the exception of LESφ4, which is very rarely identified in an alternative 
additional genomic location (Haldenby et al, unpublished). Whilst LESφ2 and 
LESφ3 have been previously shown to share the same integration site in PAO1 and 
LESB58, LESφ4 is known to be capable of inserting into several different locations 
in PAO1(James et al., 2012). The integration sites of the LES phages, and the 
relative frequency of those in each population, were determined by analysis of the 
sequence data by Sam Haldenby. LESφ2 and LESφ3 were always in the same 
position (relative to their integration site in LESB58), but LESφ4 integrated at 
numerous locations across the PAO1 genome (Appendix D). The integration sites 
identified were classified according to gene function (Figure 5.4), and the majority 
are genes involved in QS or motility. 
 
 
Figure 5.3 Frequency of bacteria in each phage-treated population with LESφ4 integrated into specific 
loci. Integration loci were grouped according to general function. The relative abundances of different 
integration sites in each populations were estimated by Sam Haldenby, and the frequency in the whole 
population determined as a proportion of the frequency of LES φ4 lysogens.  
In two of the populations, populations 7 and 11, LESφ4 was found to have integrated 
into the pilus-related fimU and pilV genes, respectively, in a high frequency of the 
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population. As designed, the sequence data in this study only provide an estimate of 
the frequency of bacteria harbouring LESφ4, and give but a snapshot in evolutionary 
time. PCR primers were designed to flank these integration sites, enabling 
determination of the exact frequency of each integration site in its respective 
population, in addition to the frequency of this integration site over time. 
PCR assays of the 40 endpoint isolates from populations 7 and 11 (using primers 
specific to each integration site) confirmed the presence of LESφ4 integrated at each 
site in the PAO1 genome at high frequency. The temporal data shows a similar trend 
in each population, with an increase in frequency over time to near fixation (Figure 
5.4). 
 
Figure 5.4 Frequency of bacterial isolates with LESɸ4 integration at specific loci. 40 isolates at multiple 
time-points throughout the ASM experiment were PCR tested in two phage-treated replicate populations 
(7 and 11) for the presence of LESɸ4 prophage at a specific site in the fimU and pilV genes, respectively. 
 
5.3.3 Temporal loss of twitching motility 
Twitching motility mutants are found at a high frequency in endpoint populations 
from both treatments. Loss of the twitching motility phenotype has previously been 
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associated with the presence of bacteriophages (Hosseinidoust et al., 2013a), so it 
was questioned whether there was any difference in the rate at which this occurred. 
Isolates obtained from each population at earlier time points were tested for the 
twitching motility phenotype. Loss of twitching motility is accelerated in phage-
treated populations (Figure 5.5); at transfer 5 (approximately 40 bacterial 
generations), there was a significantly higher frequency of twitching impaired 
isolates in the phage-treated populations than the controls (Wilcoxon-Mann-




Figure 5.5 Temporal variation in the frequencies of twitching impaired mutants in ASM populations. (A.) 
control and (B.) phage treated populations (LESφ2-4). 40 isolates were assayed per population. Asterisks 
denote a statistically significant difference between treatments at a particular time point (P < 0.05). 
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5.3.4 Distribution of SNVs in pilus-related genes between treatments 
Twitching motility is impaired in a high frequency of isolates in both control and 
phage-treated populations, but loss of motility is accelerated in phage-treated 
populations, potentially through LESφ4 disruptive integration into pilus-related 
genes. It became apparent that mutational hotspots in pilus-related genes, including 
pilY1 and pilA, were present only in the controls (Figure 5.2), leading to the 
hypothesis that LESφ4 integration can act as an alternative (and potentially quicker) 
route along the evolutionary trajectory, towards the impaired twitching motility 
phenotype at which both treatments converge. 
To test this hypothesis, the number of different SNVs per population in pilus-related 
genes were counted. Pilus-related genes are defined as those that encode structural or 
regulatory pilus components, and are known to affect twitching motility phenotype, 
as defined in (Burrows, 2012). The distribution of variants in pilus-related genes 
across the two treatments was compared. 
 More SNVs in pilus-related genes were detected in control populations; the median 
number of SNVs in each population was 3.5 and 0.5 for control and phage 
treatments, respectively (Table 5.2). The distribution of the two treatments was 
significantly different (Mann-Whitney; W = 52.5, P < 0.05).  However, when phage 
integration sites are included as a variant (i.e. in addition to SNVs), the result became 
non-significant (P > 0.05). 
Many of the pilus-related gene variants in the controls were in genes that were the 
phage integration loci in phage-treated populations. Interestingly, population 9 had 
low carriage of LESφ4, and of the 18% of the population that were LESφ4 lysogens, 
none had integrations in pilus-related genes. However, this population still had a high 
frequency of twitching impaired mutants (88%), which corresponded with 88% of 
isolates carrying a mutation in pilY1 gene. Other phage-treated populations (of which 
three had no mutations in pilus-related genes) generally had high levels of twitching 
impairment, which suggests that the LESφ4 integration into pilus-related genes 
causes loss of phenotype. Populations 8 and 10 had the lowest frequency of LESφ4 
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integrations into pilus-related genes (Figure 5.4), and also the lowest frequencies of 
twitching impaired mutants (Figure 5.5). 
Although the data are only correlational, there is reasonable evidence that loss of 
motility in populations is a result of the phage integrations or mutations in pilus-
related genes that were detected. However, there are some instances where the 
sequence and phenotype data do not correlate well. For example, no SNVs in pilus-
related genes were detected in the control population 5, yet 40% of the population 




Table 5.2 Comparison of the numbers of different variants in pilus-related genes between populations. Two types of variants were identified; those caused by single-
nucleotide polymorphisms, and those caused by LES φ4 integrations. The number of variants does not give any information about the frequency of those variants in the 
population. Phenotype data (i.e. the frequency of twitching impaired mutants in the population) is included for reference. 
Treatment Population number Number of SNVs in 
pilus-related genes 
Number of different 
LESφ4 integration 
sites in pilus-related 
genes 





Control 1 2 0 2 0.98 
2 6 0 6 0.83 
3 3 0 3 0.93 
4 4 0 4 0.93 
5 0 0 0 0.40 
6 5 0 5 0.93 
Phage-treated 7 0 1 1 1.0 
8 0 1 1 0.60 
9 1 0 1 0.88 
10 0 1 1 0.80 
11 1 1 2 1.0 




5.3.5 Temporal loss of twitching motility and phage integration sites in single 
phage controls 
In addition to the two treatments (phage treated and phage-free control) that have 
been widely discussed in the present and previous chapter, there were additional 
single-phage control treatments that ran alongside the ASM evolution experiment, 
but the endpoint populations were not characterised in detail. Each single-phage 
control treatment consisted of 6 replicates, with the addition of either LESφ2, LESφ3 
or LESφ4 at the beginning. The single-phage controls allow a comparison of 
bacterial and phage evolution in the presence or absence of the other LES phages. 
The LES phages each require type IV pili for infection (James et al., 2012), hence 
LESφ4 disruptive integration into pilus-related genes may act as a protective 
superinfection exclusion mechanism against LESφ2 and LESφ3, which may explain 
the high frequency of pilus-related LESφ4 integration sites and rapid loss of motility. 
To explore this possibility further, LESφ4 single-phage control populations (P4 i-vi) 
were characterised for the twitching motility phenotype, and the frequency of 
lysogens through time. Although single-phage control populations were not 
sequenced, IPCR was used to attempt to determine the integration sites of LESφ4 in 
12 isolates (2 per population, randomly selected). 
All isolates tested in populations P4 i-vi were LESφ4 lysogens, at every timepoint 
(data not shown). The frequency of twitching impaired isolates was high, reaching 
100% of the population in five of the six replicates at t30. In the remaining 
population (P4i) however, the frequency of twitching impaired isolates increased 




Figure 5.6 Temporal variation in the frequencies of twitching impaired mutants in single-phage control 
(LESφ4 only) populations. 
IPCR was performed on two randomly selected isolates from each population P4 i-vi. 
The method was largely unsuccessful, and the integration sites of many of the 
isolates could not be determined, as either no PCR product was obtained in the final 
step, or it was at too low a concentration for sequencing. The results obtained are 
described in (Table 5.3). 
Table 5.3 Inverse PCR to determine integration sites of LES φ4 in the PAO1 genome. Two isolates were 
tested in each of the six replicate LESφ4 only treatment populations. 
Population Isolate number Integration site (gene) Gene function(s) 
P4i 1 pqsB Part of the pqsABCDE locus (role 
in QS) 
P4i 2 Undetermined N/A 
P4ii 1 Undetermined N/A 
P4ii 2 phzG1 / phzS intergenic region Intergenic region, unknown 
function 
P4iii 1 pilW  Type IV fimbrial biogenesis 
protein 
P4iii 2 pilW Type IV fimbrial biogenesis 
protein 
P4iv 1 Undetermined N/A 
P4iv 2 Undetermined N/A 
P4v 1 Undetermined N/A 
P4v 2 Undetermined N/A 
P4vi 1 Undetermined N/A 





In this study, the genomes of the 40 phenotypically characterised isolates per 
population were sequenced using a pooling strategy. Such a strategy has a major 
advantage over sequencing a single isolate per population, as it enables one to detect 
genetic diversity in a population. However, it is a challenge to identify mutations that 
are adaptive, as opposed to those that are neutral, and may simply become fixed 
through genetic drift. Using the scoring system developed by Dr. Sam Haldenby, it 
was possible to identify mutations that are likely to be adaptive, based on their 
prevalence throughout all populations and their predicted severity. Genes that are at a 
high frequency in multiple populations (an example of parallel evolution) and genes 
with more severe mutations (e.g. frameshift and non-synonomous mutations) will 
have a high score, and these are genes that are likely to be under selection. This 
scoring method was chosen over the commonly used dN/dS ratio, where genes that 
are under selection are expected to have a higher proportion of non-synonomous 
mutations, relative to the number of synonomous mutations. This is because the 
dN/dS ratio is suitable only for distantly diverged sequences, and the assumptions are 
violated when applied to a single population (Kryazhimskiy & Plotkin, 2008). 
Some of the highest scoring mutated genes were those involved in QS, notably lasR, 
which as a regulatory gene will likely have pleiotropic effects on other genes. 
Mutations in lasR are observed frequently in chronic CF isolates (Bjarnsholt et al., 
2010; Smith et al., 2006b; Yang et al., 2011), resulting in down-regulation of many 
virulence genes. In vitro, LOF mutations in lasR confer a growth advantage with 
amino acids (D'Argenio et al., 2007), and reduced cell lysis during the death phase of 
growth in culture (Heurlier et al., 2005). PAO1 QS mutants also demonstrate altered 
biofilm formation in ASM (Haley et al., 2012; Sriramulu et al., 2005). The fact that 
multiple non-synonymous mutations in lasR, capable of reaching fixation in four 
populations were observed suggests that loss of LasR function is advantageous in 
this model. However, the same SNV reached fixation in three of the populations, and 
true parallel evolution of this degree seems highly unlikely. However, it is possible: 
parallel evolution to the level of individual nucleotides has been observed in short-
term experimental evolution of P. aeruginosa in a biofilm (McElroy et al., 2014). A 
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possible explanation in this study is that this particular variant was present at a low 
frequency in the input PAO1 culture. A single colony was grown in liquid culture 
and used to seed all the populations, so it is feasible that a spontaneous mutation 
occurred during growth, resulting in inoculation of ASM populations with a low 
frequency of mutants. However, even if this is the case, the fact that the SNV 
reached fixation in these population suggests some kind of adaptive benefit. An 
alternative explanation is cross-contamination between populations, but this seems 
highly unlikely upon examination of other SNVs in those populations.  
Mutations in regulatory genes were a common theme; in addition to lasR, mutations 
were identified in glpR, cysB and amrZ. Early adaptation to an environment through 
mutations in regulatory genes has been observed in experimental evolution 
experiments with E. coli (Wang et al., 2010a; Zambrano et al., 1993) and in CF P. 
aeruginosa isolates (Yang et al., 2011). In E. coli and Citrobacter freundii strains 
isolated from the gut and experimentally evolved in rich media, the two most 
common mutations were in the global regulators rpoS and arcA, with mutations in 
rpoS mostly LOF. These mutations were associated with improved amino acid 
utilisation, suggesting that changes in global regulators can be short-cuts to rapid 
adaptation (Saxer et al., 2014). 
 Genes involved in metabolism also scored highly, with a frameshift mutation in 
hutU that reached fixation in 7/12 populations, a strong indicator for positive 
selection. The product of hutU is an enzyme required in an early step in both the four 
and five-step histidine catabolism pathways, both of which are active in PAO1 
(Gerth et al., 2012). Transposon mutagenesis of PA14 found that hutU mutants show 
reduced biofilm formation (Müsken et al., 2010), and HutU expression is altered 
during growth in biofilm (Fung et al., 2010; Patell et al., 2010), and in response to 
phage infection (Lavigne et al., 2013) and low oxygen concentrations (Alvarez‐
Ortega & Harwood, 2007). It is possible that HutU may have other functions other 
than histidine catabolism. 
Analysis of the frequency of variants across the genome identified hotspots of 
mutations in the braB and braC genes, involved in the low affinity and high affinity 
branched chain amino acid transport systems, respectively. braC is part of a 5 gene 
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operon necessary for the Na+ independent  high-affinity LIV-I transport system 
(Hoshino & Kose, 1990) specific for alanine and threonine in addition to branched 
chain amino acids. Mutants in braC have reduced utilisation of several amino acids 
(Johnson et al., 2008), but what effect the mutations observed in this study will have 
on the cell phenotype is unknown. 
The highest frequency of variants was observed in the Pf4 region of the PAO1 
genome. Pf4 is a Pf1-like filamentous prophage , implicated in host virulence (Rice 
et al., 2008) and the formation of small colony variants (Webb et al., 2004). During 
growth in a biofilm, a superinfective, lytic form of Pf4 arises that causes the cell 
death necessary for biofilm differentiation and dispersal (Rice et al., 2008; Webb et 
al., 2003). A recent deep-sequencing study of P. aeruginosa after short-term growth 
as a biofilm revealed a high rate of evolution in the Pf4 genome (McElroy et al., 
2014). Similar to this study, they also observed mutations in type IV pili genes, and 
speculated that this may be a resistance mechanism to avoid superinfection by lytic 
Pf4.  
Impaired twitching motility is frequently observed in chronic CF isolates (Lee et al., 
2005b; Mahenthiralingam et al., 1994; Smith et al., 2006b) and was observed at high 
frequencies in most of the endpoint populations in this study (Chapter 4). 
Interestingly, the genetic mechanisms underlying loss of twitching motility appear to 
be different between the two treatments. Control populations had significantly more 
SNVs in pilus-related genes than phage-treated populations, and the SNVs observed 
in the phage-treated populations could not explain the high levels of twitching 
motility (with the exception of population 9, in which a SNV in pilY1 was detected at 
high frequency). However, LESφ4 was integrated into pilus-related genes at high 
frequency in several populations. PCR analysis confirmed the two most common 
LESφ4 integration loci, and temporal analysis revealed that both integration loci had 
risen in frequency in the population over the course of the experiment, reminiscent of 
a selective sweep. It is known that the majority of bacteria in both populations were 
LESφ4 lysogens from early on in the experiment, so the increase in lysogens with 
LESφ4 integrated at these loci suggests either a strong selective advantage for the 
bacteria, genetic drift or hitchhiking with other beneficial alleles. The fact that loss of 
twitching motility evolves repeatedly indicates the former. 
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Type IV pili are the target of many bacteriophages (Ceyssens et al., 2009a; Chibeu et 
al., 2009), including LESφ2, φ3 & φ4 (James et al., 2012), so loss may be driven by 
antagonistic pressure imposed by phages, or may be an adaptation to the ASM 
environment. Type IV pili have previously been identified as necessary for surface-
attached biofilm formation (O'Toole & Kolter, 1998; Yoon et al., 2002), although 
this can be dependent on the nutrients available (Klausen et al., 2003c). However, in 
ASM, P. aeruginosa form biofilm-like aggregates (Haley et al., 2012; Sriramulu et 
al., 2005) similar to those observed in the CF lung (Hassett et al., 2002), and the 
necessity for type IV pili in the formation of such structures is unclear. There is no 
apparent fitness cost to lack of type IV pili in this model; when ancestral PAO1 is 
competed against the phage-resistant PAO1 pilA- (does not produce type IV pili), no 
difference is observed in the Malthusian parameters of the two strains (Chapter 4). 
Loss of twitching motility is accelerated in the LES phage-treated populations, 
apparently through LES φ4 integration into pilus-related genes. As LESφ2 and 
LESφ3 also require type IV pili for infection, this has the added effect of rendering 
cells resistant to infection from phage infection. Considering the majority of 
temperate phage infections result in lytic infection, this could be advantageous to the 
bacteria (and also LESφ4), functioning as a superinfection exclusion mechanism. 
However, total loss of twitching motility in 5/6 LESφ4-only control populations 
(P4i-vi) suggests that this is not driven solely by antagonistic selective pressures 
imposed by LESφ2 and LESφ3. However, the presence of Pf4, the endogeneous 
filamentous phage (which enters through the type IV pili and develops into a 
superinfective lytic form) means that phage-driven selection is still a plausible 
explanation. 
A recent study investigating superinfection exclusion by a related transposable 
phage, D3112, found that the phage encoded a small protein that inhibits the polar 
localisation of the ATPase PilB, preventing the normal polymerisation of the pilin 
subunits and subsequent pilin production. The authors also observed that this 
conferred resistance to lysogens from other pilus-specific phages (Chung et al., 
2014). A BLASTP search of the LESφ4 predicted protein sequences revealed that 
LESφ4 does not encode this protein. Another study with the related phage DMS3 
observed lack of swarming motility and reduced biofilm formation in PA14 
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lysogens, but only in bacteria with a functional CRISPR-Cas system. An interaction 
between the CRISPR-Cas system and the phage inhibited motility, which the authors 
proposed may be a strategy by the bacteria to limit dissemination of phage 
throughout the bacterial population (Zegans et al., 2009). Together with previous 
data, this study raises the possibility that motility inhibition is widespread throughout 
Pseudomonas transposable phages, but acting via different mechanisms. Bacterial 
motility is an important virulence factor, and the potential of phage infection as a 
means of inhibiting motility and reducing virulence has been explored as a 
therapeutic option. This has been successful to a degree; D3112 infection and 
twitching motility inhibition of the virulent P. aeruginosa strain PA14 leads to 
reduced bacterial numbers and virulence in mouse and fly models of acute infection 
(Chung et al., 2012). 
Negative lysogenic conversion by bacteriophages has been identified before, but 
whether or not it confers a fitness benefit (or deficit) to host bacteria has not really 
been considered. Bacteriophages can insert into intergenic regions, tRNA or protein 
coding genes, but integration into the latter two does not normally cause LOF, as 
certain bacteriophages (those that insert by site site-specific recombination, such as 
λ) duplicate the sequence from the 3' end of the inserted gene, so a functional gene 
product is still transcribed (Campbell, 1992). However, gene disruption can still 
occur if this process does not happen, or if it is faulty; an analysis of 13 Lactobacillus 
johnsonii prophages found that two integrated into tRNA genes, and one caused gene 
disruption, as there was no reconstitution of the gene product (Ventura et al., 2003). 
Because D3112 (the close relative of LESφ4) replicates by transposition, the 
hypothesis was that it caused mutations through integration into coding regions. To 
test this, PAO1 D3112 lysogens were plated onto pyruvate-fluoroacetamide agar; 
only amidase mutants are able to grow, as amidase-mediated hydrolysis of 
fluoroacetamide produces fluoroacetate, which is toxic to cells when growing on 
pyruvate as a carbon source. Phage infection and integration increased the frequency 
of occurrence of amidase mutants 40 to 65-fold, and analysis of the lysogens found 
that D3112 had integrated into different locations in the ami regions, suggesting that 
it is not a hotspot and that D3112 inserts randomly (Rehmat & Shapiro, 1983). Even 
though LESφ4 is observed integrated frequently into motility genes, it is uncertain 
whether LESφ4 can insert anywhere, but confers an adaptive benefit to lysogens with 
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loss of function in the genes, or whether LESφ4 preferentially inserts at certain loci. 
Like D3112, LESφ4 was not observed at the same site between populations, 
suggesting that integration site is at least partly random, and lysogens with LESφ4 
integrated into type IV pilus genes have a selective advantage. 
P. aeruginosa evolution in the CF lung is somewhat unusual in that it can be 
dominated by LOF mutations (Hogardt & Heesemann, 2010). The majority of 
mutations in the study of isolates from chronic infections by Smith et al. were LOF, 
and when the mechanistic basis for this was investigated, it was found to be largely 
through transposon insertions, gene deletions and STOP codon or frameshift 
mutations, all of which would result in predicted loss of protein function (Smith et 
al., 2006b). Similarly, in this study, LOF mutations dominated, especially in QS and 
motility genes. Large chromosomal inversions (LCIs) can also cause LOF, and 
genome analysis of the highly prevalent P. aeruginosa clone C, which is the most 
common non-epidemic clone identified in CF centres (Hall et al., 2014; Scott & Pitt, 
2004), found that LCIs had disrupted the LPS biosynthesis gene wbpM, the type IV 
pilus-related pilB and the DNA repair gene mutS, resulting in impaired biosynthesis 
of the O-antigen, loss of twitching motility and hypermutability, respectively. It was 
suggested that inactivation of these genes by LCIs was advantageous was selected 
for over the course of evolution (Kresse et al., 2003). Transposable phages such as 
LESφ4 offer an alternative mechanism for achieving LOF mutations and the 
associated change in phenotype.  
A large number of SNVs were detected across all endpoint populations, yet, as with 
the phenotypic data, there were no obvious differences between the two treatments 
(with the exception of the mechanisms underlying changes in type IV pilus-related 
genes). This was associated with no difference in fitness between phage-treated and 
control populations when competed against a phage-resistant competitor, which 
removes any advantage conferred by prophage-mediated lysis of competitors 
(Chapter 4). This is perhaps surprising, given that temperate bacteriophages can carry 
genes that increase host fitness; indeed, LESφ2 and LESφ3 are necessary for the 
competitiveness of their host, LESB58 (Winstanley et al., 2009). Such benefits are 
either dependent on lysis of the competitor, host-specific or not applicable in this 
simplified in vitro system.  
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Experiments with lytic phages have shown, conversely, that coevolution can have a 
negative effect on bacterial fitness, through resistance mutations that have an 
associated cost (Brockhurst et al., 2005; Buckling et al., 2006; Koskella et al., 2012). 
A recent study found that bacteria that are coevolved with a lytic bacteriophage have 
lower fitness in the growth medium than bacteria evolved in the absence of phage. 
Bacteria evolved in the absence of phage demonstrated greater genetic divergence 
and adaptation to the media, showing increased fitness relative to the ancestor in 
pairwise competitions, and parallel evolution in a set of genes posited to be important 
for adaptation to the abiotic environment. However, when these populations were 
then coevolved with phage, the fitness benefit of these mutations was lost. In the 
reverse, coevolved populations were then evolved in the absence of phage, but they 
did not show an increase in fitness. Together, these results suggest some type of 
epistatic interaction between growth promoting and phage resistance mutations 
(Scanlan et al., 2015). The lack of difference between controls and phage-treated 
populations in this study, both in terms of fitness and sequence data, suggests a lack 
of antagonistic pleiotropy, or epistatic interactions. Such a finding is unsurprising, 
given that the LES phages are temperate, hence the same strong antagonistic 
selective pressures are unlikely to apply.  
5.5 Summary 
 SNVs were detected in all populations, across both treatments, and the 
highest scoring genes (those most likely to be under positive selection) were 
involved in motility, QS or genetic regulation. 
 A high frequency of variants was observed in the Pf4 region of the PAO1 
chromosome. 
 LESφ4 integrated at different sites in the PAO1 chromosome, but in the 
majority of lysogens had integrated into protein-coding genes involved in 
motility or QS. The two integration sites that were most common in endpoint 
isolates (both motility genes) rose in prevalence over the course of the 
experiment. 
 Twitching motility mutants are at a high frequency in endpoint populations in 




 More SNVs were detected in twitching motility-related genes in the control 
populations, suggesting that LESφ4 can act as an alternative (and more rapid) 
mechanism to achieving LOF in motility genes. 
 When PAO1 was coevolved with LESφ4 as the only phage, twitching 
motility was still lost rapidly. In the few isolates tested, LESφ4 had integrated 
into protein-coding genes involved in motility and QS, and intergenic 
regions. This suggests that LESφ4-mediated loss of motility is not driven by 
the presence of LESφ2 and LESφ3 in the triple phage treatment. 
5.6 Declaration 
All sequence data were subjected to quality control and analysed by Dr. Sam 
Haldenby, Centre for Genomic Research, University of Liverpool. SNVs were called 
and the variant position frequency determined, and phage integration sites were 
estimated by examination of contig ends. 
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Chapter 6 Allelopathy: temperate phages as a strategy for bacterial 
invasion 
6.1  Introduction 
6.1.1 Bacterial competition 
Bacteria face constant competition for resources, and inter-microbial competition is 
thought to play a large role in driving the evolution of bacterial populations. 
Essential resources are limiting factors to bacterial growth (Monon, 2012), hence 
competition for them is fierce. There are two main types of competition: scramble 
and contest. Scramble, or exploitative competition, is competition to utilise a finite 
resource that is available to all competitors.  It is passive in that it does not have 
direct, antagonistic effects on other competitors, but rather deprives them of the 
resource. A proposed analogy is young boys scrambling for pennies dropped on the 
floor, with the winners those that get there first (Hölldobler & Wilson, 1990). 
Contest, or interference competition, is direct, antagonistic interaction between 
competitors, for example, the production of toxins that harm competitors. Returning 
to the analogy, contest competition can be likened to the boys having a fight, with the 
winner taking the pennies (Hölldobler & Wilson, 1990). It is likely that bacteria 
utilise both types of competition to proliferate in the CF lung, but there is little 
research addressing this specifically.  
The CF lung is a polymicrobial environment, and there is likely to be competition 
between, as well as within, species. There is evidence for interspecies competition 
between Pseudomonas aeruginosa and Staphylococcus aureus. Colonisation by S. 
aureus is negatively associated with P. aeruginosa colonisation, and in culture, S. 
aureus reaches lower densities when in co-culture with P. aeruginosa than in 
monoculture. This also extends to a rat dialysis membrane peritoneal model, and it 
was observed that P. aeruginosa was not only capable of lysing S. aureus, but also 
downregulates expression of iron-acquisition genes. This suggests that P. aeruginosa 
uses S. aureus as an iron source (Mashburn et al., 2005), and as iron is a limiting 
resource that is sequestered by the host, this is strong evidence for interspecific 
interference competition.  
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P. aeruginosa populations in chronic CF infections are highly diverse, with several 
strains or lineages often coexisting (Williams et al., 2015), and it is likely that there 
will be competition between lineages. The LES is very prevalent in the UK and 
North America (Aaron et al., 2010) and is capable of superinfection i.e. it can replace 
resident P. aeruginosa strains in the lung (McCallum et al., 2001). In a rat model of 
chronic lung infection, LES isolate B58 is more competitive than strain PAO1 
(Kukavica-Ibrulj et al., 2008b), yet the mechanisms underlying this competitiveness 
have not been fully elucidated. A signature-tagged mutagenesis study of LESB58 
highlighted some of the genes and regions that were necessary for LESB58 
competitiveness, including several prophages (Winstanley et al., 2009). One 
hypothesis is that LES uses its prophages as an allelopathic agent, lysing resident P. 
aeruginosa in the lung, enabling LES to invade and dominate the P. aeruginosa 
population in the CF lung.  
6.1.1.1 Allelopathy 
Allelopathy is a form of interference competition, and can be defined as the 
production of agents (e.g. chemicals) that kill or inhibit the growth or reproduction of 
competitors. Allelopathy has been widely studied in plants, and it is argued that it 
plays a large role in the invasion of certain plant species (Fitter, 2003). Allelopathy 
has also been identified in bacteria, most notably in the production of bacteriocins. 
Bacteriocins are antimicrobial, proteinaceous compounds, produced by bacteria and 
capable of killing closely related species. Among others, they have been identified in 
P. aeruginosa and E. coli, where they are known as pyocins and colicins, 
respectively. Bacteriocin production is an example of a spiteful interaction (Gardner 
et al., 2004): harm occurs to the producer (cell lysis is often required to release the 
toxin) and to the recipient (probable death). Bacteria that carry the immunity gene 
are protected from the harmful effects of the bacteriocin, and close relatives of the 
producer are more likely to carry the immunity gene. Despite the high cost to the 
producing cell, bacteriocin production is maintained in the population because of kin 
selection (Hamilton, 1964); the bacteriocin targets non-relatives, conferring a fitness 
benefit to close relatives of the producer (which carry the immunity gene). The 
producer receives an indirect fitness benefit through increased fitness of its relatives, 
as the relatives can pass on its genes. Under this social theory, bacteriocin production 
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is expected to be favoured under intermediate levels of kinship, where kinship is 
defined as the relative frequencies of the “producer” and “recipient” genotypes. At 
low levels of kinship, the density of producers, and consequently levels of 
bacteriocins are low, and the bacteriocin is unable to reach a critical concentration to 
affect competitors. When kinship is high i.e. high density of producers, the density of 
susceptible competitors is low, hence there is not enough fitness benefit to justify the 
inherent cost (Gardner et al., 2004). There is experimental evidence for this in P. 
aeruginosa, as when pyocin producing PAO1 and a sensitive competitor were 
competed in vitro (with different initial starting ratios), fitness was highest when 
densities of each competitor were similar (Inglis et al., 2009). 
It has been suggested that temperate bacteriophages can also act as allelopathic 
agents (Stewart & Levin, 1984). Like bacteriocins, phages can kill susceptible 
recipient cells, are costly to produce (cell lysis of the producer is required), and 
closely related bacterial cells are more likely to carry the phage and associated 
superinfection exclusion genes, hence relatives are protected from lytic phage 
infection. Brown and colleagues compared bacteriocins and phages as allelopathic 
agents, using mathematical modelling to predict outcomes and experimental data to 
validate. Bacteriocins were superior as a strategy to resist invasion i.e. when the 
density of producing cells was high, but phage were superior as an invasion strategy, 
largely because phages are capable of amplification: upon lytic infection of a 
susceptible cell, more phages are produced. Amplification is key to the success of 
this strategy; when the experiment was repeated with a phage-susceptible competitor 
that was still killed upon infection, but was not capable of releasing infective phages, 
the producing strain was unable to invade. Prophage carriage was inferior as a 
strategy to resist invasion because the density of susceptible cells was too low for the 
phage to successfully multiply (Brown et al., 2006). 
Numerous other examples have been described in the literature of phages acting as 
allelopathic agents. Bossi et al. co-cultured Gifsy lysogens and non-lysogens of 
Salmonella enterica serovar Typhimurium, and found that lysogens dominated at the 
end of the experiment. The same did not happen when the experiment was repeated 
with a lysogen in which the phage was unable to excise, suggesting that the success 
of the lysogen was through prophage-mediated lysis of the competitor, as opposed to 
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an inherent fitness benefit conferred by the phage (Bossi et al., 2003). The authors 
also observed that the majority of non-lysogens became lysogens, something that 
was also observed in a more recent study with E. coli phage , suggesting that whilst 
phage can act as allelopathic agents, lysogenic conversion means that any advantage 
is transient (Gama et al., 2013).  
Another example of phages acting as allelopathic agents has been described in 
Bordetella bronchiseptica. The starting densities of isogenic lysogens and non 
lysogens were manipulated, and lysogens were able to invade from when initially 
rare, with a reversal in the 1:10 initial starting ratio of lysogen to non-lysogen after 
24 hours. Lysogens were also able to resist invasion and still increase in frequency 
when initially dominant, increasing from a ratio of 10:1 to 1000:1 over a 24 hour 
period (Joo et al., 2006). Lysogen invasion of phage-susceptible populations has 
recently been demonstrated in vivo; Enterococcus faecalis lysogens that produce 
composite phages outcompete non-lysogens in a mouse intestinal colonisation model 
(Duerkop et al., 2012). 
6.1.1.1.1 Factors influencing the efficacy of allelopathy 
The spatial structure of the environment is known to have an effect on the fitness 
benefits to be gained by using phage as an allelopathic agent. In competitions of E. 
coli  lysogens and non-lysogens, with different starting densities of each 
competitor, differences were observed between competitions that took place in 
structured (soft agar) or unstructured habitats (broth). The lysogen to non-lysogen 
ratio increased in structured habitats at all initial starting density ratios, but the 
opposite was observed in an unstructured habitat. In an unstructured habitat, the 
lysogen to non-lysogen ratio decreased over the course of the experiment at all 
starting densities, a finding that contradicts other similar experiments (Brown et al., 
2006; Joo et al., 2006). When the experiment was performed with reverted antibiotic 
resistance markers, lysogens were no longer at a disadvantage, which the authors 
suggested was due to the effect of the antibiotic resistance mutation on phage 
development e.g. amplification efficiency or probability of lysogeny (Gama et al., 
2013). In addition, the  phage is known to propagate poorly in unstructured 
environments, because it has very small side tail fibres. Together, these factors mean 
that the initial finding that lysogens do poorly in unstructured habitats is not 
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necessarily the case. The better performance of lysogen in structured habitats can be 
explained by an increased concentration of phages in the surrounding area, whereas 
in unstructured habitats, phages diffuse away. A high probability of lysogeny was 
also observed, for the same reason, as a high concentration of phages in one area 
(high MOI) favours lysogeny (Lieb, 1953). 
The pathogenic properties of the phage itself, or the presence of multiple phages, can 
also affect bacterial success in competitions. Lysogen invasion of S. Typhimurium 
susceptible populations is more marked in double lysogens than single lysogens. In 
addition, invasion occurs faster when the prophage carried is P22, instead of Gifsy, 
which may be attributable to the larger burst size of P22 (Bossi et al., 2003). 
Similarly, Joo et al. found that the phage pathology can affect the invasive properties 
of lysogens (Joo et al., 2006). A recent study compared the fitness of PAO1 strains 
containing two of the LES phages, LESφ2 and LESφ4, either alone or in 
combination in competition with an isogenic non-lysogen. The experiments were 
conducted in vivo, using the popular Galleria mellonella (wax moth) larvae model. 
As well as differences in the competitive abilities of lysogens harbouring each of the 
phages (LESφ4 lysogens were more competitive than LESφ2 lysogens), the double 
lysogen was significantly more competitive than either of the two single lysogens 
(Burns et al., 2014), suggesting that polylysogeny may be a useful strategy with 
regards to interference competition, possibly by delaying the emergence of resistance 
to phage lysis in susceptibles, as after lysogenic conversion by one phage, bacteria 
would remain susceptible to other phage(s). 
6.1.1.2 Apparent competition 
The use of temperate phages by bacteria to outcompete phage-susceptible 
competitors is also a form of apparent competition. Apparent competition is a form 
of parasite –mediated competition between two hosts that are both capable of 
infection by the same parasite. It was first described between two species of the flour 
beetle, Tribolium castaneum and T. confusum. Despite being competitively inferior, 
T. confusum is capable of outcompeting T. castaneum through the carriage of the 
sporozoan parasite, Adelina tribolii, which has negative effects on the latter, yet no 
such effects on the former (Park, 1948). There are relatively few empirical example 
of apparent competition, but examples in plants (Recart et al., 2013) and animals 
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(Tompkins et al., 2000) have been described in the literature. The importance of 
apparent competition in microbial interactions is largely unknown. 
6.2 Objectives 
1. Determine the effect that LES prophage carriage has on bacterial 
invasiveness in vitro, where invasiveness is defined as the ability of a 
bacterial strain to increase in proportion when in competition with another 
strain when initially rare.  
2. Consider the ability of bacterial LES phage lysogens to resist invasion by a 
phage-free strain.  
3. Contrast the effects of single or mutiple prophage carriage on bacterial 
invasiveness and resistance to invasion, and compare the dynamics of 
invasion between carriage of different prophages. 
4. Repeat bacterial competitions in vivo, to determine whether any effects of 
prophage carriage on bacterial fitness persist in a more natural, spatially 
structured environment.  
6.3 Results 
6.3.1 In vitro invasion assays 
The aim of this study was to observe whether carriage of LESφ2, LESφ3, or LESφ4 
leads to enhanced bacterial fitness when in competition with a phage susceptible 
strain. To achieve this, PAO1 LES Phage Lysogens (PLPLs) were competed in liquid 
media for 24 hours with an isogenic phage susceptible competitor, which does not 
carry any of the LES prophages, and is hereafter referred to as PAO1φ-. To 
differentiate between competitors, strains were labelled with both GFP and DsRed-
Express, separately (James et al., unpublished). Reverse markers were used to 
control for any effect of marker, with the exception of PLPLφ2, for which only the 
GFP-labelled version was used, due to an issue of the DsRed-Express marker in the 
PLPLφ2 host background. 
Two different starting ratios of the two competitors were implemented: 1:9 and 9:1 
(PLPL: PAO1φ-), in order to test the ability of PLPLs to invade a population of 
phage-susceptible bacteria, or defend against invasion by said population, 
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respectively. The density of each competitor was measured at 8-hourly intervals. At 
the end of each competition, the difference in the Malthusian parameters of the two 
competitors was calculated, returning a value that is known as the selection rate 
constant (rij). A rij value of 0 indicates no selection, but a rij value above 0 indicates 
positive selection for the PLPL. 
6.3.1.1 PLPL invasion of a phage susceptible population 
Over 24 hours, all PLPLs were able to successfully invade the phage susceptible 
population of PAO1φ- (Figure 6.1), as indicated by positive rij values. Selection rate 
constants were compared with a two-way ANOVA, fitting invading strain (5 levels, 
including a control with a rij of 0, expected if there was no selection) and marker (2 
levels) as the two factors. The interaction term was not significant (P = 0.17) so a 
simple additive model was fitted to the data. A significant effect was observed for 
PLPL (F3,16 = 14.8, MSE = 4.42, P < 0.001) but not marker (F1,16 = 1.24, MSE = 
0.37, P = 0.28). Tukey HSD tests were utilised to compare the means of the different 
PLPLs. PLPLφtriple was significantly more invasive than PLPLφ2 (P < 0.01) or 
PLPLφ3 (P < 0.001), but not PLPLφ4 (P = 0.87). PLPLφ4 was also significantly 
more invasive than PLPLφ2 (P < 0.01) or PLPLφ3 (P < 0.001). There was no 




Figure 6.1 Selection rate constant values for competition between PLPL and PAO1φ- where the starting 
ratio of PLPL to PAO1φ- is (A.) 1:9 and (B.) 9:1. Error bars ± 1 S.E.M. Asterisks denote statistical 
significance (* P<0.05; ** P<0.01; *** P<0.001), when compared to a hypothesised value of 0 (no selection). 
6.3.1.2 PLPL resistance to invasion by PAO1φ- 
The ability of PLPLs to resist invasion was also investigated. However, there was a 
clear effect of marker; the mean rij for PLPL gfp/ PAO1 DsRed-Express 
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competitions was much higher than the reverse (1.8 vs. 0.53 day-1). This is because 
the threshold bacterial density for detection of the fluorescent protein was slightly 
higher for DsRed-Express than GFP, possibly because the available filters on the 
fluorometer were not optimal. This meant that at low densities, PAO1φ- was not 
detected, resulting in an artificially high selection rate constant. Because of this issue, 
data from competitions where PAO1φ- was labelled with DsRed-Express were 
excluded, which means that PLPLφ2 must necessarily be excluded from the analysis 
(as an issue with the DsRed-Express marker in the PLPLφ2 background meant that 
this strain was not used in competitions).    
PLPLφ3, PLPLφ4 and PLPLφtriple can all resist invasion to PAO1φ- (Figure 6.1), 
with no difference between the PLPLs (one-way ANOVA; F3,8 = 0.78, P = 0.54). 
Post-hoc comparison to a control with a value of 0, expected if there was no 
selection, was non-significant (P > 0.05), suggesting a lack of selection in either 
direction for PLPLs when initially dominant.  
6.3.1.3 Dynamics of PLPL invasion over time 
Selection rate constants are a measure of the difference between the Malthusian 
parameters of two strains over a 24 hour period, using bacterial densities at the end 
and beginning of competition. However, this tells us only the outcome of the 
competition, but nothing of the dynamics of the interaction between competitors. By 
measuring the ratio of two competitors at 8-hourly intervals in PLPL invasion assays, 
a more detailed picture of the dynamics of this invasion, including differences 
between the PLPLs, can be constructed. 
For each competition, the fluorescence intensity (FI) was measured at 4 time points, 
and used to estimate the ratio of the two competitors. The ratio of PLPL to PAO1φ- 
continues to rise for all PLPLs until t16, after which the ratio stabilises in PLPLφ2 
and PLPLφ3 (Figure 6.2). However, the ratio of PLPL to PAO1φ- continues to rise 
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for PLPLφ4 and PLPLφtriple over the course of the competition. 
 
Figure 6.2 Ratio of PLPL to PAO1φ- over 24 hour coculture, with a starting ratio of 1:9 PLPL to PAO1φ-. 
Error bars ±1 S.E.M. Three biological replicates were performed for each PLPL. 
 
6.3.1.3.1 Statistical analysis 
Because of this repeated measures design, the assumption of independence between 
data points is violated, hence the analysis must account for this to avoid temporal 
pseudoreplication. To this end, natural log-transformed data were analysed with a 
repeated measures ANOVA design by fitting a general linear model (GLM). Time 
and PLPL were fitted as fixed factors, fluorescent marker as a random effect, and 
competition ID as a random effect, nested within PLPL to account for the repeated 
measures. The effect of PLPL and time was significant, as was the interaction, but 
the random effect of marker was non-significant (F1,71 = 0.73, P = 0.40), so it was 
removed from the model in order to simplify. There was no increase in deviance, so 
the new model was preferred, under the principle of parsimony. Under the simplified 
model, the main effects of PLPL (F3,72 = 4.40, P < 0.05) and time (F3,72 = 198.5, P< 
0.001) were significant, as was the PLPL x time interaction (F9,72 = 20.1, P < 0.001). 
Post-hoc Tukey HSD tests were performed for the interaction effect, comparing all 
PLPLs to each other at each time point using the hierarchical model. PLPLφtriple 
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was significantly more invasive than all PLPLs at t16 (Table 6.1), whilst there was no 
difference between the three single phage PLPLs until t24, when PLPLφ4 was equally 
invasive as PLPLφtriple, and more invasive than PLPLφ2 and PLPLφ3. 
Interestingly, carriage of three prophages appears to be associated with a minor 
fitness cost at an early stage of the competition, as the mean ratio of the two 
competitors was lowest for PLPLφtriple at t8, and significantly lower than PLPLφ3 at 















Table 6.1 Tukey HSD post-hoc comparisons of Phage x Time interaction. T value and adjusted p values are displayed for each pairwise comparison. 
PLPL 
invading 
 Φ3    Φ4    Φtriple    
Φ2 Time 0 8 16 24 0 8 16 24 0 8 16 24 
 0 t=0.0, 
p=1.0 
   t=0.0, 
p=1.0 
   t=0.0, 
p=1.0 
   
 8  t=-3.4, 
p=0.09 
   t=-0.99, 
p=1.0 
   t=2.4, 
p=0.59 
  
 16   t=1.5, 
p=0.98 
   t=-2.8, 
p=0.32 
   t=-7.1, 
p<0.001 
 
 24    t=-2.5, 
p=0.46 
   t=-9.9, 
p<0.001 
   t=-10.2, 
p<0.001 
Φ3 0     t=0.0, 
p=1.0 
   t=0.0, 
p=1.0 
   
 8      t=2.4, 
p=0.59 
   t=-5.7, 
p<0.001 
  
 16       t=-1.3, 
p=1.0 
   t=5.6, 
p<0.001 
 
 24        t=-7.5, 
p<0.001 
   t=7.7, 
p<0.001 
Φ4 0         t=0.0, 
p=1.0 
   
 8          t=-3.3, 
p=0.09 
  
 16           t=4.3, 
p<0.01 
 






6.3.1.4 Phage invasion 
The previous experiments have been concerned only with the effect that a LES 
prophage has on the competitiveness of the bacterial strain. However, unlike other 
examples of allelopathy, such as bacteriocins, bacteriophages are ultimately selfish 
genetic elements, concerned only with their own replication. In this experiment, the 
competitor is fully susceptible to the LES phages and capable of becoming a lysogen, 
so it is interesting to consider the invasiveness of the phages themselves, and whether 
invasiveness of a bacterial strain has any effect on the evolutionary success of the 
phage itself. To assess this, bacterial colonies were isolated at the end of each 
competition and PCR-tested for prophage complement. The frequency of lysogens in 
the endpoint population was determined, although this does not differentiate between 
competitors. The frequency of lysogens was very high for all PLPL competitions 
under both starting ratios (Figure 6.3). For the PLPLφtriple competition, a 
breakdown is given of the different combinations of prophages detected (Table 6.2). 
The majority are triple lysogens, presumably the PLPL host genotype. Those 
remaining are not dominated by any particular phage; lysogens of all three LES 




Figure 6.3 Frequency of bacterial lysogens after 24 hours of co-culture of various PLPL with PAO1φ- with 
an initial starting ratio of (A.) 9:1 and (B.) 1:9. Differentiation is not made between the two bacterial 
genotypes. Error bars ±1 S.E.M. Three biological replicates were performed for each strain, and a 
minimum of 46 separate colonies were tested per replicate. 
 
In order to estimate the fitness of the phages themselves, selection rate constants 
were calculated for the phage. The Malthusian parameters were calculated for 
competitors carrying the phage (i.e. all bacteria that were PLPLs at the beginning, in 
addition to all those that were PAO1φ- at the beginning, but have subsequently 
become lysogens) and for competitors not carrying the phage (i.e. PAO1φ- that has 
maintained its phage-free status). The rij was calculated as follows: 
rij = mi – mj 
 185 
 
where i is the competitor carrying the phage, and j is the phage-free competitor. For 
simplicity, this was performed for PLPL single phage competitions only.  The 
selection rate constant was high for all three phages, and there were no significant 
inter-phage differences (one-way ANOVA; F2,6 = 1.2, P = 0.37). The phage selection 
rate constant values are illustrated in (Figure 6.4), alongside the selection rate 
constants for the PLPL, which highlights the difference. The invasive ability of 
PLPLs differs depending on the prophage carried, but in terms of phage fitness, all 
the LES phages do equally well. 
Table 6.2 Prophage complement of bacterial colonies obtained after 24 hours co-culture of PLPLφtriple 
and PAO1φ-, at two different initial starting ratios of the two competitors. A minimum of 46 colonies were 





Frequency of bacteria harbouring specific prophage combination in total endpoint population 
 1:9 initial starting ratio (lysogen invading) 9:1 initial starting ratio (lysogen 
defending) 
R1 (averaged for 
markers) 
R2 R3 R1 R2 R3 
Non lysogen 0.01 0.00 0.00 0.01 0.00 0.03 
LES2+3+4 
(triple) 
0.84 0.99 0.98 0.93 0.99 0.97 
LES2 0.09 0.00 0.01 0.00 0.00 0.00 
LES3 0.00 0.01 0.01 0.00 0.01 0.00 
LES4 0.00 0.00 0.00 0.01 0.00 0.00 
LES2+3 0.01 0.00 0.00 0.00 0.00 0.00 
LES2+4 0.01 0.00 0.00 0.16 0.00 0.00 




Figure 6.4 Selection rate constants of the LES phages (coloured diamonds), compared with the selection 
rate constants of bacterial strains that harbour the LES phages when competing against phage susceptible 
PAO1φ- (grey bars). Error bars ±1 S.E.M. 
 
6.3.2 In vivo invasion assays 
6.3.2.1 PLPLφtriple in competition with PAO1φ- at different starting densities 
In order to test whether PLPLs were still capable of invading PAO1φ- in vivo, a 
similar experiment was conducted in a rat model of chronic lung infection, using a 
planned ratio of 1:9 PLPL to PAO1φ-. PLPLφtriple was selected for this experiment, 
as it was the most successful, and is the most similar to the LES parent strain, with 
regards to prophage carriage. An additional experiment was set up with a planned 
initial starting ratio of 1:1, as an “insurance experiment”, as bacterial competition 
experiments in vivo can be unsuccessful if the density of one competitor is very low. 
Instead of fluorescent markers, antibiotic markers were used, for easy separation of 
strains, both from each other, and from the rat microflora. PAO1φ- was labelled with 
a streptomycin resistance marker, and PLPLφtriple with a gentamicin resistance 
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marker. PAO1φ-SmR grew equally well on LA with and without 300 µg ml-1 
streptomycin (2 sample t-test; t = -0.24, P = 0.83) and did not grow on LA plates 
containing 10 µg ml-1, and vice versa for PLPLφtripleGmR (2 sample t-test; t = 1.13, 
P = 0.38). This suggests that there is no major fitness cost incurred by either marker. 
PLPLφtriple was capable of invading a PAO1φ- in vivo, with positive rij values for all 
replicates, across both initial starting ratios (Figure 6.5). In the 1:9 initial starting 
ratio, two clear outliers, with very high rij values, can be observed (Figure 6.5). 
These values were obtained from two rats that had to be sacrificed after 2 days, as 
they were showing symptoms of acute infection (Table 6.3), including weight loss, 
chromodacryorrhea, piloerection, hunched posture and lethargy. Their lungs were 
harvested, the density of each competitor recorded, and the rij calculated. The very 
high rij values can be explained partly by the very high ratio of lysogens to non-
lysogens at the end of the experiment, and also because of the timescale, as rij has 
units of per day. The bacterial load in the lungs was also very high (~100-fold higher 
than other rat lungs after 7 days). Due to acute nature of these infections, these rats 
were excluded from later analyses. Other rats were excluded from later analyses 
because they died after infection (Table 6.3). After exclusion of these outliers, the 
mean rij1 S.E.M. was very similar between the 1:1 (0.240.01, n = 7) and 1:9 
(0.260.02, n = 4) groups.  
The lysogen was significantly fitter than the non-lysogen when at an initial starting 
ratio of 1:1 (1 sample t-test; t6 = 20.3, P < 0.001) and when at an initial staring ratio 
of 1:9 (1 sample t-test; t3 = 15.8, P< 0.01), as evidenced by a mean rij that was 
significantly higher than 0, which is the expected value if there was no difference in 
the fitness of the two competitors. There was no difference in the mean rij between 




Figure 6.5 Selection rate constant value calculated for the outcome of competition in vivo between PAO1φ- 
and PLPLφtriple, when at two different starting ratios of the two competitors. Each data point represents 
the outcome of competition in an individual animal’s lungs after 7 days, or less if the animal had to 

































1:1 E1 1.5E+05 8.1E+05 5.4 1.0 -1 7  0.8 
1:1 E2 2.8E+05 2.0E+06 7.1 1.0 +1 7  0.09 
1:1 E3 1.4E+06 6.7E+06 4.8 1.0 -7 7  0.1 
1:1 E4 3.8E+05 2.5E+06 6.7 1.0 -1 7  0.07 
1:1 E5 1.0E+05 4.0E+05 3.9 1.0 -3 7  0.1 
1:1 E6 N/A N/A N/A 1.0 N/A 2 (died) Yes N/A 
1:1 E7 5.1E+04 2.6E+05 5.2 1.0 +11 7  0.3 
1:1 E8 4.0E+04 1.8E+05 4.5 1.0 -2 7  2 
1:9 I1 
2.6E+08 4.1E+08 1.6 0.16 -14 
2 (euthanised 
early after 




1:9 I2 4.9E+06 4.1E+06 0.8 0.16 0 7  0.1 
1:9 I3 
2.1E+08 6.2E+08 3.0 0.16 -12 
2; euthanised 
early after 











1:9 I5 N/A N/A N/A 0.16 N/A 1 (died) Yes N/A 
1:9 I6 6.9E+05 5.7E+05 0.8 0.16 -2 7  0.8 
1:9 I7 2.5E+07 1.4E+07 0.6 0.16 -10 7  0.9 




6.3.2.2 Lysogenic conversion of PAO1φ- in vivo 
In both competitions, total lysogens dominated at the end of the experiment (Figure 
6.6), but were at a higher frequency in the 1:1 initial starting ratio group, likely due 
to the higher proportion of the PLPLφtripleGmR at the end (Table 6.3). A breakdown 
of the prophage complements of the PAO1φ- SmR competitor is given in (Figure 6.7), 
and the majority maintain their prophage-free status over the 7 day competition. In 
those that became lysogens, LESφ2 and LESφ3 dominated, whereas LESφ4 lysogens 
were rare. 
Levels of free phage detected in the lungs were relatively low, with a mean ±1 S.E.M 
PBR of 0.55±0.32 for the 1:1 and 0.47±0.22 1:9 initial starting ratio groups. There 
was no difference between the 2 groups (log10 +1 transformation; 2-sample t-test; t6 
= -0.11, p = 0.91). 
 
Figure 6.6 Frequency of bacterial lysogens in rat lungs after 7 days competition between PLPLφtriple and 
PAO1φ- at two starting ratios of competitors. Lysogens are defined as bacterial isolates carrying one of 







Figure 6.7 PAO1φ- as a proportion of total bacteria (both competitors) in rat lungs 7 days post-infection. 
Height of bars denote frequency of PAO1φ- and colours denote prophage complement of isolates. Data are 
reported separately for each rat and separated based on initial starting density of PLPLφtriple to PAO1φ- 
(top-panel, 1:1 starting ratio; bottom panel, 1:9 starting ratio). 
 
6.4 Discussion 
6.4.1 Inter-phage differences in PLPL invasiveness 
The P. aeruginosa LES is widespread in individuals with CF (Aaron et al., 2002), 
more competitive than strain PAO1 in an animal model of chronic lung infection 
(Kukavica-Ibrulj et al., 2008b) and capable of superinfection (McCallum et al., 
2001). However, the mechanisms underlying its competitiveness have yet to be 
explored. The LES prophages are known to be critical to the competitiveness of this 
strain (Winstanley et al., 2009), and the purpose of this work was to examine the 
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effect that prophage carriage has on bacterial competitiveness when in competition 
with an isogenic, phage-free (and phage-susceptible) competitor. PLPLs can invade 
PAO1φ- over a 24 hour period in vitro from being initially rare, which gives support 
to the hypothesis that prophages could be used as a bacterial superinfection strategy. 
There were differences depending on the prophage carried, which is interesting, as 
LES isolates are known to differ in their prophage complement (Fothergill et al., 
2012). Carriage of LESφ4 was associated with greater bacterial invasiveness than 
carriage of LESφ2 or LESφ3, but analysis of endpoint mixed populations found that 
for all competitions, the majority of bacteria were lysogens. This indicates that rapid 
lysogenic conversion of PAO1φ- may limit the efficacy of phage as strategy for 
invasion, something that has been discussed previously in the literature (Burns et al., 
2014; Gama et al., 2013). The increased invasiveness of PLPLφ4 could be due to a 
variety of possible reasons, including the likelihood of establishing lysogeny (low 
likelihood of lysogeny would presumably delay the lysogenic conversion of PAO1φ-, 
increasing potential for invasion) or differences in phage pathology; more pathogenic 
bacteriophage are associated with a better competitive outcome (Joo et al., 2006). 
Competition experiments between S. Typhimurium P22 or Gifsy lysogens and non-
lysogens have shown that whilst a similar proportion of lysogens are detected at the 
end for both lysogens, this occurs earlier for P22 lysogens, possibly because of the 
larger burst size of this phage (Bossi et al., 2003). This is not the case for LESφ4; it 
has a smaller burst size and longer latent period than the other two phages (Chapter 
3). The increased competitiveness of PLPLφ4 is somewhat surprising, especially 
given that the STM study of LES B58 found that mutations in LESφ2 and LESφ3, 
but not LESφ4, are associated with reduced competitiveness (Winstanley et al., 
2009). However, the results do agree with a recent study that found that LESφ4 
carriage was associated with increased competitiveness in a G. mellonella model, 
compared to LESφ2 (Burns et al., 2014).  
One of the major limitations of this study is that a distinction was not made between 
increased competitiveness due to prophage-mediated lysis of competitors, or an 
intrinsic fitness benefit conferred by the phage. There are no differences in the 
growth rates of the PLPLs and PAO1 when cultured alone, which suggests that the 
prophages do not confer an intrinsic fitness benefit (in vitro at least). Despite this, it 
would be beneficial to repeat the experiments with a phage resistant competitor; if 
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the invasive ability is because of prophage-mediated lysis, PLPLs should not have a 
fitness benefit when competed against a phage resistant isogen of PAO1φ-.  
6.4.2 Carriage of multiple prophages accelerates PLPL invasion 
In this study, carriage of multiple prophages was associated with faster invasion, as 
the ratio of PLPL to PAO1φ- was significantly higher for PLPLφtriple than any of the 
single phage PLPLs. It is possibile that carriage of multiple phages extends the 
usefulness of this strategy, as establishment of lysogeny results in resistance to phage 
lysis, and resistance to multiple phages should take longer to acquire. The presence 
of multiple phages could also increase the MOI and the likelihood of phage 
coinfection, which could affect how quickly cell lysis occurs. Coinfection of E. coli 
with multiple lytic phages results in a quicker time to lysis than infection by a single 
phage (Brewster et al., 2012). On the other hand, there is evidence that a high MOI 
could actually be maladaptive for bacteria when competing in vivo. Experiments with 
S. Typhimurium P22 lysogens have shown that whilst lysogens are more invasive 
than non-lysogens in chicken macrophage cells, addition of exogenous P22 reduces 
invasion and cell survival, potentially through increased cell lysis and macrophage 
activation (Ahn & Biswas, 2014). Any results obtained in vitro must be interpreted 
cautiously, as there are many differences to the CF lung environment, including the 
immune system.  
Despite the faster invasion time of PLPLφtriple, it was associated with an apparent 
cost early on, with the lowest mean ratio of all the PLPLs at t8. Increased cell lysis 
and possibly slower growth due to the metabolic burden of extra DNA could pose a 
fitness cost, although no difference in the growth rates of the PLPLs alone was 
observed (James et al., personal communication). A temperate bacteriophage has 
been associated with a fitness cost to its bacterial host under specific environmental 
conditions (DeBardeleben et al., 2014), but there is little evidence to suggest that the 
carriage or extra DNA and risk of lysis represents a fitness cost, despite the widely 
held belief. 
6.4.3 Phage invasion 
As well as considering the fitness benefit conferred to bacteria by prophage carriage, 
the evolutionary success of the phage itself was considered. Bacteriophages are 
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ultimately selfish genetic elements, and whilst phage can increase their fitness by 
increasing the fitness of their host, spreading by vertical transmission, they can also 
spread by horizontal transmission. LESφ4 carriage was more beneficial to bacteria 
than LESφ2 or LESφ3, but the phages all did equally well, and the majority of 
bacteria were lysogens after 24 hours. This simply reconfirms that it is a short-lived 
strategy for the bacteria, as phage can quickly lysogenise the competing strain, 
removing any competitive advantage held by the initial lysogen. However, it is worth 
noting that strains used in this study, and indeed other similar studies are isogenic, 
and differ only in the presence of phage, and once phage has transferred to the 
initially phage free competitor, the competitors are equal. However, competing 
bacterial strains in the lungs are likely to differ in other ways, and a transient 
advantage afforded by prophage-mediated lysis could be enough for a strain to rise to 
dominance, using other competitive advantages.  
6.4.4 Factors affecting efficacy of phage-mediated lysis as an invasion strategy 
In addition to the problem posed by rapid lysogenic conversion, there are other 
factors that will reduce the efficacy of phage-mediated allelopathy further, including 
environmental influences that favour lysogeny rather than lysis (Gama et al., 2013). 
The LES phages have a high frequency of lysogeny in an environment that simulates 
the CF lung (Chapter 3), hence phage-mediated allelopathy could be useless in the 
CF lung environment. In addition, chronic CF isolates are known to frequently 
display loss of common phage receptors such as type IV pili (Lee et al., 2005a; 
Mahenthiralingam et al., 1994; Smith et al., 2006b; Workentine et al., 2013), flagella 
(Lee et al., 2005a; Mahenthiralingam et al., 1994; Workentine et al., 2013) and 
lipopolysaccharides (Hancock et al., 1983), rendering bacteria phage resistant and 
this strategy obsolete. It is possible that phage-mediated allelopathy is a strategy 
associated with the early stages of chronic infection. Indeed, once chronic infection 
has established, that particular strain is rarely displaced (Cramer et al., 2012), 
although LES is the exception, in that it is known to displace other P. aeruginosa 
strains, even after years of colonisation (McCallum et al., 2001). 
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6.4.5 PLPL invasion in vivo 
In order to determine whether the benefits of allelopathy extend to in vivo, the PLPL 
invasion experiment was repeated in a rat agar bead model of chronic infection. Over 
a seven day period, PLPLφtriple could successfully invade a population of PAO1φ-, 
even from when initially rare. However, the extent of the invasion was more limited 
than in vitro; PLPLφtriple increased in frequency relative to PAO1φ- in both groups, 
but in the 1:9 initial starting ratio group didn’t increase sufficiently to become the 
dominant strain. However, the two rats (I1 and I3, Table 6.3) which developed an 
acute infection and were necessarily sacrificed provide an interesting avenue for 
further study. After 2 days, PLPLφtriple was the dominating strain, but without 
doing further experiments, it is impossible to tell whether this was due to chance or if 
there is an alternative explanation. As this was not a time course experiment, nothing 
is known of the dynamics of the invasion, and it is possible that PLPLφtriple 
dominates early on and then declines, and was identified in these rats because they 
were sacrificed at an early time point. An alternative explanation is that PLPLφtriple 
was more invasive in these rats and that the competitive interactions between the two 
strains (and resulting bacterial lysis) was actually responsible for the acute nature of 
the infection. Obviously, two rats do not provide enough statistical power to draw 
any conclusions, and further experiments would be necessary, sacrificing rats at an 
earlier time point to determine whether PLPLφtriple dominates early on.  
There are issues with the rat model of infection, and it is a concern that some of the 
rats developed acute infection, or died soon after the infection procedure. The 
infection is not supposed to be acute, but PAO1 is very virulent compared to other P. 
aeruginosa strains in a murine model of acute respiratory infection (Carter et al., 
2010a). Attempts to develop a mouse nasopahryngael carriage model were 
unsuccessful because of this, as mice either developed an acute infection and died, or 
failed to become colonised, despite this model having been used successfully 
previously for a different strain of P. aeruginosa (Fothergill et al., 2014). In addition, 
the rats used are outbred, hence there will be more heterogeneity between them than 
there would be for inbred animals. There were also substantial differences in the age 
and size of the rats, which can not only affect infection outcome, but also the success 
of the infection procedure. 
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After 7 days, PAO1φ-SmR isolates were screened for the presence of prophage. The 
majority had remained non-lysogens, although the mechanism for this was not 
investigated; it could be due to phage-resistance, or it simply lack of contact with 
free phages. Of those that became lysogens, the majority were LESφ2 or LESφ3 
lysogens, similar to the results of the in vivo study in Chapter 4. 
6.4.6 Implications for bacterial virulence and human health 
There is considerable interest in factors that affect the virulence of P. aeruginosa 
when in the CF lung, in the hope that therapies could be developed that target 
bacterial virulence, rather than attempting to control bacterial numbers. Within-host 
competition for resources is predicted to increase virulence, as bacteria try to 
maximise resources. However, spiteful interactions that result in killing of one or 
more of the competitors has the opposite effect, reducing overall bacterial density 
and therefore virulence (Massey & Buckling, 2004). This is also dependent on levels 
of kinship. As described in 6.1.1.1, intermediate levels of kinship result in the highest 
fitness benefit to producing strains (Inglis et al., 2009). In this paper, the authors also 
examined the effect of this on bacterial virulence in an insect model of infection. 
Total bacterial density and virulence was lowest at intermediate levels of kinship, 
presumably because of high cell death of the susceptible strain. 
Spiteful interactions are not always associated with altered virulence. PAO1 lysogens 
are more competitive than non-lysogens in G. mellonella, presumably through 
prophage-mediated lysis, but this has no effect on virulence; time to death of larvae 
was the same for single (one competitor only) as for mixed infections (Burns et al., 
2014), although it is possible that time to death is not a sensitive enough measure to 
detect subtle differences in virulence. Models of infection must be treated with 
caution, as virulence defined and assayed in such models is not necessarily the same 
as virulence in CF, and there may be a completely different set of virulence factors 
involved in being a successful coloniser of individuals with CF. 
The ability of prophages to act as allelopathic weapons raises interesting possibilities 
with regards to phage therapy. A previous study considered the intermicrobial 
interactions between the competitively superior Streptococcus pneumoniae and 
Staphylococcus aureus. S. pneumoniae produces H2O2 at concentrations that are 
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lethal to S. aureus, and the mechanism was found to be via prophage induction and 
cell lysis (Selva et al., 2009). This raises the interesting possibility of killing bacteria 
by prophage induction, but this is really an imperfect strategy, potentially increasing 
horizontal gene transfer of virulence or antibiotic resistance genes. An alternative 
strategy would be to utilise apparent competition when targeting difficult-to-reach 
bacteria with lytic phages. Such a strategy has been used successfully to target the 
virulent Mycobacterium avium, which resides in macrophages. Treatment with lytic 
phage alone has no effect, as the phage is unable to enter the macrophages. To 
overcome this, non-pathogenic M. smegmatis was infected with the lytic phage and 
allowed to infect the macrophages, enabling the phage to access and kill M. avium, 
and also the pathogenic M. tuberculosis (Broxmeyer et al., 2002). 
6.5 Summary 
 Bacteria carrying LES prophages are able to invade a phage-susceptible 
population of PAO1, even when initially rare. 
 LES φ4 carriage is associated with greater bacterial invasiveness than LESφ2 
or LESφ3, but carriage of all three is associated with faster invasion. 
 Under all competitions in vitro, the rate of lysogenic conversion was high, 
and may limit the efficacy of temperate phage release as an allelopathic 
strategy. 
 PLPLφtriple can invade PAO1φ- in vivo, but the competitive outcome depends 
on initial starting ratio of competitors. 
6.6 Declaration  
The in vivo work was done in collaboration with Dr. Irena Kukavica-Ibrulj at the lab 
of Prof. Roger C. Levesque, Laval University.  
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Chapter 7 General discussion 
7.1 Lysogeny of bacterial pathogens 
Prophages are frequently found in bacterial genomes, and are known to carry genes 
that alter the fitness or virulence of their host (Barondess & Beckwith, 1995; Stanley 
et al., 2000) or protect host from lytic phage infection (Heo et al., 2007; McGrath et 
al., 2002). For example, Escherichia coli strain K12 harbours nine cryptic prophages, 
which have been shown to confer various benefits to their host, including enhanced 
biofilm and increased resistance to environmental stressors such as sub-lethal 
concentrations of antibiotics, acid and oxidative stress (Wang et al., 2010b). Certain 
bacteriophages have been identified that alter the antigenicity of their host by 
modifying the O-antigen of LPS (Davies et al., 2013; Verma et al., 1991), which 
could prevent recognition by the host immune system. Prophage-derived elements 
are overrepresented in pathogen genomes (Busby et al., 2013), and there is evidence 
that temperate phages are important in clinical infections, yet they still remain 
relatively understudied. 
The LES is a successful transmissible strain that carries six prophages, some of 
which are necessary for bacterial competitiveness (Winstanley et al., 2009). A recent 
study tracked bacterial and temperate phage dynamics in the lungs of LES-infected 
CF patients and identified high levels of lytic phage activity (James et al., 2014), 
suggesting a role for temperate phages in controlling bacterial densties. This was the 
first study to examine bacteria-phage dynamics in the CF lung, and underlies their 
importance. A study comparing lung viral metagenomes found that the CF virome 
was very similar between individuals. The functional genes carried by the phage 
community differed between CF and non-CF individuals, presumably reflective of 
the differing environments, and CF phages encoded more genes involved in 
anaerobic aromatic catabolism genes (Willner et al., 2009). A similar study found 
that antimicrobial resistance genes were overrepresented in the CF virome (Fancello 
et al., 2011). These results indicate that bacteriophages could also have an important 
role in HGT between bacteria in the CF lung.  
The aim of this investigation was to elucidate how the LES phages contribute to the 
success of the LES, by studying the genetics and ecology of these phages, in addition 
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to investigating their impact on the ecology and evolution of P. aeruginosa. Both in 
vitro and in vivo models were used, in order to replicate the conditions in the CF lung 
as far as possible.  
7.2 Temperate phage genomics 
Prophages can carry genes that increase the fitness of the bacterial strain; hence 
studying phage genomics can be a useful strategy to better understand their 
contribution to bacterial virulence and competitiveness. To this end, the LES phage 
genomes were re-annotated in this study, in order to identify any potential phage-
encoded genes that may increase the fitness of LES, relative to other P. aeruginosa 
strains. Whilst this strategy helped to further understanding of the phage genomes 
themselves, it did not identify genes that may confer a benefit to the bacterial host. 
Phage genomes are often poorly annotated, due to a lack of functional data and poor 
sequence similarity between phages. Bacteriophages have a higher proportion of 
ORFan genes than bacteria (Edwards & Rohwer, 2005; Lima-Mendez et al., 2007), a 
number that is still rising (Yin & Fischer, 2008). Despite assigning a putative 
function to several LES phage predicted proteins, based on sequence similarity, a 
large proportion remain unknown, as do their effects (if any) on the bacterial host. A 
proteomics approach, combining mass spectrophotometry with affinity purification 
was used in a recent study to elucidate protein-protein interaction (PPI) networks in 
P. aeruginosa phages for the first time, enabling the identification of multiple 
polypeptides that are expressed early in the lytic cycle (Van den Bossche et al., 
2014). Such an approach could be used to identify gene products encoded by the LES 
phages and identify interactions with the host cell and may deepen our understanding 
of the effect that the LES phages have on their host. 
7.3 Phage-mediated allelopathy and implications for virulence 
The fact that the LES prophage genes necessary for competitiveness are putatively 
involved in phage lysis (Winstanley et al., 2009) suggests that active phage 
replication in required for full bacterial competitiveness. Phage-encoded bacterial 
fitness factors frequently require the lytic cycle to be expressed or released (Mitchell 
et al., 2007; Tyler et al., 2013), but analysis of the LES phage genomes did not 
identify any obvious virulence factors, and phage-mediated lysis can have other 
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benefits for the bacterial host. Temperate bacteriophages can act as allelopathic 
agents, facilitating invasion of a competitor population by production of infective 
phages that kill phage-susceptible bacteria (Brown et al., 2006; Burns et al., 2014; 
Gama et al., 2013; Joo et al., 2006). In this study, carriage of LES phages φ2-4 
enabled PAO1 to invade an isogenic, phage-free competitor from when initially rare, 
in vivo. This supports the hypothesis that LES may use its bacteriophages as a 
strategy for superinfection, lysing and replacing resident P. aeruginosa strains.   
The extent to which phage-mediated allelopathy occurs in the CF lung, and its 
implications for pathogenicity, remains undetermined. Although this study provides 
evidence that such a strategy can be successful in vivo, there is currently no empirical 
evidence that this occurs in the CF lung. There is indirect evidence that bacteriocin-
mediated allelopathy occurs in the CF lung, as the majority clinical strains of P. 
aeruginosa and the Burkholderia cepacia complex produce bacteriocins that are 
inhibitory to multiple strains of both species (Bakkal et al., 2010). It is known that 
several strains of P. aeruginosa, including LES (McCallum et al., 2001) and the 
prairie epidemic strain (Parkins et al., 2014) can replace other P. aeruginosa strains 
from the lung, so intraspecific competition seems likely.  
7.4 Variable phage densities and effects on bacterial populations 
Given that the LES phages can be used as a mechanism for intraspecific competition, 
it is significant that factors that are common to the CF environment, including H2O2 
and antibiotics, alter LES phage production. In addition, there is evidence that the 
LES phages play a role in controlling bacterial densities in the CF lungs (James et 
al., 2014), so altered levels of prophage-induced lysis could have potential 
implications for the clinical outcome of patients. Similar roles for phages regulating 
bacterial densities have been described in the swine faecal microbiome (Allen et al., 
2011) and environmental microbial communities (Shapiro et al., 2010).  
Changes in the level of phage production by bacterial lysogens may have other 
effects on bacterial populations. Temperate phages are frequently capable of 
transduction, and it is logical that increased phage production would lead to 
increased rates of transduction. This is a concern that has been identified in other 
bacterial genera; temperate phages of Lactobacillus gasseri are capable of 
 201 
 
transduction and produced from their host strain at high levels by spontaneous 
induction (Baugher et al., 2014). There is evidence that transducing phages can 
actually transduce genes likely to be beneficial to their bacterial hosts; in a large-
scale study of 243 phages isolated from chicken meat, a quarter were capable of 
transducing antimicrobial resistance genes into E. coli (Shousha et al., 2015). 
Furthermore, rates of transduction can be altered with antibiotic treatment; treatment 
of mice with antibiotics causes an enrichment of phage-encoded antibiotic resistance 
genes in the gut microbiome, which can be transferred to a naïve microbiome and 
cause an increase in the density of antibiotic resistant bacteria (Modi et al., 2013). In 
summary, choice of antibiotics in CF therapy could have far-reaching implications, 
potentially affecting bacterial densities, altering the outcome of phage-mediated 
bacterial competitive interactions and changing the rate of HGT, all through altered 
phage production. The study by James et al. attempted to investigate the effect that 
antibiotic choice had on phage production, bacterial densities and patient clinical 
status, but unfortunately, the antibiotic treatment history of the study subjects was 
incomplete and so could not be used in the analysis (James et al., 2014).  A 
longitudinal study designed to address this specific issue would be needed to 
determine the importance of choice of antimicrobial therapy in relation to the role of 
temperate phages.  
What effect is altered phage production likely to have on clinical outcome of an 
infection? Some studies have suggested that bacteriophages, or their components, 
can be immunogenic. Lytic E. coli phage T4 head proteins are immunogenic, and 
antibodies to it can be detected in the sera of 80% of individuals (Dąbrowska et al., 
2014). There are no (to my knowledge) studies investigating the effect of “naturally 
occurring” (as opposed to exogenously applied) phages on the normal (or CF) human 
immune response, and this represents an interesting avenue for future research.  It is 
not simply phages that may elicit an immune response; mass phage-induced lysis can 
also be immunogenic, as the large quantities of endotoxin released from gram 
negative bacteria after phage treatment can elicit a severe (potentially fatal) immune 
response (Merril et al., 1996). 
Lessons can be learnt from temperate phages that can potentially be applied to 
further our understanding of lytic phages, which are increasingly being explored as 
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an alternative treatment to antibiotics. Certain antibiotics are likely to have similar 
effects on both temperate and exclusively lytic phages. For example, the antibiotic 
azithromycin reduces phage production in the LES (Fothergill et al., 2011) and Stx 
toxin production in E. coli (McGannon et al., 2010). This is presumably due to its 
mechanism of action (inhibiting protein synthesis), and it is likely to have the same 
effect on the lytic cycle of exclusively lytic phages. 
7.5 Phages and bacterial adaptation 
One of the interesting findings from this study is that LESφ4 can alter the trajectory 
of evolution by disruptive integration into protein coding genes. Loss of twitching 
motility occurred in both control and phage-treated populations, but it occurred faster 
in the phage treatment and by an alternative mechanism. Whilst phage-mediated 
gene disruption has been described before (Lee & Iandolo, 1986; Rehmat & Shapiro, 
1983), it has not really been considered as a mechanism for bacterial adaptation, and 
the parallel evolution of loss of twitching motility does suggest it is adaptive. 
Theoretically, if the selective pressures were different, the genomic location of 
LESφ4 would be different. This finding raises interesting questions about LESφ4 in 
its native host background, LESB58. In the sequenced LESB58 isolate, LESφ4 is 
located between two genes encoding hypothetical proteins (Winstanley et al., 2009) 
and is very rarely found in other locations (Haldenby et al., unpublished), which 
suggests that LESφ4 does not play the same role in the evolution and adaptation of 
this strain.  
In this study, there were discrepancies in the fitness of the LES phages in different 
environments. LESφ4 has higher fitness in ASM, and this could be for a variety of 
reasons, for example, increased infection efficiency of bacteria growing as a biofilm. 
Previous comparisons of lytic phage growth in ASM and liquid broth have 
highlighted differences in phage ability to infect biofilms (Garbe et al., 2010) and 
shown that alginate limits the efficiency of phage infection.  
The differences observed between the two models raise doubts about the conclusion 
of the LES genome paper that LESφ2 and LESφ3 are essential for bacterial 
competitiveness, and LESφ4 is not (Winstanley et al., 2009), as such a conclusion is 
limited only to this infection model. Examining the prophage complement of LES CF 
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isolates can give more information, as prophages that increase host fitness are 
theoretically more likely to be retained. LESφ4 is always retained, but LESφ2 is 
frequently missing (Jeukens et al., 2014), or degraded (Williams et al., unpublished), 
as is LESφ3. This is supportive of the notion that LESφ4 confers a greater fitness 
benefit to its host. P. aeruginosa transposable phages are incredibly common, 
isolated as virions or detected as prophages in bacterial genomes (Cazares et al., 
2014). They have a large accessory genome, encoding genes that are putatively 
important for host fitness, and so their potential for affecting bacterial evolution is 
great. 
7.6 Limitations of study 
The majority of the experiments in this study were performed using LES phages in a 
PAO1 host background, rather than in the native host, LESB58. Such a strategy was 
adopted for multiple reasons. Firstly, LESB58 is difficult to manipulate genetically, 
and previous attempts to delete the prophage regions had failed (Fothergill et al., 
personal communication). Secondly, PAO1 is a well characterised reference strain 
that was susceptible to three of the LES phages. In addition, PAO1 does not have any 
other endogenous prophages, other than a defective pyocin-encoding phage and Pf1-
like filamentous phage (Stover et al., 2000), similar to LESφ1 and LESφ6, 
respectively. However, there are obvious disadvantages to using PAO1 as a model 
strain, primarily that in a different host background, the LES phages may exert 
different effects. Also, PAO1 was not susceptible to LESφ5, so this was not 
considered in any experiments. This is not a huge issue though, as LES isolates have 
frequently lost LESφ5 (Jeukens et al., 2014).  Using PAO1 allowed construction of 
isogenic lysogenic and non-lysogenic strains, and means that the effect of phages in a 
naïve bacterial host can be considered, which is especially important for the invasion 
assays, for example, in which the assumption was that the competitor would be naïve 
to these phages. 
7.7 Experimental evolution as a tool to understand drivers of evolution 
In order to understand the evolution of P. aeruginosa in the CF lung, many 
researchers study sequential isolates from individuals that are chronically infected 
with P. aeruginosa, looking for correlations and patterns in the data in order to 
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identify factors that might influence the evolutionary outcome. However, to elucidate 
the drivers of P. aeruginosa diversification, an experimental approach is superior, as 
it enables the study of evolution in the presence or absence of certain factors, under 
controlled conditions. Experimental evolution was used in this study to determine the 
effect that LES phage have on P. aeruginosa diversification, as lytic phages are 
known to drive bacterial phenotypic diversity, largely through selection for resistant 
variants (Brockhurst et al., 2005; Buckling & Rainey, 2002b; Mizoguchi et al., 
2003). Whole populations can be stored periodically through time and serve as a 
frozen “fossil record”, which can be resurrected to test hypotheses. For example, 
temporal changes in the prevalence of the twitching motility phenotype, and the rise 
in frequency of LESφ4 integrated at two specific loci were both determined 
retrospectively, based on analysis of endpoint populations. Crucially, the ancestor of 
these populations is known (unlike in vivo studies), so any phenotypic or genetic 
changes are known to be a divergence from the ancestor, and competition 
experiments can be performed between evolved populations and the ancestor to 
determine if such changes are actually adaptive.  
Whilst one of the major advantages of experimental evolution is that evolution can 
be studied in a reductive manner, this is also one of its major criticisms. In the 
absence of the myriad of factors that influence evolution (a potential network of 
interactions), then the validity of any conclusions drawn is questionable. The P. 
fluorescens- φ2 model system has been widely used to study evolutionary processes 
in chemostats containing laboratory media. A recent study compared host-phage 
coevolutionary dynamics in a more natural environment (soil), and found that 
fluctuating selection dynamics was the norm, compared with arms race dynamics in 
vitro (Gómez & Buckling, 2011). Another issue with using the closed microcosms in 
this study is that populations are completely isolated from each other. In reality, 
processes such as dispersal, causing gene flow between populations, are important 
evolutionary drivers in microbial populations (Kerr et al., 2002; Venail et al., 2008), 
although we do not know whether they are in P. aeruginosa populations in CF lungs. 
The spatial structure of the CF lung may limit gene flow and migration more than in 
other environments, but there is little empirical data on the spatial location of P. 
aeruginosa populations in the CF lung and the gene flow between them, although 
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recent evidence suggests the separate lineages can coexist for long periods (Williams 
et al., 2015). 
7.8 Polymicrobial interactions and polylysogeny 
One of the key features of CF lung infections is that they are polymicrobial (Zhao et 
al., 2012). In this study, all experimental approaches only considered P. aeruginosa 
in isolation. Even in a rat model of chronic lung infection, the lungs are essentially 
sterile prior to infection. Although P. aeruginosa is frequently the dominant species 
in the CF lung, it will be subject to numerous polymicrobial interactions, all of which 
may affect P. aeruginosa survival and evolution. Species interactions can affect 
social behaviours, altering levels of cooperation (Mitri et al., 2011). For example, 
when P. aeruginosa is grown in the presence of another CF pathogen, 
Staphylococcus aureus, in an iron-limited environment, siderophore production is 
upregulated, and with that is an increased abundance of social cheats (Harrison et al., 
2008). If other species are capable of altering the outcome of intraspecific 
competition, then it is likely that they may also have an effect on the trajectory of 
evolution and the outcome of competitive interactions such as phage-mediated 
allelopathy. Moreover, the close relatedness of many bacterial species means that the 
potential for apparent competition is high. Indeed, cross infectivity between phages 
has been observed, and several temperate phages isolated from the Burkholderia 
cepacia complex are also able to infect P. aeruginosa (Langley et al., 2003). 
In addition to interspecific competition between bacteria in the CF lung, there will be 
a degree of within-host competition between bacteriophages. The P. aeruginosa 
evolution experiment in ASM in the presence or absence of phages was unique not 
only in that it utilised temperate phages (as most host-parasite coevolution 
experiments have been performed with lytic phages), but also in that multiple phages 
were used, both alone and in combination. In this study, the presence of additional 
phages altered the outcome of several experiments, and the impact of multiple 
prophages is something that should be considered more widely, particularly given 
that polylysogeny is frequently observed in bacterial pathogens (Figueroa‐Bossi et 
al., 2001; Matos et al., 2013; Winstanley et al., 2009). 
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The presence of an additional prophage reduces the baseline productivity of 
prophage, where the baseline productivity is the number of phages produced upon 
induction when the only  prophage in a cell (Refardt, 2011). A similar phenonenom 
is observed in PLPLs, as phage productivity of PLPLφtriple is very similar to single 
phage PLPLs (James et al., 2012), meaning that the production of each individual 
phage is clearly reduced. Moreover, the added productivity of two phages in a double 
lysogen does not equal one, suggesting some form of interference competition 
between them (Refardt, 2011). A study with double E. coli lysogens, carrying two 
Stx2 phages found that Shiga toxin production was actually reduced in the double 
lysogen compared to the single lysogen, as was phage production (Serra-Moreno et 
al., 2008), suggesting that polylysogeny can have a stabilising effect, reducing the 
rate of spontaneous lysis. Interestingly, LES has a much reduced rate of phage 
production compared to PLPLφtriple (James et al., 2012). It is a possible that the 
presence of additional prophages in the LES genome has a stabilising effect, or 
alternatively, that a more stable relationship has evolved over time in the LES host 
background. Clearly, a stabilisation effect could then have implications for the 
efficacy of phage-mediated allelopathy.  
Polylysogeny could potentially affect the efficacy of phage therapy; the presence of 
prophages could inhibit lytic phage infection (through superinfection exclusion, 
phage-driven loss of receptors or within-host phage-phage interactions) and may 
reduce the therapeutic potential of phage therapy, something which is often proposed 
as an alternative to antibiotic treatment for P. aeruginosa lung infections.  
Polylysogeny is a neglected phenomenom, but as more and more bacterial genomes 
are sequenced, and better software to detect phages is produced, we are realising that 
polylysogeny is incredibly common. In this study, and in a previous study (Burns et 
al., 2014), polylysogeny has been shown to increase bacterial competitiveness. 
Recent evidence suggests that prophages undergo rapid degradation in the bacterial 
genome to become lysis-defective, but then are maintained by purifying selection, 
which is strongly suggestive that prophage genes contribute to bacteria fitness 





Temperate phages of an epidemic strain of P. aeruginosa increase host fitness by 
acting as allelopathic agents, and can alter the trajectory of evolution by disruptive 
integration into protein coding genes. The LES phages are detected at high densities 
in CF sputum and they have been implicated in controlling bacterial densities. Many 
aspects of the CF lung environment alter levels of phage production, but it is still 
unclear what the clinical implications of this are.  With the renewed interest in phage 
therapy to control bacterial infections, a clear understanding of prophages and how 





A. Bacterial growth media preparation 
All growth media were prepared with double-distilled water and sterilised by 
autoclaving at 121˚C for 15 minutes. 
Lysogeny broth (LB) contains (litre-1): 
Tryptone 15 g (Oxoid) 
Sodium chloride 10 g (Sigma) 
Yeast extract 5 g (Oxoid) 
For plates, 15 g bacteriological agar (Oxoid) was added prior to autoclaving. 
Artificial sputum medium 
To make 1 litre the following components (Sigma) are required: 
Mucin (whole porcine) 5 g 
DNA (herring sperm) 4 g 
Diethylenetriaminepentaacetic acid (DTPA) 5.9 mg 
NaCl 5 g 
KCl 2.2 g 
Egg yolk emulsion 5 ml 




Cysteine and tyrosine were dissolved in 25 ml water and 0.5 M KOH, respectively. 
The remaining 18 amino acids were dissolved in 100 ml SDW. DTPA, NaCl and 
KCl were added, and SDW added to a final volume of 250 ml. When fully dissolved, 
the solutions of cysteine and tyrosine were added. 
DNA and mucin were each dissolved separately into 250 ml SDW. This was done 
slowly, at room temperature, over an 8 hour period with constant stirring. The 
solutions were stirred overnight at 4˚C to ensure complete dissolution. 
The DNA, mucin, aminoacid/ salt solution and egg yolk emulsion were combined 
and SDW added to a volume of 850 ml. 
The pH was adjusted to 6.9 by titration with a sterile 0.5 M Tris solution. Water was 
added to a final volume of 1 L. 
The ASM was sterilised by vacuum-assisted filtration through a 0.2 µm filter 
(Millipore). Filters were rinsed with SDW a maximum of 3 times before discarding. 
One filter was used to sterilise ~250 ml ASM. The ASM was stored at 4˚C. 
Pseudomonas isolation agar 
Pseudomonas isolation agar base (Oxoid) was dissolved in 500 ml ddH2O and 
autoclaved. The media was cooled to 50˚C and a vial of C-N supplement (Oxoid) 
added, prior to pouring. 
M9 Minimal media 
56.4 g M9 minimal salts (Sigma) were dissolved in 1 L SDW and autoclaved to give 
a 5X stock. 200 ml 5X stock was added to 780 ml ddH20 and autoclaved. The media 
was allowed to cool and supplemented with 2 ml 1 M MgSO4, 0.1 ml 1 M CaCl2 and 
20 ml 20% (w/v) glucose solution (all filter sterilised). For solid media, 15 g of 
bacteriological agar was added prior to autoclaving. For M9Ca-Glu broth 
(fluorescence studies), the agar was omitted and the media supplemented with 100 
ml 20% (w/v) glucose solution and 100 ml 10% (w/v) casein hydrolysate (Sigma) 




Swarming medium contains (L-1): 
NH4Cl 1.07 g 
Na2HPO41.70 g 
KH2PO4 3.0 g 
NaCl 0.5 g 
Dextrose 1.98 g 
Casein hydrolysate 5 g 
Bacteriological agar 5 g (all Sigma) 
980 ml ddH2O was added and the mixture autoclaved. After autoclaving, the media 
was cooled to 50 ˚C, supplemented with 10 ml 0.1 M MgSO4 and 10 ml 0.1 M CaCl2 
and poured immediately. The plates were dried for 30 minutes in a laminar flow 
hood and used immediately. Consistent drying of plates is necessary as bacterial 
swarming is highly affected by surface moisture levels. 
Swimming media contains (L-1): 
Tryptone 10 g 
NaCl 5 g 
Bacteriological agar 3 g 







Preparation of 5X TBE (for agarose gel electrophoresis) 
54 g Tris base (Fisher) and 27.5 g boric acid (Fisher) were dissolved in 980 ml 
ddH2O and autoclaved. 20 ml sterile 0.5 M Ethylenediaminetetraacetic acid (EDTA) 
at pH 8.0 was added aseptically. The stock was stored at room and diluted 10-fold in 
ddH2O to obtain the required working concentration of 0.5X for agarose gel 
electrophoresis. 
4X PEG/ NaCl (for phage precipitation) 
25 g polyethylene glycol (PEG) 8000 and 5.8 g NaCl were dissolved in 50 ml water 
by stirring for approximately 30 minutes. The mixture was autoclaved and stirred 
continuously during cooling to prevent phase separation. When diluted to the 
required 1X working concentration, PEG is at a concentration of 10% (w/v) and 
NaCl at a concentration of 0.5M.
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C. Reannotation of published LES phage genomes 
Table C.i Reannotation of the LES ф2 genome. Original annotation as detailed on the Pseudomonas database is given. For ORFs encoding hypothetical proteins, a PSI-BLAST 
search was conducted using default parameters, and the highest scoring significant hit to a protein with a known function is reported. Alignments were inspected manually and 
putative function of protein updated where confident.  
Gene 
number 
Locus ID Gene 
name 
Previous annotation Sub-cellular 
localisation 
Highest significant match to 
protein with annotated 
function 
Putative function Expect 
(E) value 






1 PLES_07891   Integrase Cytoplasmic  Integrase     
2 PLES_07901   hypothetical protein Cytoplasmic None Unknown    
 
3 
PLES_07911   hypothetical protein Cytoplasmic None Unknown 
   
 
4 PLES_07921   hypothetical protein Unknown None Unknown    
 
5 
PLES_07931   unknown Cytoplasmic None  Unknown 
   
 
6 
PLES_07941   
conserved hypothetical 
protein 
Unknown None Unknown 
   
 
7 






family    
 
8 
PLES_07961   transcriptional regulator Unknown  
Transcriptional 
regulator, LuxR 
family    
 
9 PLES_07971 endY EndY Unknown  EndY    
 
10 
PLES_07981   hypothetical protein Cytoplasmic None Unknown 
   
 
11 PLES_07991   hypothetical protein Unknown None Unknown    
 
12 


















3.00E-114 343 100 59 
14 
PLES_08021   DNA replication protein DnaC Cytoplasmic  
DNA replication 
protein DnaC     
15 
PLES_08031   
Putative DnaB-like replicative 
helicase 
Cytoplasmic   
Putative DnaB-like 
replicative helicase     
16 






phosphatase     
17 PLES_08051   hypothetical protein Unknown None Unknown     
18 
PLES_08061   hypothetical protein Cytoplasmic 
WP_019486505.1; 




6.00E-50 164 100 100 
19 
PLES_08071   DNA-binding protein Unknown  
DNA-binding 
protein     
20 PLES_08081   Holin, phage lambda Unknown   Holin     
21 
PLES_08091   




protein)     
22 
PLES_08101   Putative lysis protein Rz Unknown  Rz lysis protein 
    
23 PLES_08111   hypothetical protein Unknown Conserved hypothetical protein Unknown     
24 
PLES_08121   
Putative small subunit (Nu1 
homolog) of DNA packaging 
dimer 
Cytoplasmic   
Small subunit (Nu1 
homolog) of DNA 
packaging dimer     
25 
PLES_08131   
Putative large subunit (GpA 
homolog) of DNA packaging 
dimer 
Cytoplasmic   
Large subunit (GpA 
homolog) of DNA 
packaging dimer     
26 
PLES_08141   Putative portal protein Cytoplasmic   Portal protein 
    
27 
PLES_08151   
chaperone with DnaK; heat 
shock protein 
Unknown   
Chaperone with 





PLES_08161   hypothetical protein Unknown 
WP_014232304.1; 




2.00E-09 60.1 71 44 
29 
PLES_08171   hypothetical protein Cytoplasmic 
YP_006561142.1; Minor tail 
protein (Burkholderia phage 
AH2) 




iterations) 53.5 59 24 
30 PLES_08181   hypothetical protein Unknown None Unknown     
31 
PLES_08191   hypothetical protein Unknown 
CCD58454.1; Structural protein 





iterations) 137 98 16 
32 
PLES_08201   hypothetical protein Unknown 
AHK93583.1; Pre-pilin like 
leader sequence (Pseudomonas 
aeruginosa LES400) 
Unknown 
6.00E-51 171 39 100 
33 
PLES_08211   
Putative tail length tape 
measure protein 
Unknown  
Tail length tape 
measure protein     
34 PLES_08221   hypothetical protein Unknown None Unknown     
35 
PLES_08231   hypothetical protein Unknown 
KDF04243.1; Phage tail fibre 
protein (Raoultella planticola 
ATCC 33531) 




iterations) 114 83 37 
36 PLES_08241   hypothetical protein Unknown None  Unknown     
37 PLES_08251   hypothetical protein Unknown None Unknown     
38 




    
39 
PLES_08271   hypothetical protein Unknown 
YP_009030620.1; Structural 




4.00E-17 84.7 96 34 
40 PLES_08281   hypothetical protein Unknown None Unknown     
41 PLES_08291   hypothetical protein Unknown None Unknown     
42 
PLES_08301   hypothetical protein Cytoplasmic 
YP_009030615.1; Structural 
protein (Pseudomonas phage 
KPP25) 
Structural protein 
2.00E-48 160 97 80 
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43 PLES_08311   hypothetical protein Unknown None Unknown     
44 PLES_08321   hypothetical protein Cytoplasmic None Unknown     
 
Table C.ii. Reannotation of the LES ф3 genome. Original annotation as detailed on the Pseudomonas database is given. For ORFs encoding hypothetical proteins, a PSI-
BLAST search was conducted using default parameters, and the highest scoring significant hit to a protein with a known function is reported. Alignments were inspected 
manually and putative function of protein updated where confident. 
Gene 
number 






Highest significant match to 
protein with annotated 
function 
Putative function Expect 
(E) value 











Unknown  Arsenate reductase 
    
2 
PLES_13211   
phage integrase, 
putative 
Cytoplasmic  Integrase 
    
3 
PLES_13221   
excisionase, 
putative 
Unknown  Excisionase 
    
4 
PLES_13231   
hypothetical 
protein 
Unknown None Unknown 
    
5 
PLES_13241   
hypothetical 
protein 
Cytoplasmic None Unknown 
    
6 
PLES_13251   
hypothetical 
protein 
Unknown None Unknown 
    
7 
PLES_13261   
hypothetical 
protein 
Unknown None Unknown 
    
8 
PLES_13271   
hypothetical 
protein 
Cytoplasmic None Unknown 
    
9 
PLES_13281   
hypothetical 
protein 
Unknown None Unknown 




PLES_13291   
hypothetical 
protein 
Unknown None Unknown 
    
11 
PLES_13301   
hypothetical 
protein 
Cytoplasmic None Unknown 
    
12 





methyltransferase     
13 
PLES_13321   
hypothetical 
protein 
Unknown None Unknown 
    
14 
PLES_13322   
hypothetical 
protein 
Unknown None  Unknown 
    
15 




Cytoplasmic  Unknown 
    
16 









9.00E-62 210 84 45 
17 
PLES_13351   
hypothetical 
protein 
Cytoplasmic None Unknown 
    
18 
PLES_13361   
protein of unknown 
function DUF1654 
Unknown  Unknown 
    
19 
PLES_13371   
hypothetical 
protein 
Unknown None  Unknown 
    
20 





Transcriptional regulator PrtR 
(Pseudomonas aeruginosa) 
Transcriptional 
regulator; LexA like 
2.00E-180 508 99 99 
21 





binding protein (Pseudomonas 
aeruginosa) 
DNA-binding protein 
4.00E-169 478 100 100 
22 





protein (Pseudomonas putida) 
Putative replication 
protein 
1.00E-58 200 100 42 
23 PLES_13411   unknown Unknown None Unknown     
24 
PLES_13421   ninG protein Cytoplasmic   ninG protein 















3.00E-12 68.6 94 33 
26 










regulator 1.00E-96 286 99 99 
27 









2.00E-34 121 98 100 
28 







6.00E-86 258 100 100 
29 





putative chitinase     
30 
PLES_13481   
hypothetical 
protein 
Unknown None Unknown 
    
31 
PLES_13491   
hypothetical 
protein 
Unknown None  Unknown 
    
32 
PLES_13501   
Putative small 
subunit (Nu1 





    
33 
PLES_13511   
Putative large 
subunit (GpA 




subunit of DNA 
packaging dimer 
    
34 









0 1168 100 100 
35 





(ClpP)     
36 










iterations) 81.9 90 33 
37 
PLES_13551   
hypothetical 
protein 
Cytoplasmic  None  Unknown 








CCD58454.1; Structural protein 





iterations) 197 98 15 
39 




AHK93583.1; Pre-pilin like 
leader sequence (Pseudomonas 
aeruginosa LES400) 
Unknown 
6.00E-51 171 39 100 
40 
PLES_13581   






    
41 
PLES_13591   
hypothetical 
protein 
Unknown None Unknown 
    
42 
PLES_13601   
hypothetical 
protein 
Unknown None Unknown 
    
43 




KFD04243.1; Phage tail fibre 





iterations) 116 85 36 
44 
PLES_13621   
hypothetical 
protein 
Unknown None Unknown 
    
45 
PLES_13631   
hypothetical 
protein 
Unknown None Unknown 
    
46 




KCW18267.1; Bacterial Ig-like 






iterations) 208 74 16 
47 









2.00E-20 94.4 94 35 
48 
PLES_13661   
hypothetical 
protein 
Unknown None Unknown 
    
49 




WP_003150136.1; Tail fiber 
protein (Pseudomonas 
aeruginosa) 
Putative tail fibre 
protein 
5.00E-117 353 78 68 
50 









8.00E-42 143 100 58 
51 PLES_13691   hypothetical Unknown WP_001175088.1; Phage tail Unknown 7.00E-16 77.7 97 21 
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protein protein (Vibrio cholerae)  (4 
iterations) 
52 
PLES_13701   
hypothetical 
protein 
Unknown None Unknown 
    
53 
PLES_13711   
hypothetical 
protein 
Unknown None Unknown 
    
 
Table C.iii Reannotation of the LES ф4 genome. Original annotation as detailed on the Pseudomonas database is given. For ORFs encoding hypothetical proteins, a PSI-
BLAST search was conducted using default parameters, and the highest scoring significant hit to a protein with a known function is reported. Alignments were inspected 
manually and putative function of protein updated where confident. Putative function was assigned based on BLASTP searches of published anti-CRISPR gene protein 
sequences. a - reported in the form Genbank accession number; Protein name (Organism). b - no matches to proteins with an annotated function in the NCBI database.  
Gene 
number 






Highest significant match to 
protein with annotated 
function 
Putative function Expect 
(E) value 






1 PLES_15491  Putative c repressor Unknown  c repressor     
2 PLES_15501 orf2 Ner-like protein Unknown  Ner-like protein 
(transcriptional 
regulator) 
    
3 PLES_15511    hypothetical 
protein 
Cytoplasmic None Unknown     
4 PLES_15521   hypothetical 
protein 
Unknown None  Unknown     
5 PLES_15531 orf6 transposase A Cytoplasmic  Transposase A and 
DNA binding protein 
(dual function) 
    
6 PLES_15541 orf7 DNA transposition 
protein 
Cytoplasmic   DNA transposition 
protein 
    
7 PLES_15551 orf8 hypothetical 
protein 
Cytoplasmic YP_004934660.1; TroR domain 
transcriptional regulator 
(Rhodobacter phage RcapMu) 
Unknown 4.00E-09 61.1 78 24 
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8 PLES_15561   hypothetical 
protein 





6.00E-16 78.6 71 38 
9 PLES_15571   hypothetical 
protein 
Unknown None  Unknown     




Cytoplasmic  Host-nuclease 
inhibitor protein 
Gam 
    
11 PLES_15591   hypothetical 
protein 
Unknown YP_002332437.1; Host 
nuclease inhibitor protein 
(Pseudomonas phage MP29) 
Unknown 1.00E-75 237  99 95 
12 PLES_15601   hypothetical 
protein 
Unknown YP_950438; Host nuclease 
inhibitor protein (Pseudomonas 
extremaustralis) 
Unknown 2.00E-06 51.2  98 40 
13 PLES_15611   Hypothetical 
protein 
Unknown None Unknown     
14 PLES_15621   Hypothetical 
protein 
Unknown None Unknown     
15 PLES_15631   hypothetical 
protein 
Cytoplasmic None Unknown     
16 PLES_15641   putative integral 
membrane protein 
Unknown gi|371779623; Putative Mor 
protein (Pseudomonas phage 
LPB1) 
Integral membrane 
and Mor protein 
(dual function) 
4.00E-80 231 100 98 





acetyl transferase YedL 
(Bordetella bronchiseptica 
OSU054) 
Membrane protein     
18 PLES_15661 orf21 putative structural 
protein 
Unknown  Structural protein     
19 PLES_15671 orf21a hypothetical 
protein 
Unknown None Unknown     
20 PLES_15681 orf22 hypothetical 
protein 
Unknown gi|371779627; Rz protein 
(Pseudomonas phage LPB1) 
Rz protein 8E-85 255 100 94 
21 PLES_15691 orf23 hypothetical Unknown gi|492020221; Phage Unknown 8e -13 (4 68.4 93 19 
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protein transposase (Pasteurella 
multocida) 
iterations) 
22 PLES_15701   conserved 
hypothetical DNA-
binding protein 
Cytoplasmic  DNA-binding 
protein 
    
23 PLES_15711   hypothetical 
protein 
Cytoplasmic None Unknown     
24 PLES_15721   phage 
uncharacterized 
protein 
Cytoplasmic None Unknown     
25 PLES_15731   portal protein (DNA 
packing) 
Unknown  Portal protein     
26 PLES_15741   virion 
morphogenesis 
protein 
Unknown  Virion 
morphogenesis 
protein 
    
27 PLES_15751   hypothetical 
protein 
Cytoplasmic None Anti-CRISPR 
proteinb ACR3112-
31 
8.00E-25 96.7 98 94 
28 PLES_15761 orf29b hypothetical 
protein 
Unknown None Anti-CRISPR 
proteinb (similar to 
gp33 and gp35) 
8.00E-84 253 98 88 
29 PLES_15771   hypothetical 
protein 
Unknown None Anti-CRISPR 
proteinb gp36 
2.00E-16 76.6 64 92 
30 PLES_15781   hypothetical 
protein 
Unknown None Unknown      
31 PLES_15791   protease (I) and 
scaffold (Z) proteins 
Unknown  Protease (I) and 
Scaffold (Z) proteins 
    
32 PLES_15801   hypothetical 
protein 
Unknown None Unknown     
33 PLES_15811   putative major 
head subunit 
protein 
Unknown  Major head subunit 
protein 
    
34 PLES_15821   hypothetical 
protein 
Unknown None Unknown     
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35 PLES_15831   hypothetical 
protein 
Cytoplasmic None Unknown     
36 PLES_15841   hypothetical 
protein 
Unknown None Unknown     
37 PLES_15851   hypothetical 
protein 
Unknown CCD58454.1; Phage structural 
protein (Pseudomonas phage 
LPB1) 
Structural protein 1.00E-174 493 100 96 
38 PLES_15861   hypothetical 
protein 
Cytoplasmic None Unknown     





tape measure protein 
(Pseudomonas phage JD024) 
Tail-length tape 
measure protein 
0 2248 100 99 
40 PLES_15881 orf46e hypothetical 
protein 
Unknown YP_006560542.1; Structural 
protein (Pseudomonas phage 
LPB1) 
Structural protein 2.00E-94 294 100 96 
41 PLES_15891 orf48 hypothetical 
protein 
Unknown YP_001595894.1; Structural 
protein (Pseudomonas phage 
YuA) 
Structural protein 7.00E-14 79.7 73 28 
42 PLES_15901 orf49 hypothetical 
protein 
Unknown CCD58460; Structural protein 
(Pseudomonas phage LPB1) 
Structural protein 0.00E+00 1075 99 96 
43 PLES_15911   hypothetical 
protein 
Unknown gi|491717003; Phage-tail 
protein (Aggregatibacter 
actinomycetemcomitans) 
Tail protein 3.00E-41 153 99 34 
44 PLES_15921   hypothetical 
protein 
Unknown gi|34610153; Tail assembly 




9.00E-18 80.5 91 49 
45 PLES_15931   hypothetical 
protein 
Unknown gi|371779657; Tail protein 
(Pseudomonas phage LPB1) 
Tail protein 0.00E+00 1441 100 97 
46 PLES_15941   hypothetical 
protein 
Unknown gi|371779658; Structural 
protein (Pseudomonas phage 
LPB1) 
Structural protein 0.00E+00 725 100 90 
47 PLES_15951   hypothetical 
protein 
Cytoplasmic None Unknown     
48 PLES_15961   hypothetical 
protein 
Cytoplasmic None  Unknown     
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D. LESφ4 integration sites in PAO1 
Table D.i LESφ4 integration site frequencies in PAO1 populations cultured for 120 days in ASM in the presence of LESφ2-4. 
Gene 
function 
Gene name Frequency of isolates with LES φ4 prophage integrated into gene 
Population and integration site location (nt) in PAO1 
7 8 9 10 11 12 
Motility fimU 0.92 5098546 
 
0.00  0.00  0.00  0.00  0.00  
fimU/T (intergenic) 0.00  0.00  0.00  0.00  0.00  0.49 5098163 
pilV 0.00  0.00  0.00  0.35 5098936 0.90 5099014 0.46 5098868 
pilW 0.00  0.38 5100022 0.00  0.00  0.00  0.00  
pilY1 0.00  0.10 5100846 0.00  0.00  0.00  0.05 5101059 
Quorum 
sensing  
lasR 0.00  0.00  0.00  0.32 1558410 0.00  0.00  
mvfR 0.08 1086791 
 
0.00  0.00  0.17 1086270 0.00  0.00  
pqsA 0.00  0.45 1079138 
 
0.08 1079047 0.00  0.05 1078619 0.00  




0.00  0.00  0.00  0.00  0.04 902610 0.00  
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